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Abstract 
Two important biophysical characteristics of proteins, their interaction with 
ligands and their post-translational modifications, modulate various biological processes 
including signal transduction, chemical synthesis, and cell function. Protein-ligand 
interactions include the interactions with protein, peptide, DNA, and metal. 
Characterization of the physical properties of these interactions (binding interfaces, 
binding affinities, and the protein conformational changes due to the binding) is essential 
in understanding the mechanism of related diseases and, more importantly, in future drug 
design. 
Mass spectrometry, with its own revolution and improvement, becomes a 
powerful tool in protein and peptide analysis. In this thesis, we applied two mass 
spectrometry-based strategies, proteomics and protein footprinting, to characterize these 
biophysical properties of three disease-related proteins, connexin 43 (Cx43), troponin, 
and apolipoprotein E (ApoE), and Fenna-Matthews-Olson protein (FMO), which is the 
key factor in energy transfer of the photosynthetic system of green sulfur bacteria.    
By the combination of standard proteomics workflow and two fragmentation 
methods, collision-induced dissociation (CID) and electron transfer dissociation (ETD), 
we successfully identified 15 serine residues, including one novel site, in the Cx43-CT 
iii 
 
that are phosphorylated by CaMKII, the activity of which may be important in regulating 
Cx43 in normal and diseased hearts. 
We further utilized hydrogen/deuterium exchange (H/DX), one mass 
spectrometry-based protein footprinting strategy, to examine the binding affinities of 
troponin C (TnC), a cardiac disease-related protein, with its four metal binding ligands 
(Ca
2+
), and their binding order. We then expanded this approach to elucidate the 
dynamics of TnC within the complex and its interactions with other subunits (TnT and 
TnI) at peptide-level resolution. This same approach was also applied to two protein-
ligand complexes: (1) the interaction of FMO and its binding partner, CsmA baseplate 
protein, in which the orientation of FMO between chlorosome and membrane can be 
confirmed, and (2) the interaction of ApoE and Aβ40, which are both key factors in 
Alzheimer’s disease. Moreover, we improved the spatial resolution of H/DX to residue-
level by conducting ETD fragmentation in the study of ApoE oligomerization. Our 
results reveal, for the first time, the amino acid residues involved in its self-
oligomerization.  
These six applications of mass spectrometry-based approaches show their 
potential in the characterization of different protein biophysical properties. The 
investigation of a more complex protein system can then be pursued.    
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Chapter 1 
Introduction: 
Protein-ligand Interaction, Protein Post-translational Modification, 
Hydrogen/Deuterium Exchange, and Mass Spectrometry  
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1.1 ABSTRACT   
One of the essential steps in proteomics is the identification and location of post-
translational modifications. Furthermore, an additional need is the characterization of 
protein-ligand interactions. Both are essential in understanding various biological 
processes including signal transduction, chemical catalysis, and cellular communication. 
The recent evolution and improvement of mass spectrometry (MS) makes it a powerful 
technique for the study of protein chemistry. Given that the measurement is fast, and the 
sample-size requirement is small, its application has expanded from academic institutes 
into biopharmaceutical companies. Mass spectrometry coupled with HPLC separation 
and product-ion sequencing (MS/MS) can not only confirm the protein sequence but also 
localize chemical modification sites. Moreover, the implementation of MS-based protein 
footprinting strategies, including hydrogen/deuterium exchange, enable us to study the 
biophysical properties of proteins (e.g. their dynamics, binding affinities, binding 
interfaces). The principles and instrumentation of protein/peptides mass spectrometry and 
hydrogen/deuterium exchange are introduced in this chapter.  
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1.2 PROTEIN-LIGAND INTERACTION 
Protein-ligand interactions occur both inside and outside the cell and are the basis 
of complex, coordinated, dynamic network systems that coordinate various biological 
processes and  modulate, for example, cell growth and cell cycles (1). The ligands that 
bind proteins include other proteins, peptides, DNA, small organic molecules, and metal 
ions. These complex interactions alter protein function and further influence downstream 
signal cascades. Malfunctioning of these systems can result in disease (2). Drugs, as a 
category of  ligands, are designed to interact with proteins and adjust their functions and 
prevent unwanted downstream responses (2).  
Troponin C, for example, which is one subject of study in this thesis, presents in 
both skeletal and cardiac muscle, interacts with Ca
2+
, and further interacts with other 
subunits (troponin I and T). These interactions are the basis of muscle contraction (3). 
Any factor that changes the interactions between the various troponins may be involved 
in cardiac-related diseases, and some drugs are, therefore, designed to maintain the 
multiple functions of troponins (4).           
Given that understanding the properties of protein-ligand interaction is the 
foundation of drug design, we propose that any method that expedites the study of 
protein-ligand interactions will facilitate drug development. Moreover, these methods can 
- 4 - 
 
help us understand the mechanisms of the complex biological networks and further 
improve our knowledge of biological therapies for diseases. 
1.3 PROTEIN POST-TRANSLATIONAL MODIFICATION 
Protein post-translational modification (PTM), a late step in protein biosynthesis 
that places a chemical modification on a side chain, is another important element in 
biological processes. It regulates protein function, signaling transduction, and cell 
behavior. Protein methylation or acetylation, for example, can be the basis for protein 
recognition by chromodomains (5). Protein nitration may be involved in cardiovascular 
diseases (6, 7). Protein glycosylation, a common PTM, has been recognized as a key 
element in protein folding, internalization, binding, and is also crucial to immune 
response (8, 9). Protein phosphorylation is involved in protein functional activity, occurs 
principally at the hydroxyamino acids, tyrosine, serine, and threonine, and converts a 
neutral side chain to a negative charge, thereby mediating  cell-signaling transduction  (5). 
Protein PTMs, especially phosphorylation, normally require kinase activation, 
which is another category of protein-protein interaction. It occurs differently under 
different biological conditions. Connexin 43 (Cx43), for example, which is also studied 
as part of this thesis, is a channel protein that modulates normal electrical and contractile 
activity. Cx43 can be phosphorylated by several different kinases, under both normal and 
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disease conditions. The modification regulates the gap-junction-channel assembly, 
function, and turnover. The locations of the phosphorylation sites on Cx43 with the 
activation of calmodulin protein kinase II (CAMKII), however, were unknown prior to 
our study. Therefore, understanding protein PTMs either qualitatively or quantitatively, 
and especially under different biological environments, is essential for understanding 
global protein function in specific biological processes.      
1.4 RESOLUTION OF PROTEIN-LIGAND INTERACTIONS 
The ability to locate protein-ligand interaction and protein PTMs has been 
acknowledged as one of the challenging issues in biomedicine and biophysics owing to 
the complex architecture and the lack of a complete suite of approaches. 
The qualitative analysis of protein PTMs is often achieved by gel-based analyses 
(SDS page staining and western blot), which provide only positive/negative information. 
Most of the strategies that are used to predict or characterize protein-ligand interaction, 
such as circular dichroism (CD) (10), fluorescence (11), small angle X-ray scattering 
(SAXS) (12), size-exclusion chromatography (13), and native gel (14), give global 
information on protein structure or size as modified owing to ligand binding. These 
techniques provide fast measurements but at low resolution (little if any site specificity). 
X-ray crystallography (15) and NMR (16), on the other hand, provide  high resolution (~ 
- 6 - 
 
2 Å) measurements of protein structures. The protein concentration and sample amount, 
however, need to be high (mM or high µM range for NMR, and mg of sample for x-ray). 
Furthermore, the protein cannot be large for NMR, and protein dynamics (e.g., 
flexibility) are difficult to measure by X-ray crystallography. 
MS, on the other hand, can provide fast measurement for small amounts of 
sample (µg). Our goal is to continue to develop MS tool to study protein-ligand 
interactions and to utilize MS in the identification and localization of protein PTMs  
1.5 MASS SPECTROMETRY; REVIEW OF BASIC PRINCIPLES 
The basic functions of MS are to generate ions from either inorganic or organic 
compounds, to separate these ions by their mass-to-charge ratios (m/z) and to detect them 
according to their respective m/z values. A mass spectrometer is composed of an ion 
source, a mass analyzer, and a detector. The majority of application before 1980’s were 
the analysis of small molecules. It was not until the late 1980’s, when John Fenn invented  
electrospray ionization (ESI) (17), Franz Hillenkamp and Michael Karas developed 
matrix-assisted laser desorption ionization (MALDI) (18), and numerous researchers 
improved mass analyzers, that the analysis of large bioorganic molecules including 
proteins, peptides, carbohydrates, and pieces of DNA and RNA became possible.  
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One property of ESI is that it multiply charges the analyte. Under denaturing 
conditions, the protein is highly charged and shows a broad distribution. MALDI, on the 
other hand, usually gives a dominant singly charged species and minimal multiple 
charging. ESI is the dominant ionization method used in the research reported in this 
thesis. 
Nowadays, the large variety of ionization techniques and mass analyzers makes 
the analysis of proteins and peptides feasible and powerful. Moreover, the combination of 
different mass analyzers (hybrid mass spectrometers) provides protein measurement and 
sequencing in a high-resolution manner. 
In conducting this thesis research, two hybrid mass spectrometers were mainly 
used (ESI-quadrupole/time-of-flight and ESI-linear ion trap/orbitrap). These are 
described in the following sections. 
1.5.1 Quadrupole/time-of-flight  
A quadrupole mass analyzer consists of four hyperbolically or cylindrically 
shaped rod electrodes. The pairs of opposite rods are held at the same polarity, which is 
composed of a DC and an AC component. If the applied voltage is composed of a DC 
voltage U and a radio frequency (RF) voltage V with the frequency ω, the total potential 
Φ is given by equation 1. 
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Φ        ω                 Eq. 1  
The equations of ion motion are given as equation 2 in which the distance between two 
rods is 2r0. These differential equations can be expressed as the Mathieu equation, for 
which a solution can be found.  
 2 
  2
 
 
 i 0
2                
 2 
  2
 
 
 i 0
2                    Eq. 2 
The dimensionless form of equation 2 can be written as: 
 2 
  2
                       Eq. 3 
where u represents the coordinate axes x and y, ξ is defined as ωt/2, and au and qu are 
defined as: 
 u  
   
 i 0
2  
  
 u  
   
 i 0
2  
        Eq. 4 and 5 
By plotting the parameter a vs. q when the ion trajectory is stable, one obtains the 
stability diagram of the two-dimensional quadrupole field. Any ion that stays within the 
stability region can be transmitted through the quadrupole analyzer and be detected.  
When operating near the tip of the stability diagram, other ions, even those of nearby m/z, 
will have unstable trajectories. This property enables a quadrupole to function as a mass 
selector in which only ion with specific m/z range can be transmitted to and fragmented 
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in the collision cell (usually an octupole). The product ions can then be analyzed by a 
sequel mass analyzer. This concatenation is known as mass spectrometry/mass 
spectrometry (MS/MS).  
In the MS-only mode, the quadrupole is operated under RF only condition (au = 0) 
in which all ions can be transmitted and analyzed by the following mass analyzer.  
The principle of time-of-flight (TOF), which is the second mass analyzer in the 
quadrupole-TOF (Q-TOF) instrument, is that ions of different m/z are dispersed in time 
during their flight through a field-free drift path of known length. Provided all the ions 
are given the same kinetic energy, lighter ions will arrive earlier at the detector than the 
heavier ions. Given that an ion with electric charge q and mass m at high electrical 
potential U is accelerated, converting its potential energy into kinetic energy (Ek), we can 
equate two types of energy as: 
     
 
 
                     Eq. 6 
The velocity (v) of the ion in the flight tube, therefore, can be obtained. 
   
   
 
                                    Eq. 7 
This characteristic of ion movement in the flight tube, however, demands that ions 
emerge from a pulsed ion source, such as MALDI, in which all the ions start their journey 
at the same time or at least within a sufficiently short time interval. This arrangement is 
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not suitable for continuous ion sources such as ESI because the ions will overlap. 
Incompatibility between continuous ion sources and pulsed ToF instruments was resolved 
in early 1990’s. The solution is an orthogonal TOF in which ions are introduced into the 
TOF mass analyzer along an axis perpendicular to their initial direction of motion. By 
taking advantage of this orthogonal design, quadupole and ToF mass analyzers can be 
combined to form the basis of a powerful tandem mass spectrometer. To complete the 
MS/MS design, we need only to incorporate some means of causing ions selected by the 
Q to be activated and undergo fragmentation. 
If the TOF is coupled with a reflectron, the dispersion of kinetic energy of ions 
having the same mass is minimized, and the mass resolving power is improved 
significantly. A modern Q-TOF instrument can have mass resolving power as high as 
40,000 over a wide mass range or even higher; such high resolving power is an asset in 
protein analysis.    
1.5.2 Linear ion trap/Orbitrap 
A linear ion trap, or linear quadrupole ion trap (LIT or LTQ), functions similarly 
as a quadrupole mass analyzer but uses a trapping potential well formed by placing 
electrodes of slightly higher potential adjacent to the front and rear ends of the multipole. 
This property enables the LTQ to trap ions with high capacity, accumulate ions until a 
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population suitable for the sequel analyzer is reached, select ions of interest, and 
fragment ions with relatively higher efficiency as compared to the quadrupole.   
The orbitrap, also known as the Kingdon trap (19), is a type of Fourier transform 
(FT) mass analyzer. It incorporates a straight electrode along the axis of a surrounding 
cylindrical electrode (Figure 1-1). Ions tangentially approaching the central electrode 
that is set to an attractive electric potential do not hit the electrode but become captured in 
a rotational motion around it, owing to a balance of an outward centrifugal forces and an 
inward electrical force. Their trajectory is defined by an equilibrium of the centrifugal 
force and the electrostatic force generated by applying a voltage between central 
electrode and enclosing cylinder. The oscillation of ions, thus, creates an image current as 
detected by a differential amplifier connected to the halves of the outer electrode; the 
image current  is then transformed to frequency-based signal. The correlation between the 
frequency of harmonic axial oscillation ωz with field curvature k and ion with mass mi 
and charge q can be defined as:  
 z     
 
 i
                        Eq. 8 
The combination of an LTQ and an orbitrap provides extremely high resolving 
power (100,000 at m/z 400, accurate mass measurement (0.5 - 5 ppm), and efficient 
MS/MS capability that increases the confidence in protein and peptide identification, for 
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example. For this reason, we conducted much of the research reported in this thesis with 
the LTQ-Orbitrap.   
 
Figure 1-1. Cutaway view of the Orbitrap mass analyzer. Ions are injected into the 
Orbitrap at the point indicated by the red arrow. Taken from Perry et al. 2008. Mass 
Spectrometry Reviews. 
1.6 GAS-PHASE FRAGMENTATION 
The ability to induce ion fragmentation in tandem mass spectrometry (MS/MS) is 
important to identify peptides and proteins with high confidence, especially when dealing 
with complex protein mixtures. Moreover, it allows one to localize protein modification 
sites such as phosphorylation, which will be important in chapter two of the thesis. 
Peptide ions that are fragmented in the gas phase produce a series of product ions 
indicated by a, b, or c if the charge is retained on the N-terminus and by x, y or z if the 
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charge is maintained on the C-terminus (Figure 1-2). Obtaining these sequential ions is 
essential to reconstruct peptide sequences.   
 
Figure 1-2. The fragmentation sites of peptide during gase-phase fragmentation. 
There are two types of fragmentation strategies, collision-induced dissociation, or 
collisionally activated dissociation (CID/CAD), and electron transfer or electron capture 
dissociation (ETD/ECD). They are now widely used in general proteomics approaches 
(20, 21).  
1.6.1 Collision-induced dissociation 
Collision-induced dissociation (CID) occurs when an ion beam passes through a 
collision cell where an inert collision gas (e.g., He, N2, Ar) is set to a pressure 
approximately 1000 times above that of the surrounding high vacuum. Ions with initial 
internal energy will take up energy by making collisions with the inert gas atoms or 
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molecules and dissociate along any fragmentation pathway available at this specific level 
of internal energy.  
CID typically yields fragment ions whereby a peptide bond is cleaved to produce 
y and b-type ions (Figure 1-3) (22). Given that a basic requirement for the CID process is 
the collision gas, which is used in most of the tandem mass spectrometers, CID has 
become a standard and routine fragmentation strategy in the proteomics work flow (20). 
The propensity to lose labile functional groups during CID, however, has been 
recognized as an obstacle in localizing protein post-translational modifications. 
Phosphorylated peptides, for example, can easily lose their phosphate group (as H3PO4) 
during CID (Figure 1-4) (22). This phenomenon makes an unambiguous identification of 
multiple phosphorylation sites on a single peptide difficult, especially when 
unphosphorylated peptides that undergo water loss are present in the same ion cluster. It 
was later found that a unique electron-based fragmentation strategy, electron transfer 
dissociation (ETD) or electron-capture dissociation (ECD), can prevent this phenomenon.  
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Figure 1-3. The mechanism of CID fragmentation pathway, which yields y and b-type 
ions. Taken from Syka et al. 2004. PNAS. 
 
Figure 1-4. The neutral loss of phosphate group (H3PO4) of a phosphorylated peptide 
during CID. Taken from Syka et al. 2004. PNAS. 
1.6.2 Electron transfer dissociation  
Electron transfer dissociation (ETD) was invented in early 2000’s by Hunt,  Syka, 
and Coon (23). ETD employs a radical anion in the gas phase to transfer an electron to a 
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peptide ion of interest, leading to a unique fragmentation pathway that produces z and c-
type ions (Figure 1-5). The Thermo LTQ-Orbitrap XL (ETD) instrument, for example, 
which was used to conduct much of the research in this thesis, utilizes fluoranthene as the 
reagent and produces fluoranthene radical anions via a chemical ionization (CI) process 
(called electron capture). The electron-transfer process then takes place in the linear ion 
trap whereby the radical anion transfers an electron to the positively charged peptide or 
protein in a process that is promoted by the opposite charges of the two species.   
 
 
 
Figure 1-5. A proposed mechanism of ETD fragmentation, which yields z and c-type 
ions. Taken from Syka et al. 2004. PNAS. 
ETD cleaves randomly along the peptide backbone while side chains and 
modifications such as phosphorylation remain intact. The technique only works well for 
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higher charge state ions (z > 2). Relative to CID, ETD is advantageous, however, for the 
fragmentation of longer peptides or even entire proteins. This makes the technique 
important for top-down proteomics.  
Although a number of workers have investigated ETD, its mechanism is still 
under debate (24, 25). The advantage of ETD in the identification of protein post-
translational modifications, especially phosphorylation, is unquestioned (22, 26). An 
example of the combination of CID and ETD in the identification of phosphorylation 
sites on Cx43 under the activation of CaMKII is described in this thesis.     
1.7 MASS SPECTROMETRY-BASED PROTEIN FOOTPRINTING 
Mass spectrometry-based protein footprinting (27-29) is a modern strategy that 
utilizes the advantages of MS and chemical modification (hydrogen/deuterium exchange, 
hydroxyl-radical oxidative modification, chemical crosslinking, etc.) to  generate a mass 
shift that is readily seen by MS. Footprinting can capture minor changes in protein 
solvent accessibilities that are induced by interactions or by the presence of PTMs. These 
approaches can probe protein conformational changes associated with protein-ligand 
(ligand: protein, DNA, peptide, drug etc.) interactions and protein dynamics. 
Hydrogen/deuterium exchange is considered here to be a footprinting strategy because 
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like other strategies, it introduces new covalent bonds in a protein. The modifications, 
however, are reversible. 
1.8 HYDROGEN/DEUTERIUM EXCHANGE 
Kaj Ulrik Linderstrøm-Lang in late 1940’s first developed hydrogen/deuterium 
exchange (H/DX) by measuring the small molecular mass increments that occur 
following uptake of D. Given that hydrogen and deuterium nuclei are grossly different in 
their magnetic properties, nuclear magnetic resonance (NMR) soon became the main 
means to measure the extent of deuterium uptake (30). In the 1990’s, mass spectrometry 
began to evolve as another powerful tool in protein analysis and H/DX. The utilization of 
hydrogen/deuterium exchange MS (H/DX-MS) for the study of protein-ligand 
interactions, protein dynamics, and protein folding is now an accepted approach (28, 31-
33).  
Proteins have three types of hydrogens with different deuterium exchange rates 
(Figure 1-6). The first class includes amide hydrogens that exchange with deuterium at 
middle rates (half lives of seconds to hours). A second class are hydrogens attached to the 
functional groups of side chain, and they exchange with deuterium at very fast rates (half 
lives of µs), and they are easily back-exchanged to hydrogen by returning the protein to a 
protic solvent. The third class includes hydrogens covalently bonded to carbon. These are 
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essentially not exchangeable with deuterium in D2O. These characteristics of H/DX 
enable us to measure the extent of deuterium uptake of the amide residues (amino acids) 
on a reasonable time frame, thereby revealing a wide range of protein dynamics. 
 
 
Figure 1-6. Proteins have three types of exchangeable hydrogens: (1) amide hydrogens, 
green; (2) carbon hydrogens, blue; (3) side-chain hydrogens, red. 
1.8.1 Rates of H/DX are pH and temperature dependent  
H/DX is an acid and base-catalyzed reaction. The intrinsic rate of exchange is 
expressed as equation 9: 
                        -                                 Eq. 9 
Given that the rate of water catalysis is six orders of magnitude smaller than that of acid 
catalysis and 13 orders of magnitude smaller than that of base catalysis, this term is 
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usually ignored. Although the amide hydrogens of different amino acids have different 
intrinsic exchange rates, the overall exchange rate reaches its lowest value near pH 2.5  
and 0 ºC (Figure 1-7) (34). Therefore, H/DX can be quenched by adding sufficient acid 
to bring the pH to 2.5 and by cooling in ice water prior to MS analysis. 
 
 
Figure 1-7. The rates of H/DX depend on pH (A) and temperature (B). Taken from 
HXMS website: http://www.hxms.neu.edu/research/tutorial_theory.htm. 
The overall half life of H/DX, however, is relatively short as compared to other 
covalent labeling strategies even under the quenching condition (overall half life ~ 40 
min) (31). Thus, it is essential to keep the analyzing time short, within 10 min, to obtain 
sufficient information of deuterium uptake. One can correct the extent of back exchange 
by incorporating a 100% deuterated sample under the same analysis process and follow 
equation 10: 
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   0 
 100   0 
           Eq. 10 
where D is the adjusted deuterium level, N is the total number of exchangeable amide 
hydrogens, m is the experimentally measured mass, m0% is the mass of the undeuterated 
protein/peptide, and m100% is the mass of the fully deuterated protein/peptide (31). 
1.8.2 Exchange kinetics (EX1 vs. EX2) 
In the H/DX experiment, the concentration of D2O present at the equilibrium is 
much greater than that of water. Therefore, H/DX follows pseudo-first order kinetics in 
which the correlation between the number of deuteriums taken up and the exchange rate 
can be illustrated as:  
                              Eq. 11 
where D is the deuterium level, N is the total number of exchangeable amide hydrogens, 
k is the exchange rate, and t is the exchange time. One can calculate the number of amide 
hydrogens at different exchange rates by fixing the rate constants and using kinetic curve 
fitting processes, or calculate the exchange rates corresponding to different groups of 
amide hydrogens that are defined prior to the fitting process (31). 
H/DX kinetics, sometimes, becomes more complex according to different 
characteristics of protein folding. The most popular model for hydrogen exchange of 
native proteins dissolved in D2O is: 
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  D    Eq. 12 
in which the opening motion of protein proceeds with the rate constant kop and the closing 
motion with the rate constant kcl. In the open form, deuterium exchange can occur with 
the rate constant krc. Therefore, the observed exchange rate kex can be described as (35): 
 e  
 op rc
 cl  rc
       Eq. 13 
When krc << kcl, equation 13 simplifies to kex = krc(kop/kcl). Proteins having this 
behavior, called EX2 kinetics, give one major group of deuterium uptake distribution in 
H/DX experiments, and one can obtain the overall information of H/DX kinetics of the 
protein. The apparent free energy of opening or exchange, ΔGHX, is expressed as -RTln 
Kop and can be calculated with data from EX2 exchange. Thus, hydrogen exchange in the 
EX2 model provides thermodynamic data. Most proteins, including those discussed in 
this thesis, follow EX2 behavior.  
When  kcl << krc, then kex = kop. Proteins having this behavior, called  EX1, give 
mutiple groups of deuterium uptake distribution in H/DX experiments, making the data 
interpretation difficult. The information of protein folding/unfolding, however, can be 
obtained under this condition. The shortest H/DX time in solution that has been captured 
by MS, thus far, is in the range of µs (36). 
1.8.3 H/DX at the Global-level 
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The extent of deuterium uptake of a protein can be measured globally by 
investigating the average differences between the masses of the deuterated protein and 
the undeuterated protein. H/DX is initiated by diluting the proteins in D2O buffer at 
physiological pH (or any suitable pH) and held for various times at 25 °C (or other 
suitable temperatures) before quenching the exchange by adding acid to decrease the pH 
to 2.5 and by lowering the temperature to 0 °C. The deuterated samples are loaded onto a 
C8 or C18 trap column, allowing labile side-chain sites to back exchange and salts and 
ionic buffers to be removed. After elution from the column, the protein may be purified 
further via a cooled HPLC system and analyzed by mass spectrometry. This strategy 
enables us to monitor the global changes of hydrogen bonding and solvent accessibility 
of the protein of interest owing to various perturbations including ligand binding. 
1.8.4 H/DX at the Peptide-level 
Protein conformational changes sometimes occur only at small regions of a large 
protein, and in that case, differences reported by H/DX are very often “washed out” by 
investigating the whole protein. To reveal these minor changes, we need higher spatial 
resolution provided by H/DX-MS. H/DX coupled with enzymatic digestion prior to mass 
spectrometry analysis, as mentioned above, affords spatial resolution at the “peptide-level” 
(i.e., to regions of the protein that are 6-10 amino-acid residues in length (37)) (Figure 1-
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8). The uptake extent of deuterium is measured as the mass-to-charge differences 
between the centroid of the isotopic distribution of the deuterated peptide and the 
undeuterated peptide. The enzymes used to achieve peptide resolution in H/DX are 
mainly acidic proteases, such as pepsin or protease XIII, which are active under the 
quenching conditions (pH  ~ 2.5). 
 
Figure 1-8. H/DX workflow that provides “peptide-level” information. Taken from 
Chalmers et al. 2011. Expert Review Proteomics. 
1.8.5 H/DX at the Residue-level 
To refine the spatial resolution to the “residue (amide) level”, one can incorporate 
multiple enzymatic digestions and analyze overlapping peptides (38), or apply 
appropriate gas-phase fragmentation of the deuterated peptides released upon pepsin 
digestion. 
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Gas-phase hydrogen scrambling, however, is an obstacle to achieving this goal, 
especially when using collision-induced dissociation (CID) or collisionally activated 
dissociation (CAD) to fragment the peptide (39-44). Scrambling of H and D in the gas 
phase, however, can be largely prevented by fragmenting the peptides with electron-
transfer dissociation (ETD) or electron-capture dissociation (ECD) (45, 46).  
To provide assurance that the conditions are accompanied by minimal scrambling, 
Jørgensen (44-46) established a set of standard peptides that can be evaluated as test 
cases for scrambling. Several other methods were also established for the same purpose 
(47, 48). Two approaches, top-down (49-53) and bottom-up H/DX (54, 55), allow single-
residue resolution to be achieved. The former strategy does not require an enzymatic 
digestion step, thereby shortening the time of the experimental protocol and lowering the 
extent of back exchange, but it does require that the protein be pure and fragmentation be 
complete and the coverage be good. Both are difficult to achieve as protein size becomes 
larger. The latter strategy, on the other hand, utilizing enzymatic digestion, LC/MS 
analysis, and tandem mass spectrometry (ETD or ECD), provides information with fewer 
restrictions and more confidence that the results are not compromised by scrambling. An 
example of utilizing bottom-up H/DX for the study of ApoE oligomerization is included 
in this thesis. 
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1.9 STUDY THE BIOPHYSICAL PROPERTIES OF PROTEINS BY H/DX 
1.9.1 Protein dynamics 
Protein conformational changes affect many biological functions, including 
enzymatic catalysis and selective interactions of macromolecules. Proteins consisting of 
multiple domains joined by flexible linkers can undergo large movements that result in 
the repacking of adjacent domains. The slow dynamics of protein conformational changes 
usually involve breaking and making relatively strong hydrogen bonds, and they are 
associated with low-solvent accessibility at short times of exchange. Therefore, H/DX 
kinetics has the potential to identify, with reasonable resolution, domain-packing 
interactions that correspond to different protein conformational states in large proteins.  
1.9.2 Affinity of protein-ligand interaction 
 Measuring the affinity of protein-ligand interactions is important in many areas 
of biophysics and in the design of future drugs. Several methods can be used to measure 
binding affinities including FRET (fluorescence resonance energy transfer) (56), NMR 
(57), CD (circular dichroism) (58), calorimetry (59), SPR (surface plasmon resonance) 
(60, 61), and ESI mass spectrometry (62).  
There are two approaches that utilize H/DX to measure the thermodynamic 
properties of protein-ligand interactions: SUPREX (Stability of Unpurified Proteins from 
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Rates of H/D Exchange) (63, 64), and PLIMSTEX (Protein-Ligand Interactions by Mass 
Spectrometry, Titration, and H/D Exchange) (65-67). One may ask why MS methods 
could play a role in this well-developed area. The answer is MS can provide site 
specificity. 
SUPREX incorporates different amounts of denaturants (urea or guanidinium 
chloride) in the solution of a protein. A SUPREX curve can be obtained by plotting the 
deuterium uptake of protein (at constant exchange time) as a function of increasing 
amounts of denaturant. Because proteins unfold in the presence of denaturants, increasing 
deuterium uptake occurs with the unfolding. Once a binding ligand is present in solution, 
the protein stability usually increases compared to the protein in the apo state, causing the 
SUPREX curve to shift to higher denaturant concentrations. By measuring the differences 
of C 
1/2
SUPREX, which is the midpoint of the transition between the native state and 
unfolded state, and by following equation 14 and 15, one can obtain the dissociation 
constant of the protein-ligand complex. 
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One disadvantage of SUPREX is that the presence of denaturant may influence the 
protein-ligand interactions; after all, proteins in vivo do not bind ligands in solutions 
containing denaturants. 
PLIMSTEX, developed in the M. Gross group, utilizes deuterium uptake 
differences between apo (absence of ligand) and holo states (ligand bound). A 
PLIMSTEX curve can be obtained by titrating a protein solution with increasing amounts 
of ligand followed by subjecting the protein to H/DX for a given, constant time, a time 
for which H/DX is relatively constant and for which small errors in sampling time would 
have minimal impact on the titration.  
The fitting process of the PLIMSTEX curve involves three parameters (D0, ΔDi, 
and βi) in which D0 is the deuterium uptake of the apo state, ΔDi is the decrease of 
deuterium uptake due to each ligand binding, and βi (i = 1 to n) is the overall binding 
constant. To fit the data, a model must build a relationship between the overall deuterium 
shift and the total ligand concentration as shown in equation 16. 
                                        
     -     
       
             Eq. 16 
ΔDi is weighted by its binding fraction [Prot-Ligt]/[ProtT], which is a function of total 
ligand concentration [LigT] and the overall binding constant βi.  βi is the product of all the 
stepwise equilibrium constants as shown in equation 17. 
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                    Eg. 17 
The binding fraction in equation 16 for each protein-ligand species can then be expressed 
as: 
     -   i 
     T 
 
 i     
i
    i     
i 
   
       Eg. 18 
The calculation of the binding fractions requires the free-ligand concentration, [Lig], 
which can be inferred from the total ligand concentration and the extent of complexation. 
The analytical derivative of [Lig] with respect to [LigT], which is a function of [Lig], 
[ProtT], and βi, can be written as:  
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      Eg. 19 
We applied the concept of PLIMSTEX to troponin C, a Ca
2+
 binding protein, and 
to the troponin C-troponin I interactions, and described the outcomes in this thesis. 
1.10 SCOPE AND SIGNIFICANCE OF THE THESIS 
Mass spectrometry, introduced in this chapter, is now a powerful tool in the 
characterization of both protein post-translational modifications and protein-ligand 
interactions. Mass spectrometry-based proteomics and protein footprinting are two 
strategies with significant growth rates, and they are now widely used to address various 
biochemical/biophysical issues including protein dynamics, folding and unfolding, and 
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protein interactions. We are interested in utilizing and expanding these two approaches to 
gain a better understanding of three disease-related proteins, connexin 43, troponin, and 
apolipoprotein E, and another protein (Fenna-Matthews-Olson protein) that is important 
in the photosynthetic system of green sulfur bacteria.   
Thus, we first describe in the thesis a mass spectrometry-based proteomics 
strategy to identify the phosphoylation sites of connexin 43 in vitro, under the activation 
of CaMKII, and in vivo. The neutral loss of the phosphate group from phosphorylated 
peptide ions under CID gas-phase fragmentation, however, presented an obstacle to the 
unambiguous identification of multiple phosphorylation sites on a single peptide. We 
show that the combination of CID and ETD offers complementary identification of the 
phosphorylation sites on this heavily phosphorylated protein. This strategy, therefore, is 
becoming a standard platform for future studies of protein phosphorylation. 
We then utilized hydrogen/deuterium exchange (H/DX), one of the mass 
spectrometry-based protein footprinting strategies, to study the biophysical properties 
(binding interfaces, binding affinities, and protein dynamics) of five protein-ligand 
interaction systems. These systems are: (1) troponin C and its interaction with four Ca
2+
 
ions, (2) troponin C dynamics within the troponin complex and the interactions of the 
three subunits (TnC, TnI, and TnT) with each other, (3) the oligomerization of human 
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apolipoprotein E as compared to a mutant-forced monomer, (4) the apolipoprotein E-
Aβ40 interactions, and (5) the interactions between Fenna-Matthews-Olson protein 
(FMO) and CsmA baseplate protein. We also applied ETD, a newly explored 
fragmentation method that can provide H/DX information at the residue-level, in the 
study of ApoE oligomerization.  
Our results show that H/DX is, indeed, a powerful strategy that can provide the 
investigation of protein-ligand interaction in a high-resolution manner and provide 
solutions to important biochemical problems. 
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Chapter 2* 
Identification of CaMKII Phosphorylation Sites in Connexin43 by 
High-Resolution Mass Spectrometry 
 
 
 
 
 
 
 
 
* 
This chapter is based on recent publication: Huang, R. Y. C., Laing, J. G., Kanter, E. M., 
Berthoud, V. M., Rohrs, H. W., Townsend, R. R., Bao, M., and Yamada, K. A. 
Identification of CaMKII Phosphorylation Sites in Connexin43 by High-Resolution Mass 
Spectrometry. Journal of Proteome Research, 2011, 10, 1098-1109. Copyright 2011 
American Chemical Society (Huang, R. Y. C., and Laing, J. G. contributed equally to this 
work.)
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2.1 ABSTRACT 
Connexin43 (Cx43), a major cardiac gap junction channel protein, plays an 
important role in normal electrical and contractile activity. Phosphorylation of Cx43, 
under both normal and disease conditions, regulates the gap junction channel assembly, 
function and turnover. The C-terminal domain of Cx43 contains numerous amino acid 
residues that are phosphorylated by protein kinases. Our knowledge of the specific 
residues and kinases involved, however, is incomplete. The objective of this study is to 
identify amino acid residues in the Cx43-CT that are targets of the multi-functional 
protein kinase, Ca
2+
/calmodulin protein kinase II (CaMKII), an enzyme known to play 
critical roles in Ca
2+
 homeostasis, transcription, apoptosis and ischemic heart disease.  
We subjected fusion protein containing the Cx43-CT to phosphorylation by CaMKII in 
vitro, digestion with Lys-C and trypsin followed by enrichment of phosphorylated 
peptides using TiO2, and analysis with a combination of two fragmentation strategies 
(collision-induced dissociation (CID) and electron transfer dissociation (ETD)) in an 
LTQ Orbitrap.  We deduced the sites of modification by interpreting tandem spectra from 
these “orthogonal” methods of gas phase peptide fragmentation. We have identified 15 
serine residues, including one novel site, in the Cx43-CT that are phosphorylated by 
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CaMKII, the activity of which may be important in regulating Cx43 in normal and 
diseased hearts. 
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2.2 INTRODUCTION 
Cardiovascular gap junctions, formed by 2 docking hemichannels, each composed 
of 6 connexin subunits, are large specialized aggregates of intercellular channels and are 
important in cell-to-cell communication (1). There are five different connexins expressed 
in cardiac muscle and vasculature (1-3). Connexin43 (Cx43) is the predominant connexin 
expressed in working myocardium (2). Cx43 is not only responsible for electrical 
propagation throughout the chamber walls, and thus for normal electrical activation and 
subsequent ventricular contraction, but it is also a critical determinant of abnormal 
propagation, contractile dysfunction and arrhythmia secondary to pathophysiological 
remodeling during disease states (4, 5). 
The expression, trafficking, distribution, turnover, permeability and gating of 
Cx43 are regulated primarily by phosphorylation (6, 7). There are eighteen serine 
residues in the carboxyl terminal tail of Cx43 that have been reported as sites of protein 
phosphorylation (6, 8-10),
 
the majority of which have been identified as targets of a 
variety of kinases including mitogen-activated protein kinase (MAPK), protein kinase C 
(PKC), cyclin-dependent kinase p34
cdc2
, casein kinase (CK) and protein kinase A (PKA) 
(6). Interestingly, four serine residues in the carboxyl terminus of Cx43 show a complex 
time-dependent pattern of both phosphorylation and dephosphorylation during 
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myocardial ischemia. Specifically, S306 is dephosphorylated and S330 is phosphorylated 
early after ischemia; subsequently, S297 and S368 are dephosphorylated during the 
critical time when gap junction uncoupling occurs (8). Finally, S330 is also 
dephosphorylated during the later stages of ischemia (8). Correspondingly, Lampe et al. 
have observed an 8-fold reduction in phosphorylated (p)S325/S328/S330 in ischemic 
tissue (11). 
Details pertaining to the phosphorylation and dephosphorylation of the eighteen 
serine residues in the carboxyl terminus of Cx43 are incomplete and, at times, 
contradictory. Phosphorylation of S368, for example, the most widely studied 
phosphorylated residue, has been associated with reduced gap junction intercellular 
communication via a PKC-dependent mechanism in epithelial cells and fibroblasts (12). 
Changes in gap junctional conductance in response to PKC activation, however, depend 
on cell type and the state of phosphorylation of Cx43. Furthermore, the exact role of 
phosphorylation of S368 in ischemia and ischemic preconditioning is not clear because 
conflicting results have been reported (8, 13-16).
 
The availability, affinity and specificity 
of commercial antibodies directed toward phosphorylated residues in Cx43 may, in part, 
limit the studies on alterations in the phosphorylation state of different amino acid 
residues.  
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With the recent evolution and improvement of mass spectrometry, it now appears 
to be a powerful technique that can be used as a tool to identify the modified amino acid 
residues in phosphorylated peptides. Collision-induced dissociation (CID), a 
fragmentation strategy utilized in the general proteomics workflow, will cause the neutral 
loss of the phosphate group from phosphorylated peptide, thus making an unambiguous 
determination of muti-phosphorylated sites difficult. Electron transfer dissociation (ETD) 
and electron capture dissociation (ECD), as introduced in chapter 1, leave post-
translational modifications intact during fragmentation and prevent this phenomenon 
(17).  
 We report here the use of high-resolution tandem mass spectrometry with the 
combination of CID and ETD to identify targets of the multifunctional protein kinase, 
Ca
2+
/calmodulin-dependent protein kinase II (CaMKII) (18), on the carboxyl terminus of 
Cx43. CaMKII plays a central role in regulating a variety of cellular functions in the heart 
such as Ca
2+
 homeostasis, transcription and apoptosis (18, 19). In addition, increased 
expression and/or activation of CaMKII have been shown to occur in cardiac disease 
states such as hypertrophy, heart failure, myocardial ischemia and infarction, and are 
thought to promote disease pathogenesis (20-24). Recently, we have found that CaMKII 
co-localizes with Cx43 at intercellular junctions in the infarct border zone (25). Cx43, 
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however, has never, to our knowledge, been shown to be a target of CaMKII. De Pina-
Benabou et al. (26) hypothesized that CaMKII phosphorylation of the carboxyl terminus 
of Cx43 was the mechanism by which K
+
 produced an increase in coupling between 
spinal cord astrocytes, and they predicted four serine residues that could be potential 
phosphorylation targets for CaMKII based on the consensus sequence RXXSX.  
Although Cx43 has not been shown to be a substrate for CaMKII, this enzyme has been 
shown to phosphorylate Cx32 in hepatocytes and Cx36 in neurons (27, 28). The specific 
CaMKII phosphorylation sites, however, have not been identified in Cx32, and the 
phosphorylation sites identified in Cx36 do not share homology with Cx43. 
The current study, therefore, was performed to test the hypothesis that the 
carboxyl terminus of Cx43 is subject to phosphorylation by CaMKII. We found that 
CaMKII phosphorylates a variety of reported residues, and one novel serine residue, in 
the carboxyl terminus of Cx43 in vitro. These results suggest that Cx43 may be a 
substrate for CaMKII in vivo. The data will be discussed in the context of remodeling of 
Cx43 during the pathogenesis of chronic ischemic heart disease.  
2.3 MATERIALS AND METHODS 
2.3.1 Cx43 Fusion Protein 
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A DNA construct coding for a fusion protein containing amino acids 237-382 of 
the carboxyl terminus (CT) of rat Cx43 (GI:6978896) subcloned in frame with GST in 
pGEX-2T (GST-Cx43-CT, MW 42,122 g/mol) was grown in BL21-CodonPlus 
competent cells (Stratagene/Agilent Technologies, Santa Clara, CA). The fusion protein 
was purified using a B-PER GST Fusion Protein Purification Kit (Pierce/Thermo 
Scientific, Rockford, IL) and subsequently dialyzed against Tris-buffered saline for 48 hr.  
The sequence of the fusion protein was confirmed at the Washington University Protein 
and Nucleic Acid Chemistry Laboratories. The amino acid sequence of the Cx43-CT 
present in the fusion protein is shown in bold in Figure 2-1. 
 
 
Figure 2-1. Tandem mass spectrometric coverage of Cx43-CT. The N-terminal, 
transmembrane, extracellular loop and intracellular loop domains of the protein are 
indicated in grey. The amino acids of the Cx43-CT present in the fusion protein used in 
this study are indicated in bold black or red (98% coverage). Amino acids in red were 
positively identified by tandem mass spectrometry. The 15 serine residues underscored 
and highlighted in yellow were phosphorylated by CaMKII in vitro. 
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2.3.2 In vitro Phosphorylation of GST-Cx43-CT by CaMKII 
GST-Cx43-CT fusion protein was subjected to in vitro phosphorylation using 
CaMKII ( ew England Biolabs, Ipswich, MA) per the manufacturer’s instructions.  
Briefly, GST-Cx43-CT fusion protein (1 – 8 μg) was incubated with 1.2 μmol/L 
calmodulin, 2 mmol/L CaCl2, 210 μmol/L ATP and 1,500 U CaMKII in a final volume of 
10.5 μL at 30ºC for 24 h, after which the reaction was stopped on ice and phosphatase 
inhibitors were added to a final concentration of 1 mmol/L NaF and 2 mmol/L Na3VO4.  
Control reactions contained fusion protein, calmodulin, CaCl2, ATP and buffer, but no 
CaMKII.  In one experiment we used CK1 (New England Biolabs, 1,500 U, 24 h) per the 
manufacturer’s instructions to test a protein kinase known to phosphorylate the C 43-CT 
(11). 
2.3.3 Immunoprecipitation 
Mouse ventricles flash-frozen in liquid N2 were pulverized and homogenized in 
lysis buffer containing 1.5% NP-40 (Surfact-Amps NP-40, Pierce) in phosphate-buffered 
saline (PBS, Diamedix),  rotating for 30 min at 4ºC. 
Monoclonal anti-C 43 (50 μg, Millipore/Chemicon) or mouse IgG (50 μg, Santa 
Cruz, negative control) antibody was crosslinked to 200 μL of protein G-bound magnetic 
Dynabeads (Invitrogen) using dimethyl pimelimidate (DMP, Pierce) and triethanolamine 
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(Sigma) in silanized (10% dimethyldichlorosilyl, P.J. Cobert) tubes. The crosslinked 
beads were washed in PBS, citrate buffer (pH 5.0), sodium phosphate buffer (pH 8.1), 
sodium deoxycholate (0.5%) and Tween-20 (0.1%). Each set of antibody-crosslinked 
beads was incubated with protein from the right and left ventricles of one mouse heart, 
NaF (1 mM), Na3VO3 (2 mM) and protease inhibitor cocktail (1:100, Sigma) for 2 h at 
4ºC, rotating.  Immunoprecipitated protein was eluted with Rapigest (1.7%, Waters) and 
8 M urea in 100 mM Tris buffer (pH 8.5) at 60ºC for 5 min; the elution was repeated and 
the two volumes were combined. The eluent was dialyzed (Slide-A-Lyzer, Thermo) 
against 1 L of water for 2 h at 4ºC followed by dialysis against 1 L of water overnight at 
4ºC. 
2.3.4 Phosphopeptide Clean-up and Enrichment 
In vitro phosphorylated GST-Cx43-CT fusion protein or immunoprecipitated full-
length native Cx43 was precipitated by using a 2-D Clean-Up Kit (GE Healthcare 
Waukesha, WI) and resolubilized in 20 μL of 8 M urea in 100 mM Tris, pH 8.5. Proteins 
were then reduced with 10 mM Tris(2-carboxyethyl)phosphine (TCEP, Thermo Fisher, 
Rockford, IL) at 25ºC for 30 min followed by alkylation with 20 mM iodoacetamide 
(Sigma-Aldrich, St. Louis, MO) at 25ºC for 30 min in the dark and quenched with 10 mM 
dithiothreitol (DTT, Thermo Fisher) at 25ºC for 15 min. The proteins were digested with 
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1 μg endoproteinase Lys-C (Roche, Mannheim, Germany) at 37ºC overnight, diluted 1:4 
with 100 mM Tris pH 8.5, and further digested with 1 μg trypsin (Sigma-Aldrich) in 1 
mM triethylammonium bicarbonate, pH 8.5 (TEAB, Sigma-Aldrich) at 37ºC overnight.  
The peptide solutions were acidified with 2% trifluoroacetic acid (TFA) (Sigma-Aldrich).  
Phosphopeptide samples were enriched using TiO2 tips (Glygen, Columbia, MD) that 
were equilibrated in 0.1% TFA before drawing each sample onto the media. Tips were 
washed with 100 mM glutamic acid at pH 2.0 and the bound peptides eluted with 1.5% 
ammonium hydroxide. The eluates were desalted using carbon NuTips (Glygen), 
lyophilized, and resuspended in 20 mL of 1% formic acid and 1% acetonitrile. 
To verify the activity of CaMKII in vitro, 1.5 μg of autocamtide 
(KKALHRQETVDAL, Calbiochem/EMD Chemicals, Gibbstown, NJ) was incubated 
with CaMKII for 24 h as described above to produce phospho-autocamtide 
(KKALHRQEpTVDAL). Commercially available phospho-autocamtide (AnaSpec, 
Fremont, CA) was run as a positive control. 
2.3.5 Mass spectrometry 
Autocamtide phosphorylation was verified by using matrix-assisted laser 
desorption ionization (MALDI). Peptide solution was mixed 1:1 with α-cyano-4-
hydroxycinnamic acid (CHCA, Sigma-Aldrich). For MALDI analyses using an ABI 4700 
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Proteomics Analyzer (Applied Biosystems, Framingham, MA) equipped with an 
Nd:YAG laser (355 nm, 3 to 7 ns pulses), the instrument was operated in reflector, 
positive-ion mode with an acceleration voltage of 20 kV. Spectra were averaged from 
1000 laser shots at 200 Hz for each spot. 
For analysis with a Thermo LTQ Orbitrap XL with electron transfer dissociation 
(ETD) and/or collision-induced dissociation (CID) (Thermo Fisher, San Jose, CA),  
samples were loaded and eluted using an autosampler and an Ultra 1D+ UPLC (Eksigent, 
Dublin, CA). The 75 μm diameter columns were pulled (Sutter Instruments,  ovato, CA) 
and a 12-cm length was packed with Magic C18AQ reverse phase media (Michrom 
Bioresources, Auburn, CA) (29). Columns were mounted in a PicoView nanospray 
source (New Objective, Woburn, MA) and eluted with a 60 min gradient from 2% - 60% 
acetonitrile with 0.1% formic acid. Fluoranthene anion was used for ETD (30). One full 
mass spectrometry acquisition was used to trigger 3 alternating scans each of CID and 
ETD. The Orbitrap parameters were: spray voltage, 2.0 kV; capillary temperature, 200ºC; 
tandem mass spectrometry (MS2) selection threshold, 1000 counts; activation q, 0.25; 
activation time, 30 ms for CID and 100 ms for ETD. For ETD, isolation width was 3.0 
m/z and reaction time was set as charge-state dependent. Supplemental activation was 
enabled. MS2 data were centroided during acquisition. 
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For analysis with an LTQ-FT Ultra (Thermo Fisher, San Jose, CA), samples were 
loaded onto a C18 75 μm diameter column using a NanoLC-1D (Eksigent). They were 
eluted with a 180 min analytical gradient from 2% - 50% acetonitrile containing 0.1% 
formic acid at 260 nL/min. The solution was sprayed into the mass spectrometer by using 
a PicoView nanospray source (New Objective). One full MS acquisition was used to 
trigger 8 CID scans. The FT parameters were: spray voltage, 2.0 kV; capillary 
temperature, 200ºC; MS2 selection threshold, 500 counts; activation q, 0.25; activation 
time, 30 ms.  MS2 data were centroided during acquisition. 
Alpha and beta casein (Sigma-Aldrich) and/or bovine serum albumin (BSA, 
Michrom Bioresources) were analyzed as controls in each experiment. In addition, casein 
was used to determine the optimal amount of protein to be used for detection of 
phosphopeptides.   
Tryptic peptides from immunoprecipitated full-length native Cx43 were analyzed 
as above with the following exceptions. A 180 min gradient from 2% - 60% acetonitrile 
with 0.1% formic acid was used for separation. Both data dependent (discovery) and 
data-directed (inclusion list) methods were used to acquire mass spectra on the Thermo 
LTQ Orbitrap XL with ETD and CID (31). Parent mass lists for the latter experiment 
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were created from all doubly, triply and quadruply charged phosphopeptide ions 
identified in the in vitro experiments. 
2.3.6 Mascot database search and determination of phosphorylation sites 
Thermo RAW files were processed by using extract_msn (2007 version 4.0, 
Thermo Fisher, San Jose, CA) with a grouping tolerance of 0.8 Da, an intermediate scan 
setting of 1, and a minimum of 1 scan per group. The NCBI nonredundant database 
(version 20090105, restricted to mammals) was searched using MASCOT 2.2.06 (Matrix 
Science, Oxford, U.K.) with the following settings: enzyme, trypsin; MS tolerance, 10 
ppm; MS/MS tolerance, 0.6 Da; maximum number of missed cleavages, 3; peptide 
charge of 1+, 2+ and 3+; variable modifications were carbamidomethylation of C, 
oxidation of M, phosphorylation of Y, T, and S, and deamidation of N-terminal Q to E. 
All identifications of phosphopetides were manually analyzed as described below. 
Tryptic peptides containing S, T, or Y, including those with up to 3 missed 
cleavages, were predicted by in silico digestion (Protein Prospector MS-Digest, 
prospector.ucsf.edu). Theoretical MS2 spectra were generated (Protein Prospector MS-
Product, prospector.ucsf.edu) for phosphopeptides that were identified in the Mascot 
search. When there were multiple possibilities for phosphorylation (e.g., more than one S, 
T, or Y in a singly-phosphorylated peptide, or more than two S, T, or Y in a doubly-
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phosphorylated peptide) a table of ions was made for each possible phosphopeptide. The 
product ion spectrum was manually compared to each table and the best match was 
identified. In cases where the elution profiles of phosphopeptides overlapped, they were 
separated using extracted ion chromatograms for diagnostic product ions. 
2.4 RESULTS AND DISCUSSION 
The amino acid sequence of carboxyl terminal domains varies widely across 
connexins and is thought to confer specific properties to the channels composed of 
different connexin subtypes (32). The carboxyl terminal domain of Cx43 is structurally 
disordered, this intrinsically flexible property is important in both cell signaling and 
regulatory activity (33, 34). It has been shown that this region is involved in intra- and 
intermolecular interactions (35, 36). Phosphorylation of this region regulates the protein 
structure, subcellular distribution and function (6-8, 11-16).
 
Seventeen serine and two 
tyrosine residues in the Cx43-CT have been shown to be targets of various protein 
kinases under control, stimulated and pathological conditions. Phosphorylation of the 
Cx43-CT by CaMKII, however, has not been reported. 
2.4.1 The phosphorylation activity of CaMKII 
To identify sites of CaMKII phosphorylation in the Cx43-CT under controlled 
conditions in vitro, we first optimized the amount of fusion protein required for recovery 
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of phosphopeptides and identification of phosphorylated amino acid residues using 
casein, a known phosphoprotein, at 3 different concentrations:  0.3 μg/20 μL, 1 μg/20 μL 
and 3 μg/20 μL. We identified 10 phosphorylation sites in casein (Figure 2-2), and 
determined that 3 μg casein in 20 μL reaction volume yielded the best results. 
 
Figure 2-2. The numbers of phosphorylation sites identified on alpha-casein (total 11 
phosphorylation sites) with respect to different protein amounts as starting material (0.3, 
1.0, 3.0 ug). 
To validate the in vitro conditions used for the CaMKII reactions, we incubated a 
peptide containing the threonine autophosphorylation site of CaMKII, nonphosphorylated 
autocamtide (KKALHRQETVDAL), with CaMKII in the presence of ATP, Ca
2+
 and 
calmodulin as described in Materials and Methods. We used nonphosphorylated 
autocamtide in the absence of CaMKII as a negative control, and phospho-autocamtide 
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(KKALHRQEpTVDAL) as a positive control. The MALDI spectrum obtained from 
autocamtide subjected to in vitro phosphorylation demonstrated a phosphopeptide that 
was identical to that observed from phospho-autocamtide obtained from AnaSpec 
(Figure 2-3). No phosphopeptide was detected in the reaction performed in the absence 
of CaMKII. 
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Figure 2-3. MALDI spectra of Autocamtide. (A) Positive control shows the 
phosphorylated peptide (KKALHRQEpTVDAL) of m/z 1588.6028. (B) Negative control 
shows the non-phosphorylated peptide (KKALHRQETVDAL) of m/z 1508.7915. (C) In 
vitro phsohphorylation shows the phosphorylated peptide (KKALHRQEpTVDAL) of m/z 
1588.8795. 
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2.4.2 Phosphorylation of Cx43-CT by CaMKII 
We next incubated GST-Cx43-CT fusion protein with CaMKII and subjected the 
reaction products to enzymatic digestion with Lys-C followed by trypsin and mass 
spectrometric analysis to identify the amino acid residues that are phosphorylated by 
CaMKII. Tandem mass spectrometry yielded 98% coverage of the Cx43-CT (Figure 2-
1). Coverage was comparable for results obtained by using CID and ETD; however, two 
phosphorylation sites were identified by ETD alone (see below). This is not surprising 
because ETD-derived alternative fragmentation patterns that complement CID-derived 
data have been reported previously (37). The sequence corresponding to amino acid 
residues 259-293, a non-phosphorylated region, was only identified in one experiment, 
possibly because we used TiO2 to enrich for phosphopeptides (38). The lack of 
phosphorylated residues observed in this sequence agrees with previous reports that 
S262, S279 and S282 are targets of protein kinases other than CaMKII (39, 40). 
Four independent phosphorylation experiments were performed followed by 
digestion and tandem mass spectrometry. No serine residues were phosphorylated in the 
negative control samples that were incubated in the presence of Ca
2+
, calmodulin and 
ATP, but in the absence of CaMKII. Amino acid residues in Cx43-CT that were 
identified as being phosphorylated by CaMKII are reported in Table 2-1, and the 
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diagnostic ions for these identifications are listed in Table 2-2. Several interesting 
observations can be made from these data. 
 
Table 2-1. Serine residues in Cx43-CT phosphorylated by CaMKII with previously 
published kinase information where available. 
 
  
- 65 - 
 
 
Table 2-2. Phosphoserine-containing peptides from Cx43-CT in vitro phosphorylation by 
CaMKII. 
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One previously identified phosphorylation site, S306, was identified in each of the 
four experiments (Figure 2-4). This serine is dephosphorylated in response to global 
ischemia in Langendorff perfused rat hearts (8). Dephosphorylation of S306 has recently 
been shown to contribute to reduce coupling (41). CaMKII and other protein kinases 
were tested by Axelsen et al. (8) in the in vitro phosphorylation assays using synthetic 
peptides containing this site; however, they could not identify the kinase(s) responsible 
for this phosphorylation. The discrepancy between their results and ours is likely due to 
their use of a short peptide containing amino acid residues 291-313 (with cysteine 298 
substituted with an alanine (8)) instead of a protein containing the full length of the 
carboxyl terminus of Cx43 as substrate for the CaMKII in vitro phosphorylation reaction.  
We can only speculate that the presence of C298 or a more extensive surrounding 
sequence may allow the protein to adopt a conformation required for phosphorylation of 
S306 by CaMKII. 
 
- 67 - 
 
 
Figure 2-4. CaMKII phosphorylation of Cx43-CT at S306. (A) Extracted chromatogram 
of m/z 988.3930-988.3990. (B) MS spectrum of m/z 988.4019 represents doubly charged 
peptide QASEQNWANYSAEQNR (one phosphorylation site). (C) CID MS2 spectrum 
indicates phosphorylation on S306. (D) Extracted chromatogram of m/z 659.2617-
659.2717. (E) MS spectrum of m/z 659.2708 represents triply charged peptide 
QASEQNWANYSAEQNR (one phosphorylation site). (F) ETD MS2 spectrum indicates 
phosphorylation on S306.  
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Another substrate for CaMKII was the previously identified serine residue at 
position 330 (Figure 2-5). S330 is one of three serine residues (S325/S328/S330) that has 
been shown by Lampe et al. (11) to be phosphorylated on Cx43 localized at intercalated 
disks, and that are involved in the electrophoretic mobility shift of Cx43 to the slowest 
migrating phosphorylated form (P2) in immunoblots (7). S330 is phosphorylated after 7 
min of global ischemia, and subsequently dephosphorylated between 30 and 45 min of 
ischemia (8). Cooper and Lampe found that S325/S328/S330 are phosphorylated by CK1 
(42). Interestingly, we observed phosphorylation of S325/S328/S330 by CaMKII (Figure 
2-5), but not by CK1. Although we could not detect phosphorylation of S325/S328/S330 
by CK1, we found that this kinase phosphorylated S306 and S296. Additional studies will 
be required to determine whether CaMKII and CK1 compete for target sites on Cx43 in 
vivo. One e ample in which these two kinases share target sites is in the Alzheimer’s 
disease protein, tau (43-46). 
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Figure 2-5. CaMKII phosphorylation of Cx43-CT at S330. (A) Extracted chromatogram 
of m/z 953.7332-953.7428. (B) MS spectrum of m/z 953.7358 represents triply charged 
peptide MGQAGSTISNSHAQPFDFPDDNQNAK (one phosphorylation site, two 
deamidated sites). (C) CID MS2 spectrum indicates phosphorylation on S330.  (D) ETD 
MS2 spectrum indicates phosphorylation on S330. 
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 Importantly, we found one novel serine phosphorylation site that has not been 
reported previously, S244, and a second site, S314, that has recently been described in the 
mouse brain synaptosomal preparations
 
(9) and  human embryonic stem cells
 
(10) (Table 
2-1). The spectra identifying these residues are shown in Figures 2-6 and 2-7, 
respectively. We also identified S257, S296 and S297, which have not been linked 
previously to a specific kinase, as phosphorylation sites for CaMKII. Moreover, 
phosphorylation of S255, S364, S365, S369, S372 and S373, which have been reported 
previously to be directly or indirectly associated with other protein kinases was also 
identified in the GST-Cx43-CT fusion protein after in vitro phosphorylation by CaMKII.  
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Figure 2-6. CaMKII phosphorylation of Cx43-CT at a novel site, S244. (A) Extracted 
chromatogram of m/z 617.6179-617.6203. (B) MS spectrum of m/z 617.6193 represents 
triply charged peptide GRSDPYHATTGPLSPSK (one phosphorylation site). (C) CID 
MS2 spectrum indicates phosphorylation on S244. (D) ETD MS2 spectrum indicates 
phosphorylation on S244.  
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Figure 2-7. CaMKII phosphorylation of Cx43-CT at S314. (A) Extracted chromatogram 
of m/z 659.2613-659.2717. (B) MS spectrum of m/z 659.2708 represents triply charged 
peptide QASEQNWANYSAEQNR (one phosphorylation site). (C) CID MS2 spectrum 
indicates phosphorylation on S314. (D) ETD MS2 spectrum indicates phosphorylation on 
S314.  
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In summary, we identified a total of 15 putative serine phosphorylation sites for 
CaMKII in the carboxyl terminus of Cx43, bringing the total number of reported 
phosphorylation sites in the carboxyl terminus of Cx43 to 21 (19 Ser and 2 Tyr).  
Interestingly, two of these sites, S328 and S369, were identified by ETD alone. In each 
case, the phosphorylated serine is part of a multiply phosphorylated peptide fragment, 
therefore hampers the unambiguous identification under CID fragmentation. This is an 
example in which combined use of CID and ETD as complementary fragmentation 
techniques provides enhanced identification of post-translationally modified amino acid 
residues. Because no phosphopeptides were identified in the control, CaMKII-free 
reactions, it is unlikely that phosphorylation of these residues was non-enzymatic or 
nonspecific. 
In one experiment, we identified phosphorylation of S306, S372 and S373 in full-
length native Cx43 immunoprecipitated from murine ventricular myocardium.  
Additional studies will be required to determine whether the serine residues in Cx43-CT 
identified in the present study, both in vitro and in vivo, are phosphorylated by CaMKII 
in vivo. Our data suggest that some residues may be targets for multiple protein kinases, 
implying that modulation of gap junction assembly and/or intercellular communication 
may depend on the combined levels of activity of the different protein kinases under 
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different pathophysiological conditions. It also remains to be determined not only which 
protein kinase pathways are activated in the initial phases of ischemic injury that result in 
phosphorylation of Cx43, but also which pathways are activated subsequently that lead to 
dephosphorylation of Cx43 during ischemia and subsequent rephosphorylation in post-
ischemic tissue. 
2.5 CONCLUSIONS AND LIMITATIONS 
Mass spectrometry is a powerful technique that has allowed for identification of 
several phosphorylation sites, including a novel site at S244, that are targets of an 
important, biologically relevant protein kinase, CaMKII. In the present study, we 
identified four putative CaMKII serine phosphorylation sites (S296, S365, S369 and 
S373) that had been postulated by Payne et al. (47) and confirmed by Pearson et al. (48) 
as CaMKII phosphorylation sites based on an RXXS consensus sequence. Two CaMKII 
sites identified in our study (S244 and S306) conform to a KXXS sequence, which is also 
a consensus sequence for PKC (49). Utilization of ETD can potentially enhance the 
ability in phosphorylation site localization, particularly when multiple potential 
phosphorylation sites are present in a given peptide. It should be noted that conditions 
used in the present study were to drive the phosphorylation reaction to completion, and 
that steady state phosphorylation of Cx43 by CaMKII was not meant to represent 
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transient signaling activity of CaMKII. Thus, residues observed to be phosphorylated in 
the present study exist in different structural environments and may not be 
phosphorylated by CaMKII in vivo under the same physiological or pathophysiological 
condition or time frame. Finally, because CaMKII activity levels exhibit dynamic 
changes during acute and chronic ischemia, the mass spectrometric analyses performed in 
our study should be applied to full-length protein isolated from native cardiac tissue 
subjected to various pathophysiological conditions to elucidate whether and to what 
extent CaMKII regulates the phosphorylation state of Cx43 in diseased myocardium. For 
example, analysis of Cx43 extracted from CaMKII transgenic mice subjected to 
myocardial infarction
 
(50) would reveal how activation and inhibition of CaMKII 
influence phosphorylation of Cx43 associated with cardiac dysfunction or 
arrhythmogenesis during myocardial ischemia in vivo. 
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Chapter 3* 
HD Exchange and PLIMSTEX Determine the Affinities and Order of 
Binding of Ca
2+
 with Troponin C 
 
 
 
 
 
 
 
 
 
* 
This chapter is based on recent publication: Reproduced with permission from Huang, R. 
Y. C., Rempel, D. L., and Gross, M. L. HD Exchange and PLIMSTEX Determine the 
Affinities and Order of Binding of Ca
2+
 with Troponin C. Biochemistry, 2011, 50, 5426-
5435. Copyright 2011 American Chemical Society
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3.1 ABSTRACT   
Troponin C (TnC), present in all striated muscle, is the Ca
2+
-activated trigger that 
initiates myocyte contraction. The binding of Ca
2+
 to TnC initiates a cascade of 
conformational changes involving the constituent proteins of the thin filament. The 
functional properties of TnC and its ability to bind Ca
2+
 have significant regulatory 
influence on the contractile reaction of muscle. Changes in TnC may also correlate with 
cardiac and various other muscle-related diseases. We report here the implementation of 
the PLIMSTEX strategy (Protein Ligand Interaction by Mass Spectrometry, Titration and 
H/D Exchange) to elucidate the binding affinity of TnC with Ca
2+
 and, more importantly, 
to determine the order of Ca
2+ 
binding of the four EF hands of the protein. The four 
equilibrium constants, K1 = (5 ± 5) x 10
7
 M
-1
, K2 = (1.8 ± 0.8) x 10
7
 M
-1
, K3 = (4.2 ± 0.9) 
x 10
6
 M
-1
, and K4 = (1.6 ± 0.6) x 10
6
 M
-1
, agree well with determinations by other 
methods and serve to increase our confidence in the PLIMSTEX approach. We 
determined the order of binding to the four EF hands to be III, IV, II, and I by extracting 
from the H/DX results the deuterium patterns for each EF hand for each state of the 
protein (apo through fully Ca
2+
 bound). This approach, demonstrated for the first time, 
may be general for determining binding orders of metal ions and other ligands to proteins. 
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3.2  INTRODUCTION 
The basis of muscle contraction has been well studied over four decades. There 
are primarily two types of proteins involved in this process: troponin and tropomyosin (1-
11). Muscle contraction is initiated by an increase in intracellular free Ca
2+ 
concentration 
and is controlled by the binding of Ca
2+ 
to troponin (1-3, 8-10, 12-17). Troponin, which is 
present in skeletal and cardiac muscle of various species of mammals, birds, and some 
invertebrates, has three subunits: troponin C (TnC), troponin T (TnT), and troponin I (6). 
Each subunit plays a special rule in modulating the movement of muscle filament.  
Troponin C, which is the subject of this study, is an 18 kDa protein that is 
structurally homologous in skeletal and cardiac muscle (1, 3) but has different Ca
2+ 
stoichiometry in these two tissues. Skeletal troponin C has four helix-loop-helix motifs 
(EF hands) that bind to Ca
2+
. The EF-hand motif, which is a conserved structure first 
identified in parvalbumins (18), allows Ca
2+ 
to interact with carboxyl and hydroxyl 
groups of amino-acid sidechains located at positions 1, 3, 5, 7, 9, and 12 of a 12-
membered loop (1, 19). One of the EF hands (EF-I) in cardiac troponin C is defunct so 
the protein binds only three Ca
2+ 
(1, 2, 7, 20-23). In skeletal troponin C, two of four EF 
hands are located in the C-terminal (EF-III and EF-IV) and have higher affinities for Ca
2+ 
(Ka ~ 10
7
 M
-1
) than the other two EF hands; they are usually saturated with Ca
2+ 
or Mg
2+ 
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in tissue. The binding of Ca
2+ 
at these two sites helps maintain the interaction between the 
C-terminus of troponin C, the N-terminus of troponin I, and the C-terminus of troponin T 
(1, 24-27). The latter subunit binds to tropomyosin on the muscle thin filament, serving 
as a key in complex formation. When the two N-terminal EF hands (EF-I and EF-II), 
which have lower affinities for Ca
2+ 
(Ka ~ 10
5
-10
6
 M
-1
), bind to Ca
2+
, troponin C 
undergoes a conformational change to form a hydrophobic core (15, 23, 26, 28-30). The 
inhibitor region on the C-terminus of troponin I then interacts with this core and releases 
tropomyosin and actin. The free actins are able to interact with the myosin heads on the 
thick filament and produce muscle contraction (1-3).   
The Ca
2+
 binding to troponin C and its relation to muscle-contraction disorders 
have implications in cardiac-related diseases. The amino-acid sequence of troponin C and 
the phosphorylation of troponin I induced by over-activation of protein kinase A and C 
(31, 32) affect the binding of Ca
2+ 
to troponin C. Newly designed drugs interact with 
troponin C and adjust its affinities to Ca
2+ 
(33, 34). 
The Ca
2+
-binding and protein-target binding properties of troponin C have been 
the subjects of numerous studies using NMR (21, 25, 35-37), calorimetry (38) and 
fluorescence (26). Hydrogen/deuterium exchange (H/DX) coupled with mass 
spectrometry is another powerful method to study protein conformation, protein-protein 
- 88 - 
 
or protein-ligand interactions (39-46). With H/DX, one can measure the relative rates of 
exchange of backbone amide hydrogen with deuterium and thereby follow changes in H-
bonding, which often is parallel to relative solvent accessibilities. Recently, H/DX was 
applied to study the regulatory function of human cardiac troponin complex and the 
conformational changes of troponin complex induced by Ca
2 
binding (47, 48). 
 We describe here the use of PLIMSTEX (Protein–ligand interactions by mass 
spectrometry, titration, and H/D exchange) (49-51) to determine again the affinities of 
Ca
2+ 
to rabbit skeletal troponin C. The purpose of the determination is to test the ability of 
PLIMSTEX to extract these values in a complex 4:1 interaction. From the determined 
affinities (equilibrium constants), we calculated the fractional species for the variousTnC-
Ca
2 
states as a function of [Ca
2+
]. The deuterium exchange patterns of four peptic 
peptides representing the four EF hands of rabbit skeletal troponin C (EF-I peptide 28-44: 
DADGGGDISVKELGTVM; EF-II peptide 63-73: EVDEDGSGTID; EF-III peptide 100-
109: FRIFDRNADG; EF-IV peptide 136-149: MKDGDKNNDGRIDF) were then 
measured. Guided by the fractional species calculation, the deuterium patterns for each 
EF-hand were measured as a function of the various Ca
2+
 binding states (i.e., 0, 1, 2, 3, 
and 4) to determine how D distributions change as a function of the binding states. 
Previous efforts to elucidate the binding properties of Ca
2+
 to troponin C used NMR, 
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fluorescence measurement, Ca
2+
 ion-selective electrode measurements, and mutagenesis 
(36, 37, 52, 53). Although some insights were achieved, a full understanding on the Ca
2+
 
binding order is still lacking. Our strategy provided data that, for the first time, gives the 
binding order of Ca
2+
 to full length troponin C in a single and relatively simple 
experiment. Our ultimate goal is to extend the approach to study the effect of troponin I 
and troponin T on the affinities and orders of binding of Ca
2+
 to troponin C. 
3.3 EXPERIMENTAL PROCEDURE 
3.3.1 Materials 
Rabbit skeletal Troponin C (TnC) was purchased from Ocean Biologics Inc 
(Seattle, WA). Potassium chloride, calcium chloride, EGTA tetra sodium salt [ethylene-
bis(oxyethylenenitrilo)tetraacetic acid tetrasodium], and HEPES hemisodium salt [N-(2-
hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) hemisodium salt] were purchased 
from Sigma-Aldrich (St.Louis, MO). Deuterium oxide was purchased from Cambridge 
Isotope Laboratories Inc (Andover, MA). Immobilized pepsin on agarose was purchased 
from Pierce (Rockford, IL).  
3.3.2 Apo TnC preparation 
TnC was dialyzed against EGTA to obtain apo-TnC. A 1 mL protein solution 
containing 180 μg of TnC was prepared in 10 mM HEPES and 150 mM KCl. The 
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solution was dialyzed by using Slide-A-Lyzer Dialysis Cassettes 7000 MWCO (Pierce, 
CA). The dialysis membrane was first boiled two times in 10 mM EGTA for 10 min to 
remove heavy metals from the membrane and then soaked in deionized H2O for 10 min. 
The protein solution was then injected into the cassette and dialyzed against 10 mM 
HEPES, 150 mM KCl and 1 mM EGTA for 2 h. The buffer was exchanged for fresh 
buffer, and the solution was dialyzed overnight at 4 °C. The protein solution was then 
dialyzed against 10 mM HEPES, 150 mM KCl for 3 h, fresh buffer was added, and the 
protein was dialyzed again for 3 h at 4 °C. The concentration of the final protein solution 
was measured by using a UV spectrophotometer at 280 nm absorption (a = 0.2 (mg/mL)
-1
 
cm
-1
). The protein solution was stored at -80 °C.          
3.3.3 H/D exchange (H/DX) protocol 
H/DX was initiated by diluting the protein solution 1:40 into D2O buffer (10 mM 
HEPES, 150 mM KCl) at 25 °C. At various times, H/DX was quenched by adding 
sufficient 1 M HCl at 0 °C to give a final pH of 2.5. 
For Global protein H/DX experiments, a quenched protein solution was loaded 
onto a C8 guard column (1 mm x 15 mm, Optimize Technologies, Oregon, City, OR). 
The column was pre-equilibrated with 200 μL 0.2  formic acid in water (0 °C). After 
loading the protein solution, the column was washed with 250 μL 0.2  formic acid in ice 
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cold normal water (0 °C) to back-exchange the labile sites on side chains. The protein 
was eluted by using a gradient from 5% to 40% solvent B in 3 min, 40% to 100% solvent 
B in 3 min and back to 5% solvent B in 2 min. (Waters CapLC, Manchester, U.K; solvent 
A, water containing 0.1% formic acid; solvent B, acetonitrile containing 0.1% formic 
acid). 
For peptide-level H/DX experiments, 5 μL of immobilized pepsin on agarose was 
added to the solution. Protein digestion took place at 0 °C for 3 min. The final solution 
was centrifuged for 2-3 s to bring down the agarose beads. The peptide-containing 
supernatant was then loaded onto a C18 guard column (1 mm x 15 mm, Optimize 
Technologies, Oregon, City, OR). The column was pre-equilibrated with 200 μL of 0.2  
formic acid in water (0 °C). After loading, the column was washed with 250 μL of 
aqueous 0.2% formic acid (H2O) to back-exchange the labile sites. The protein was 
eluted by using a gradient from 5% to 35% solvent B in 3 min, 35% to 80% solvent B in 
4 min, 80% to 100% solvent B in 1 min and back to 5% solvent B in 2 min. All LC 
connection lines were immersed in a water-ice (0 °C) bath. (Waters nanoACQUITY 
UPLC, Manchester, U.K; solvent A, water containing 0.1% formic acid; solvent B, 
acetonitrile containing 0.1% formic acid). 
3.3.4 LC-ESI/MS analysis with a Q-TOF mass spectrometer 
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Global protein H/DX results were acquired on a Waters (Micromass) 
(Manchester, U.K.) Q-TOF Ultima spectrometer equipped with a Z-spray ESI source. 
The instrument settings were: capillary voltage, 3.0 kV; cone voltage, 80 V; source and 
desolvation temperatures, 80 °C and 180 °C, respectively. The cone and desolvation gas 
flow rates were 40 and 400 L/h, respectively. The MS profile used for quadrupole 
transmission was: scan from m/z 500, dwell for 5% of the scan time, ramp to m/z 1000 for 
45% of the scan time, and then dwell at m/z 1000 for 50% of the scan time. 
Peptide-level H/DX results were acquired on a Maxis (Bruker) (Bremen, 
Germany) Q-TOF spectrometer. The instrument settings were: capillary voltage, 3.8 kV; 
nebulizer gas, 0.4 Bar; drying gas flow rate and temperature, 4.0 L/min and 180 °C; 
funnel RF, 400 V(pp).  
3.3.5 LC-ESI/MS/MS analysis of protein digests 
To establish the peptide profile from the pepsin digestion of TnC, 100 pmol TnC 
was digested with pepsin for 3 min, and the peptides were identified by accurate mass 
and sequencing by product-ion analysis on a Thermo LTQ XL Orbitrap (Thermo Fisher, 
San Jose, CA). Samples were loaded and eluted by using an Ultra 1D+ UPLC and 
autosampler (Eksigent, Dublin, CA). A 75 μm diameter column was pulled with a laser-
based column puller (Sutter Instruments, Novato, CA) and packed with 12 cm of Magic 
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C18AQ reverse-phase media (Michrom Bioresources, Auburn, CA). The column was 
interfaced via a nanospray source (New Objective, Woburn, MA) and eluted with a 60 
min gradient from 2-98% solvent B (acetonitrile with 0.1% formic acid). The spray 
voltage was 2.0 kV, and the capillary temperature was 200 °C. One full mass spectral 
acquisition triggered six scans of MS/MS whereby the most abundant precursor ions were 
activated for sequencing. The product-ion spectra (MS/MS) data were centroided during 
the acquisition. 
3.3.6 Mascot database search 
Thermo RAW files were processed using extract_msn (2007 version 4.0, Thermo 
Fisher, San Jose, CA) with a grouping tolerance of 0.8 Da, an intermediate scan setting of 
1, and a minimum of 1 scan per group. The NCBI nonredundant database (version 
20080718, restricted to mammals) was searched by using MASCOT 2.2.06 (Matrix 
Science, Oxford, U.K.) with the following settings: enzyme, none; MS tolerance, 10 ppm; 
MS/MS tolerance, 0.8 Da; maximum number of missed cleavages, 3; peptide charge of 
1+, 2+ and 3+; oxidation of methionine was set as variable modification. 
3.3.7 Data analysis 
The uptake of deuterium by the global protein was the average mass differences 
between the masses of the deuterated protein and the undeuterated protein. The back-
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exchange rate was measured to be one deuterium loss per minute (45). No correction for 
back exchange was applied because the time between sample quench and the 
measurement with the mass spectrometer was less than 3 min, and all data were treated 
consistently. For global protein analysis, deconvoluted spectra were generated by using 
the MaxEnt1 algorithm (MassLynX version 4.0). The parameter settings were: resolution, 
1.00 Da/channel; uniform Gaussian width at half height, 1.00 Da; minimum intensity 
ratios, 33% for left peaks and right peaks.  
3.3.8 Kinetic modeling 
The global protein kinetic data were fit with a fixed-rate-constant binning model 
by MathCAD (Math-Soft. Inc. Cambridge, MA) in which the root mean square (RMS) 
was minimized (50, 51). All e changeable H’s were separated into four fi ed rate-
constant bins (k = 10, 1, 0.1, 0.01 min
-1
). These rate constants were selected because the 
rates of exchange change measurably in the time frame 0.17 min to 540 min, and the 
H/DX became relatively constant after 60 min; hence the brackets of 10 min
-1
 (fast 
exchangers, half-life ~0.07 min) and 0.01 min
-1
 (slow exchangers, half-life ~69 min) 
were chosen. Although the largest rate constant for H/DX is >100 min
-1
 for unstructured 
peptides (54), we are yet unable to obtain data at the short times that correspond to this 
rate constant. Three trials were fit separately, and the results were averaged and reported 
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with standard deviations.  
3.3.9 Titration and species fraction calculation 
The method for fitting the titration curve was described previously (51). Briefly, 
there are nine parameters involved in the 1:4 protein-ligand binding systems: Ka1, Ka2, 
Ka3, Ka4, D0, ΔD1, ΔD2, ΔD3, ΔD4; Ka is the binding constant; D0 is the deuterium uptake of 
protein in the absence of ligands (Apo form); ΔDx is the difference between the average 
of deuterium uptake of the complex in the presence of x ligands and that of the apo form. 
The non-linear least squares fitting utilized the “Minimize” function of MathCAD (Math-
Soft. Inc. Cambridge, MA) to minimize the root mean square (RMS) of all inputs by 
optimizing the parameters being searched. To obtain the nine parameters in single fitting 
cycle with acceptable precision, a significant number of titration points would be needed 
(>500) by applying a resampling statistical method (51). Because it was difficult to fit the 
titration curve by varying all nine parameters in one fitting cycle, a repeat fitting cycle 
strategy was used to obtain the K’s and ΔD’s values reported here. 
    The fitting process was started by making a guess of the D’s (D0, ΔD1, ΔD2, ΔD3, 
ΔD4) values. The initial values for D0 was set as experimental data, and the values for 
ΔD1, ΔD2, ΔD3, ΔD4 were obtained through a PLIMSTEX experiment at high-protein 
concentration (100 times the 1/Ka or Kd as reported previously) (Figure 3-3). We fixed 
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these D’s values and searched for K’s in the initial fitting process. After the four K’s (Ka1, 
Ka2, Ka3, Ka4) were obtained, the repeat-fitting processes were then started. In the first 
half cycle, we fixed the K’s obtained in the initial process and searched for the D’s. We 
then fixed the ΔD1, ΔD2, ΔD3, and searched for Ka1, Ka2, Ka3, Ka4, D0, and ΔD4 to finish the 
cycle. This fitting cycle was repeated until the relative differences between K’s values 
before and after each cycle of fitting were less than 10%. Three trials of experiments 
were applied with this strategy separately, and the results were averaged and reported 
with standard deviations.         
Once the binding affinities of Ca
2+
 were determined, the information for 
fractionally bound TnC species as a function of Ca
2+
 was obtained and presented as a 
deuterium pattern (d0, d1, . . .) in which other isotopes (e.g.,
13
C, 
15
N, 
18
O) had been 
removed by using an isotopic pattern calculation. To obtain these patterns, each mass list 
from three experimental trials was extracted from their individual spectra as an x,y file (x: 
mass-to-charge ratio; y: intensity). A program in MathCAD was applied to find the 
isotopic peak envelope among the list by providing the chemical formula and charge state 
of the target peptide. The peak area in each envelope was applied for fractional species 
calculation, and the isotopes (
13
C, 
15
N, 
18
O) were removed from the output by using the 
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information provided via the Isotope Simulation function in Qual Browser 2.0.7 
(Xcalibur, Thermo Fisher, San Jose, CA).      
3.4 RESULTS 
3.4.1 H/DX kinetics of apo- and holo-TnC 
Binding of four Ca
2+
 induces a conformational change in troponin C. Previous 
studies showed that the structure of the holo (Ca
2+ 
saturated) state of skeletal troponin C 
is more structurally open than the semi-apo state (two Ca
2+ 
bound). The center partial-
loop structure between the N and C-terminal EF hands forms a less flexible helix whereas 
the Ca
2+ 
is bound to the two EF hands near the N-terminus (EF-I and EF-II) (1, 4, 12, 55).  
A detailed structure of apo-troponin C has eluded determination owing to the 
unstructured C-terminus in the absence of Ca
2+ 
(37, 56). 
 
We began our study by measuring the kinetics of H/DX of rabbit skeletal troponin 
C in the Ca
2+ 
saturated (holo) and Ca
2+ 
absent (apo) states (Figure 3-1); the output is a 
plot of deuterium uptake as a function of exchange times (10 s to 9 h). To generate the 
holo state of troponin C, we made the protein stock solution (40 μM) containing 10 mM 
HEPES, 150 mM KCl, and 1 mM CaCl2, pH 7.4. Using KCl mimics physiological 
conditions, and excess Ca
2+ 
(the ratio of Ca
2+ 
concentration to protein concentration was 
25) insures that the four EF hands of troponin C are saturated with Ca
2+
. To generate the 
- 98 - 
 
apo state of troponin C, we replaced CaCl2 with 3 mM EGTA to insure that no Ca
2+ 
was 
present in the protein. 
 
Figure 3-1. Kinetics of H/D exchange for rabbit skeletal troponin C. Apo-troponin C in 3 
mM EGTA (squares, red) shows more extensive D uptake than holo troponin C in 1 mM 
CaCl2 (diamonds, black). The fitted curves are shown as solid lines.   
Rabbit skeletal troponin C has 158 exchangeable amide protons (excluding one 
proline). Because the percentage of D2O in the experiment was 97%, the maximum 
number of observable exchange events is 153. After 20 min of H/DX, the mass of apo 
troponin C shifted by 116 ± 1 Da, indicating that ~75% of the amide sites are 
exchangeable at this time. This high level of exchange is in accord with the general view 
that troponin C in solution is highly flexible, dynamic, and solvent-exposed in the 
absence of Ca
2+
. In the presence of Ca
2+
, the number of amides undergoing H/DX 
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decreased to 83 ± 1 Da after 20 min of exchange, indicating that ~32 amide sites no 
longer exchange as a consequence of Ca
2+
 binding. A more stabilized secondary structure, 
an increase in hydrogen bonding, a decrease in solvent accessibility of some amide sites, 
and/or a combination of these factors decreased the H/DX rates.  
To understand quantitatively how Ca
2+ 
binding affects the exchange rate, we fit 
the kinetic curve with four exchange rate bins (k = 10, 1, 0.1, 0.01 min
-1
) (Table 3-1). 
The results show that the apo state has 79 ± 1 sites with an exchange rate constant of 10 
min
-1
, whereas the holo state has only 26 ± 2 sites with the same rate constant, indicating 
that ~53 fast-exchanging sites are affected by Ca
2+ 
binding. In the holo state, these sites 
shift to the lower exchange rates including those with an exchange rate constant of 1 min
-
1
 where the apo state has 1 ± 1 sites whereas the holo state has 24 ± 2 sites. There are also 
significant differences for those amides undergoing exchange with a rate constant of 0.01 
min
-1
; whereas the holo state has 61 ± 3 sites, 37 ± 4 amides in the apo state exchange at 
this corresponding low rate. The overall shift to states having low exchange rate constants 
is consistent with troponin C possessing a more rigid secondary structure upon Ca
2+
 
binding.     
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Kinetic Fit # of H's per fixed-rate bin 
k (min
-1
 ) 10 1 0.1 0.01 
Apo 79 ± 1 1 ± 1 16 ± 3 37 ± 4 
Holo 26 ± 2 24 ± 2 3 ± 2 61 ± 3 
Table 3-1. Numbers of amide hydrogen undergoing exchange for D for apo and holo 
troponin C. The kinetic modeling used four fi ed e change rate constants and “binned” 
the number of amides with respect to the rate constants.      
3.4.2 Affinities for Ca2+ binding of troponin C 
Several methods can be used to measure the binding affinities for protein-protein 
interactions and protein-small molecule interactions; these methods include FRET 
(fluorescence resonance energy transfer) (57), NMR (58), CD (circular dichorism) (59), 
calorimetry (60) and SPR (surface plasmon resonance) (61, 62). Because there is a 
significant difference in deuterium uptake between apo-TnC and holo-TnC, we can apply 
PLIMSTEX (Protein–ligand interactions by mass spectrometry, titration, and H/DX) to 
measure the equilibrium constants for Ca
2+
 binding to TnC (45, 49-51, 63) in a relatively 
simple experiment.  
Our titration format varies the relative concentration of Ca
2+
 and monitors by MS 
the extent of H/DX as a function of time. Because EF-III and EF-IV are known from 
previous studies to be high-affinity sites, they are often saturated with Ca
2+
. To insure the 
protein was in the full apo state (no bound Ca
2+
), we carried out a two-step dialysis 
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procedure (see Experimental). The deuterium uptake of the dialyzed TnC was 
comparable to that of TnC in the presence of EGTA (data not shown), indicating the 
dialysis was successful in removing Ca
2+
 from the protein. This purified protein sample 
was used as the starting material for the titration (Figure 3-2); the troponin C 
concentration for the titration was 0.3 μM, which falls into the range of Kd’s determined 
previously (64). The time for H/DX (97% D2O buffer, 10 mM HEPES, 150 mM KCl, pH 
7.4) was necessarily constant at 1 h, a time for which H/DX had become relatively 
constant, and for which small errors in sampling time would have minimal impact on the 
titration. We also performed the titration at high-protein concentration, 15 μM, which is 
~100 times the Kd values (Figure 3-3). A titration at this protein concentration will 
usually give a “sharp break” curve that reveals the stoichiometry of the ligand binding 
(49); in this case, rabbit skeletal troponin C binds four Ca
2+
, in agreement with previous 
findings. The other purpose for conducting this “sharp break” titration is to obtain an 
estimate of the ΔD’s values to aid the PLIMSTEX curve fitting process (see 
Experimental). At high-protein concentration, the equilibrium shifts toward the protein-
ligand complex, and the resulting ΔD’s values will be similar to the actual ΔD’s, which 
report the change in the protein secondary structure owing to each ligand binding. 
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Figure 3-2. PLIMSTEX curve of Troponin C titrated with Ca
2+
 and followed by MS-
based H/DX.  The concentration of the protein for the titration was 0.3 μM. 
 
 
Figure 3-3. “Sharp-break” PLIMSTEX titration curve; protein concentration = 15 μM. 
The junction of the two arms of the curves indicates the stoichiometry of Ca
2+
 binding is 
4:1. 
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In this manner, we obtained ΔD1, ΔD2, ΔD3, and ΔD4 as 6, 15, 31, and 37, 
respectively. These values serve as the initial guesses for the repeat-fitting cycle 
described in the experimental section. The relative variations of K2, K3 and K4 all 
decreased to ~10% after we performed three cycles of the fitting (Figure 3-4). Although 
the relative variation of K1 was not constrained over each fitting cycle, probably because 
the number of experimental points is insufficient, its value still is in a reasonable range. 
Given that the affinities are known and that the main purpose of the study is to investigate 
the order of binding, we did not pursue the titration further because additional 
improvements would not affect significantly the determination of the binding order.   
Previous studies show that skeletal troponin C has two Ca
2+ 
binding sites, EF-III 
and EF-IV, located near the C-terminus; their binding affinities are comparable at (2.1 ± 
0.7) x 10
7
 M
-1 
(64). Two additional sites are located near the N-terminus of skeletal 
troponin C, EF-I and EF-II, and their binding affinities for Ca
2+
 are in the range of 3 x 10
5
 
to 5 x 10
6
 M
-1
 (20, 64). Although the equilibrium constants show variability from study to 
study (possibly because the affinities are relatively small), the consensus is that the 
equilibrium constants for the N-terminal EF hands are in the range of 10
5
-10
6
 M
-1 
and 
smaller than those for the C terminus (37). 
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Figure 3-4. Relative differences between K’s values before and after each cycle of fitting 
as a function of the number of fitting cycles.  
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We fit the titration curve to a non-linear least squares model that was previously 
described (51). The output of the fitting produced four Ka’s (Table 3-2), two with high 
values of (5 ± 5) x 10
7
 M
-1
 and (1.8 ± 0.8) x 10
7
 M
-1
, which are within a factor of 3 of 
previous results. The other two Ka’s have smaller values of (4.2 ± 0.9)   10
6
 M
-1
 and (1.6 
± 0.6) x 10
6
 M
-1
, which are also within the range of values from previous studies. The 
fitting parameter D0 (127 ± 1), which represents the deuterium uptake in the apo state is 
in agreement with the experimental results (127 ± 2).   
K Experimental Value Literature Values 
K1 (5 ± 5) x 10
7
 M
-1
 2 x 10
7
 M
-1
 (1);(2.1 ± 0.7) x 10
7
 M
-1
(64) 
K2 (1.8 ± 0.8) x 10
7
 M
-1
 2 x 10
7
 M
-1
 (1);(2.1 ± 0.7) x 10
7
 M
-1
(64) 
K3 (4.2 ± 0.9) x 10
6
 M
-1
 5 x 10
6
 M
-1
 (20);(3.2 ± 1.3) x 10
5
 M
-1
(64) 
K4 (1.6 ± 0.6) x 10
6
 M
-1
 5 x 10
6
 M
-1 
(20) ;(3.2 ±1.3) x 10
5
 M
-1
(64); 
ΔD4 38 ± 1 N/A 
D0 127 ± 1 N/A 
RMS 0.62  
Figure 3-2. Four Ca
2+
 binding constants of troponin C obtained by fitting PLIMSTEX 
titration curves. 
3.4.3 Fractional species and binding order 
The titration study provides us the four equilibrium constants (Ka) for Ca
2+
 
binding to troponin C. These values are not new, and they can be determined by other 
approaches.  Remarkable, however, is that three of the four values (K2, K3 and K4) can be 
extracted with reasonable precision from a single titration, probably because each 
addition of Ca
2+ 
to the protein induces a change in conformation that responds to H/DX. 
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Because the binding affinities are different, it is likely that Ca
2+
 binding is cooperative 
and occurs, at least in part, in a stepwise manner. 
The next level of information is the order of binding, which we sought to 
determine by following the H/DX extent at the EF-hand level. One prospect is to examine 
the deuterium distribution for the various EF hands as a function of Ca
2+
 concentration. 
These EF-hand regions may be removed from the protein following H/DX as peptides by 
pepsin digestion and submitted to LC-MS analysis. When an EF hand binds Ca
2+
, we 
expect the extent of H/DX will decrease. By identifying the state of Ca
2+
 binding (e.g., 0, 
1, 2, 3, 45 for which the change occurs, we should be able to determine in a 
straightforward way the order for Ca
2+ 
binding. The interaction between Ca
2+ 
and 
troponin C at any titration point, however, results in a mixture of Ca
2+
-binding states, and 
the deuterium distribution of any given EF hand at each titration point is of a mixture of 
different Ca
2+ 
bound states. The challenge is to extract from this mixture of states the 
deuterium distribution of an EF hand for a single state (Figure 3-5).  
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Figure 3-5. Fractional species curves showing the distribution of each TnC:xCa
2+
 as a 
function of Ca
2+
 concentration (μM). (Blue: zero Ca2+-bound; Pink: 1 Ca2+-bound;, 
Yellow: 2 Ca
2+
-bound; Light blue: 3 Ca
2+
-bound; Purple: 4 Ca
2+
-
 
bound).  
The four equilibrium constants, determined by PLIMSTEX or any other method, 
are a source of fractional species information that allow the determination of the 
population of the various Ca
2+
 states as a function of [Ca
2+
]. We hypothesized that 
knowing these fractional species will lead us to the required deuterium distributions. To 
test this hypothesis, we used the previously reported and likely more reliable K1 value 
(2.1 x 10
7
 M
-1
) and the K2, K3, and K4 values (1.8 x 10
7
 M
-1
, 4.2 x 10
6
 M
-1
, 1.6 x 10
6
 M
-1
, 
respectively) determined by PLIMSTEX to calculate the fractional species as a function 
of total [Ca
2+
] and determine the population of the five troponin C species, TnC:xCa
2+
 (x 
= 0-4) when the protein concentration was 4.2 μM (Figure 3-5). The reason for choosing 
a literature K1 is the precision for our K1 value is not high because the titration is 
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underdetermined, and we don’t want that to affect the precision for the fractional-species 
determination. We chose seven Ca
2+ 
concentrations from the fractional-species plot, 
including [Ca
2+
] = 0 (100% apo TnC) and Ca
2+
 = 2 mM (100% holo TnC) (Table 3-3) for 
our search for the required deuterium distributions. To obtain the needed experimental 
data, we conducted H/DX for 1 h in 90% D2O buffer (10 mM HEPES, 150 mM KCl, pH 
7.4), quenched the exchanging solution, digested the protein with pepsin for 3 min on ice-
water, and analyzed the peptide mixture by LC/MS. 
 
[Ca] 
μM 
TnC-
0Ca 
TnC-
1Ca 
TnC-
2Ca 
TnC-
3Ca 
TnC-
4Ca 
0 100.0% 0.0% 0.0% 0.0% 0.0% 
8.4 7.4% 19.7% 44.5% 23.7% 4.7% 
10.4 2.3% 10.4% 39.8% 35.6% 11.9% 
12.1 0.0% 4.9% 29.7% 42.6% 22.8% 
13.8 0.0% 0.0% 18.2% 43.1% 38.7% 
16.7 0.0% 0.0% 0.0% 29.1% 70.9% 
2000 0.0% 0.0% 0.0% 0.0% 100.0% 
Table 3-3. Various solution concentrations chosen for H/DX to determine the order of 
binding of Ca
2+
 with troponin C. The values are calculated fractional species of each 
Ca
2+
-bound TnC species and are taken from the fractional species curves in Figure 3. 
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MS analysis directly gave us the complete isotopic distribution for specific 
deuterated peptides, but this distribution represents various states of the protein, not the 
single state we sought. Nevertheless, from these distributions, we can calculate the 
representative isotopic distribution for each Ca
2+
-bound troponin C species (see Figure 
3-6 for an example of this idea). The upper left spectrum shows the deuterium-containing 
isotopic distribution when [Ca
2+
] = 16.7 μM for the triply charged peptic peptide 
FRIFDRNADG, which is from the EF-III region. From Table 3-3, we know that there is 
30% TnC-3Ca
2+
 species and 70% of TnC-4Ca
2+
 species in the solution when the total 
[Ca
2+
] is 16.7 μM. Because we know the deuterium distribution of this peptide when 
[Ca
2+
] = 2 mM (representing 100% TnC-4Ca
2+
 species, lower left in Figure 3-6), we can 
remove that pattern from the experimental distribution to give the deuterium distribution 
for the peptide representing this region of the protein when it exists as TnC-3Ca
2+
 (right 
pattern in Figure 3-6).    
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Figure 3-6. (A) Deuterium-containing isotopic distribution of the triply charged peptic 
peptide 100-109 (FRIFDRNADG). The distribution can be represented as a mixture of 
70% holo (TnC-4Ca
2+
, red area in C) and 30% TnC-3Ca
2+
 states as shown in (C), which 
is an enlarged view of A. (B) Deuterium-containing isotopic distribution of triply charged 
peptic peptide 100-109 (FRIFDRNADG). The distribution represents 100% Holo state 
(TnC-4Ca
2+
) in 1 mM CaCl2. (C) Enlarged view of (A). Although the triply charged 
peptide is for demonstration, the doubly charged peptide was used for analysis. 
To sort out the required isotopic distributions, we implemented an algorithm with 
Mathcad 2001 Professional (Math-Soft, Inc., Cambridge, MA). We extracted mass lists 
containing all peptide information from each spectrum and input them into MathCAD as 
x,y files for peak-finding and fractional-species calculation. The basis for this algorithm 
is in matrix algebra as given in equation 1. 
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(1) 
In this equation, matrix A is the input of the experimental results; that is, the 
isotopic abundances for a single peptide, I, from peak 0 to peak n as a function of the 
various ligand concentrations. Matrix C provides the fractional species information; that 
is, the population of each species, PS, from species 0 to x as a function of the ligand 
concentrations. For troponin C, binding to Ca
2+
, x = 4, and there exist five species: TnC-
0Ca
2+
, TnC-1Ca
2+
, TnC-2Ca
2+
, TnC-3Ca
2+
, and TnC-4Ca
2+
. Matrix B is the output of 
isotopic abundances of species, IS, from peak 0 to peak n as a function of various Ca
2+
 
binding states.  
In the implementation, we normalized each row of each matrix so that their sum is 
equal to 1, and we required that the values in matrix B be positive. We fit the output in 
matrix B to the best values; this procedure requires minimizing the differences between 
matrix A and the product of matrix B and C. The intensity input can be the intensity of 
the peak centroid or its area in a peak-profile mode; the latter was used in this work so 
that each part in the isotopic distribution pattern was considered, in principle increasing 
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the accuracy of the calculation. By comparing the distribution of the peaks and their area, 
we obtained a deuterium isotopic pattern of each peptic peptide as a function of the Ca
2+
 
binding state. Changes in H-bonding or solvent accessibility for various regions of the 
protein induced by Ca
2+
 binding can be determined by simply analyzing the shift of the 
isotopic distribution. 
3.4.4 Order of Ca2+ binding 
Our hypothesis was that changes in the deuterium distributions for peptides from 
regions involved in Ca
2+
 binding as a function of the states of the protein (TnC-0Ca
2+
 to 
TnC-4Ca
2+
) will report the order of Ca
2+
 binding. To test this hypothesis, we needed four 
abundant peptic peptides each representing one of the four EF hands to follow as a 
function of the fractional species calculation, and we were able to obtain these reporter 
peptides by pepsin digestion. The four peptides are doubly charged 
DADGGGDISVKELGTVM (28-44) containing EF-I; doubly charged, EVDEDGSGTID 
(63-73) containing EF-II; doubly charged FRIFDRNADG (100-109) containing EF-III; 
and triply charged, MKDGDKNNDGRIDF (136-149) containing EF-IV. The outcome of 
the matrix-algebra calculation gave us the deuterium distributions convolved with the 
native distribution of C-13, N-15 and O-18 of each EF hand for the five states of Ca
2+ 
binding to troponin C. We then removed all isotope components except D for these four 
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unique peptic peptides by using the theoretical isotope ratio provided via the Isotope 
Simulation function in Qual Browser 2.0.7 (Xcalibur, Thermo Fisher, San Jose, CA). The 
isotope deconvolution process is illustrated in Figure 3-7. Briefly, each deuterium-
containing isotopic pattern is a mixture of various numbers of deuterium-containing 
species (d0, d1, d2…) with their isotopic species. By knowing the chemical formula for a 
particular peptide, we can calculate the isotope distribution (except that of D from H/DX) 
and remove it from the distribution, leaving a pure deuterium distribution (Figure 3-8). 
We submit that any slight change of the deuterium uptake can be readily revealed by this 
strategy.  
 
Figure 3-7. Deuterium distribution convolved with the native isotopic distribution of 
doubly charged peptide 63-73. Bars represent the different numbers of deuteriums (d0, d1, 
d2…) comprising each peak, and their heights include other isotopic contributions (C-13, 
N-15, O-18) (dark blue to light blue). Removing the native isotopic distribution leaves 
the deuterium distribution (bars outlined with red frames). 
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Figure 3-8. Top: Each column represents the deuterium distributions of the peptic 
peptide of EF hands: III, IV, II, I (left to right). Each row represents the various Ca
2+
 
bound TnC states: Apo (Absent Ca
2+
) to 4 Ca
2+
 bound TnC (top to bottom). Bottom: X-
ray crystal structure of rabbit skeletal troponin C (PDB: 1TCF) in gray, and the four EF 
hands are in black. 
Comparing the variation of the deuterium-distribution centroid for the four peptic 
peptides as a function of different Ca
2+ 
bound troponin C states (Figure 3-8), we see that 
the first shift from higher to lower deuterium content (indicating onset of protection) 
occurs for peptic peptide 100-109 containing EF-III for the transition of TnC-0Ca
2+
 to 
TnC-1Ca
2+
 whereas the deuterium distributions of the peptides representing the other 
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three EF hands remain largely unaffected. This indicates that EF-III in skeletal troponin C 
is first to bind Ca
2+
, although the binding may not be complete as the D distribution 
continues to shift to more protection as more calcium binds. Peptic peptide 136-149 from 
EF-IV showed a similar but more conclusive shift from a centroid of six to four 
deuteriums for TnC-2Ca
2+
,
 
indicating that EF-IV is the second Ca
2+ 
binding site. Similar 
to EF-III, the D distribution shows additional minor shifts as the protein continues to take 
up calcium. Although the shifts for EF-III and IV do not occur sharply as various states 
of Ca
2+
 binding are achieved, the results clearly show the higher propensity for binding 
Ca
2+
 by EF-III and EF-IV (~10
7
 M
-1
) than by EF-II and EF-I. Sykes and coworkers (53) 
studied the binding of Ca
2+ 
to synthetic EF-III and EF-IV peptides of troponin C by 1H-
NMR. Their results show that Ca
2+
 binds to synthetic EF-III peptide; the resulting Ca
2+
-
EF-III then associates with the apo-EF-IV peptide to form a heterodimer Ca
2+
-EF-III/EF-
IV. The heterodimer then binds the second calcium to give 2Ca
2+
-EFIII/EFIV. Our results 
on the intact protein agree with this general picture of stepwise binding. 
Because the N-terminal EF-I and EF-II have lower binding affinities to Ca
2+ 
(~10
6
 
M
-1
), they should bind after EF-III and IV. Indeed, the deuterium content (most abundant 
ion) of the peptic peptide containing EF-II shifts from four to two deuteriums at the 
transition to TnC-3Ca
2+
, whereas the peptic peptide representing EF-I shifts from eight to 
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six deuteriums at the transition to TnC-4Ca
2+
. Thus, the third Ca
2+ 
binds at EF-II followed 
by the last Ca
2+ 
binding at EF-I. Sykes and coworkers (37) also studied Ca
2+ 
binding to 
EF hands in N-terminus of chicken skeletal troponin C by using NMR. Although the 
overall binding picture for full length TnC remained unclear, they could conclude that 
EF-II is the first site in the N-terminus of troponin C that binds to Ca
2+ 
and EF-I is the last 
Ca
2+ 
binding site, a conclusion that is consistent with the results of H/DX presented here. 
To illustrate more clearly the order of Ca
2+ 
binding, we normalized the deuterium-
uptake values for the four peptides to their most probable deuterium (highest intensity 
peak) uptake. This allows us to view the relative deuterium uptake as a function of 
different TnC-Ca
2+ 
states (Figure 3-9). The outcome clearly shows that the order of Ca
2+ 
binding to the four Ca
2+ 
binding sites in intact skeletal troponin C is EF-III > EF-IV > EF-
II >EF-I, although there is likely to be some simultaneous binding of Ca
2+
 by EF-III and 
IV.      
 
- 117 - 
 
 
Figure 3-9. A plot of the normalized relative deuterium uptake based on the centroids of 
the deuterium distributions for four peptic peptides containing the four EF hands as a 
function of various Ca
2+
-bound TnC states. 
3.5 DISCUSSION 
The advantage of H/DX coupled with MS is that changes in the extent of H/DX, 
whether caused by increased H bonding or decreased solvent accessibility or both, can be 
used to compare two or more states. The conclusions do not depend highly on the 
abundances of the various isotopomers but principally on their m/z. The PLIMSTEX 
strategy further extends the advantage of H/DX by affording, via ligand titrations at a 
fixed concentration of protein, the protein-ligand binding affinities. The equilibrium 
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constants are essential for the design of an experimental approach to extract deuterium 
distributions for regions of a protein as a function of its binding state. 
We illustrate the approach to determine the binding order of Ca
2+
 to troponin C. 
Although troponin C is a well-studied protein, establishing the order of Ca
2+ 
binding has 
proven difficult. The kinetics of HDX at the protein or global level demonstrates that the 
protein is considerably stabilized as a consequence of Ca
2+ 
binding. The differences in the 
apo and holo states allow the binding affinities of troponin C with Ca
2+
 to be measured in 
a single-titration format. The values of the equilibrium constants allow calculation of 
fractional species for troponin C. From H/DX experiments at known fractional species, 
we can extract the deuterium distribution of four regions of the protein that bind Ca
2+
. 
Those distributions shift to lower mass when Ca
2+
 binds at the site, providing a basis for 
determining the binding order of the four Ca
2+
 ions.  
Previous studies on Ca
2+ 
binding to troponin C by Ca
2+ 
titration (36, 37, 52, 53, 64) 
indicated the binding is cooperative and affected by pH. Those studies, however, did not 
give a clear outcome of the binding order of Ca
2+
 to troponin C probably because the 
similar binding affinities of Ca
2+ 
in each terminal region of troponin C cause the states to 
coexist at various Ca
2+
 concentrations. Nevertheless, our results indicate the Ca
2+ 
binding 
to skeletal troponin C occurs in the order EF-III > EF-IV > EF-II > EF-I. This 
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determination is attributed to the high sensitivity of MS in the H/DX platform and the 
ability to extract from the data specific D distributions for the five binding states of the 
protein.  
The reasons for this trend of binding are not completely understood. Preferential 
binding at the C terminus is well-established. Binding details may be an outcome of the 
various charge states of the protein in different pH environments or the difference of the 
secondary and tertiary structure of the Ca
2+ 
binding sites with respect to individual Ca
2+ 
binding (52). Nevertheless, our results can help understanding the detailed mechanism of 
the muscle contraction. It will be of interest to see whether this approach can be applied 
to determine binding orders of other proteins and ligands. 
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Hydrogen-Deuterium Exchange Mass-Spectrometry Reveals Troponin 
C Dynamics and Binding within the Troponin Complex 
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4.1 ABSTRACT   
The troponin protein complex exists in the thin filament of striated muscle 
myocytes (along with tropomyosin and actin) and plays a regulatory role in muscle 
contraction by binding calcium ions released by nerve impulses. The complex is 
composed of three subunits; troponin C (TnC), the calcium binder; troponin I (TnI), the 
inhibitor; and troponin T (TnT), the anchor and structural support. The interactions within 
the troponin complex to produce muscle contraction and the role of the complex plays in 
cardiac-related diseases motivate its study. We used solution phase hydrogen/deuterium 
exchange (H/DX) monitored by mass spectrometry at both the global and peptide level to 
understand better the structural dynamics within the rabbit skeletal troponin complex. We 
determined that the major effector of structure in calcium-activated TnC is TnI, and that 
TnT plays a minor role in the interactions of TnC. We also compared the binding affinity 
between TnC and TnI in the absence or presence of TnT by using PLIMSTEX (protein-
ligand interaction by mass spectrometry, titration, and H/D exchange). Our titration 
curves, when fit with 1:1 binding model, provided binding constants, (1.9 ± 0.4) x 10
6
 M
-
1
; (2.4 ± 0.2) x 10
6
 M
-1
 in the absence or presence of TnT. The outcomes further confirm 
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that TnT has little effect on the binding between TnC and TnI and is a demonstration of 
the utility of H/DX in studying the properties of one protein in a complex. 
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4.2 INTRODUCTION 
Troponin, a 72 kDa protein complex in skeletal and cardiac muscle of mammals, 
is composed of three subunits: troponin C (TnC), troponin I (TnI) (1), and troponin T 
(TnT) (2, 3). Each subunit has its own unique function, and all are essential for muscle 
contraction (4). TnT binds to tropomyosin on the thin filament, serving as a key in 
complex formation (5, 6). TnI blocks the actin from interacting with the myosin head by 
anchoring its C-terminal region (Inhibitor region) (2). TnC, a calcium sensor, usually has 
four Ca
2+ 
binding sites (only three for cardiac TnC). Two sites located at the C-terminal 
domain have high Ca
2+ 
binding affinities (~10
7
 M
-1
), are saturated with Ca
2+ 
under normal 
physiological conditions so as to maintain the stability of the complex (3, 7, 8). When the 
intracellular free Ca
2+ 
concentration increases, Ca
2+
 binds to the N-terminal domain of 
TnC, changing the conformation of TnC and forming a hydrophobic pocket in the N-
terminal region (4, 9, 10). This region then interacts with the “inhibitor region” of TnI 
and releases actin, whereby muscle contraction is initiated through the interaction of actin 
and the myosin head. Any factor that affects the TnC-TnI interaction will influence the 
efficiency of muscle movement and may have implications in cardiac disease. For 
example, phosphorylation of TnI may be induced by over-activation of protein kinase A 
and C to affect both the binding of Ca
2+ 
to TnC and the interaction between TnC and TnI 
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(11-14). To overcome this, some drugs are designed to interact with TnC and adjust its 
affinities to Ca
2+ 
(15, 16). 
The binding of TnC, TnI and TnT in the complex have been studied by numerous 
approaches including NMR (17, 18), calorimetry (6), and fluorescence (19, 20). An X-ray 
crystallography study on the chicken-skeletal troponin complex (2) shows that complex 
formation utilizes an interaction between the C-terminal region of TnC and the N-
terminal region of TnI such that the C-terminal regions of TnI can bind to TnT through a 
coiled-coil helical interaction (Figure 4-1). The detailed conformation changes of each 
subunit upon the addition of each neighboring subunit, however, are not well understood. 
 
Figure 4-1. X-ray crystal structure of chicken skeletal troponin complex. Blue: troponin 
C (TnC); Red: troponin I (1); Yellow: troponin T (TnT 103-248). The complex with 
2Ca
2+
 loaded onto TnC is shown on the left (PDB: 1YVO), and the complex with 4Ca
2+
 
loaded onto TnC is on the right (PDB: 1YTZ)   
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We recently studied the binding of Ca
2+
 to rabbit skeletal TnC, as shown in the 
previous chapter, and determined the binding affinities and binding order by using 
hydrogen/deuterium exchange (H/DX) coupled with mass spectrometry (21). This 
approach is now widely used to study protein conformation, protein-protein, or protein-
ligand interactions (22-25). With H/DX, one monitors the changes in H-bonding caused 
by changes in folding and interactions with ligands and other proteins. Recently, H/DX 
was applied to study the regulatory function of human cardiac troponin complex and the 
conformational changes of troponin complex induced by Ca
2+ 
binding (26, 27). 
To understand more completely the role played by individual subunits in the 
troponin complex formation, we extended our study on the physical properties of rabbit 
skeletal TnC from that of the protein itself to that of the protein within the troponin 
complex. By monitoring the changes of the extent of deuterium uptake of TnC with the 
addition of TnI and TnT, we probed changes in H-bonding caused by changes in solvent 
accessibility of TnC in the complex. We then examined the binding affinities between 
TnC and TnI in the absence or presence of TnT by PLIMSTEX (protein-ligand 
interaction by mass spectrometry, titration, and H/D exchange) (28, 29) to determine 
whether TnT influences the TnC-TnI interaction. Finally, by conducting enzymatic 
digestion and comparing the deuterium uptake of peptide regions from each subunit with 
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the addition of neighboring subunits, we verified the interface locations for each 
interaction site to assess whether H/DX can determine whether the troponin complex is 
stabilized by binding to TnT.  
This H/DX study of the skeletal troponin complex is also motivated by our 
general goal to develop and implement mass-spectrometry-based methods to determine 
biophysical properties of proteins alone and in more complex settings such as in protein 
complexes.            
4.3 EXPERIMENTAL 
4.3.1 Materials 
Rabbit skeletal Troponin C (TnC), troponin I (1), troponin T (TnT) were 
purchased from Ocean Biologics Inc (Seattle, WA). Porcine pepsin, citric acid, sodium 
citrate, sodium chloride, ethanolamine, potassium chloride, calcium chloride, EGTA 
tetrasodium salt [ethylene-bis(oxyethylenenitrilo)tetraacetic acid tetrasodium], and 
HEPES hemisodium salt [N-(2-hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) 
hemisodium salt] were purchased from Sigma-Aldrich (St.Louis, MO). Deuterium oxide 
was purchased from Cambridge Isotope Laboratories Inc (Andover, MA). The synthetic 
TnI inhibitor peptide RGKFKRPPLRR was purchased from Genscript (Piscataway, NJ).  
4.3.2 Troponin complex preparation 
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TnC, TnI, and TnT were dialyzed against HEPES buffer (10 mM HEPES, 150 
mM KCl, pH 7.4) for 2 h at 4 °C using Slide-A-Lyzer Dialysis Cassettes 7000 MWCO 
(Pierce, CA) followed by exchange with fresh buffer and overnight dialysis. The 
concentration of the final protein solution was measured by the BCA protein assay 
following the manufacturer’s protocol (Thermo Fisher, Rockford, IL). The protein 
solution was aliquoted and stored at -80 °C.  
The TnC alone was prepared in the presence of 1 mM CaCl2 or 3 mM EGTA in 
HEPES buffer (10 mM HEPES, 150 mM KCl, pH 7.4) to generate Ca
2+
 absent or 
saturated form of TnC. To generate troponin complexes with different compositions of 
subunits, TnC, TnI, or TnT was mixed separately in 1:1 ratio in the presence of 1 mM 
CaCl2 in HEPES buffer and equilibrated at 25 °C for at least 1 h. All samples were 
prepared in 20 μM protein concentration.            
4.3.3 H/D exchange (H/DX) protocol 
For global protein HDX measurement, 40 pmol of protein sample was diluted 
tenfold in D2O buffer (10 mM HEPES, 150 mM KCl) at 25 °C. At various times, the 
exchange was quenched by adding sufficient 1 M HCl at 0 °C to give a final pH of 2.5. 
The quenched protein solution was then loaded onto a C8 guard column (1 mm x 15 mm, 
Optimize Technologies, Oregon, City, OR) via an Agilent 1100 HPLC (Santa Clara, CA) 
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operated at 50 μM/min flow rate with 0.1  TFA for 3 min. The protein was eluted by 
using a gradient from 5% to 50% solvent B in 0.3 min, 50% to 100% solvent B in 5.2 min 
and isocratic flow at 100% solvent B for 0.5 min, then back to 5% solvent B in 0.1 min at 
50 μM/min flow rate. All LC connection lines were immersed in a water-ice (0 °C) bath. 
(Waters nanoAcquity UPLC, Manchester, U.K; solvent A, water containing 0.1% formic 
acid; solvent B, acetonitrile containing 0.1% formic acid). 
For peptide-level H/DX measurement, 80 pmole of protein sample was diluted 
tenfold in D2O buffer (10 mM HEPES, 150 mM KCl) at 25 °C for 30 min and quenched 
by adding 1 M HCl. The quenched sample was injected into an on-line pepsin-digestion 
device, immersed in a water-ice (0 °C) bath, containing immobilized pepsin in a 1 mm × 
2 cm guard column (Upchurch Scientific, WA) (30) via an Agilent 1100 HPLC (Santa 
Clara, CA) operated at 50 μM/min flow rate with 0.1  TFA for 3 min. The digested 
protein solution was trapped on a C18 guard column (1 mm x 1.5 cm, Optimize 
Technologies, Oregon City, OR) and separated by a C18 analytical column (1 mm x 5 cm, 
Dionex, Bannockburn, IL) via an Agilent 1200 HPLC (Santa Clara, CA) with a gradient 
operated under 50 μM/min flow rate. The gradient settings were: 5% to 15% solvent B in 
0.3 min, 15% to 50% solvent B in 5.2 min, 50% to 100% solvent B in 0.5 min, and 
isocratic flow at 100% solvent B for 1.5 min, then back to 5% solvent B in 0.1 min. 
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Solvent A was water containing 0.1% formic acid, and solvent B was 80% acetonitrile in 
water containing 0.1% formic acid.   
4.3.4 LC-ESI/MS analysis with a Q-TOF mass spectrometer 
Global protein H/DX results were acquired on a Waters (Micromass) 
(Manchester, U.K.) Q-TOF Ultima spectrometer equipped with a Z-spray ESI source. 
The instrument settings were: capillary voltage, 3.2 kV; cone voltage, 80 V; source and 
desolvation temperatures, 80 °C and 180 °C; the cone and desolvation gas flow rates 
were 40 and 400 L/h. The MS profile used for quadrupole transmission was to scan from 
m/z 300, dwell for 5% of the scan time, ramp to m/z 1000 for 45% of the scan time, and 
then dwell at m/z 1000 for 50% of the scan time. 
Peptide-level H/DX results were acquired on a MaXis (Bruker) (Bremen, 
Germany) Q-TOF spectrometer. The instrument settings were: capillary voltage, 3.8 kV; 
nebulizer gas, 0.8 Bar; drying gas flow rate and temperature, 5.0 L/min and 200 °C.  
4.3.5 LC-ESI/MS/MS analysis of protein digests 
To confirm the peptide sequences for peptic peptides of TnC, TnI and TnT, three 
protein solutions were subjected to on-line pepsin-digestion separately as described 
previously (31) and analyzed on a Thermo LTQ XL ETD Orbitrap (Thermo Fisher, San 
Jose, CA). The instrument settings were: spray voltage, 3.5 kV; sheath gas flow rate, 8 
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(arbitrary units); capillary temperature, 275 °C; capillary voltage, 35 V; and tube lens, 
110 V. One full mass spectral acquisition triggered six MS/MS scans (precursor ion 
activation with CID). The peaks in the product-ion spectra (MS/MS) were centroided for 
each peptide during the acquisition. 
4.3.6 Mascot database search 
Thermo RAW files were processed by using extract_msn (2007 version 4.0, 
Thermo Fisher, San Jose, CA) with a grouping tolerance of 0.8 Da, an intermediate scan 
setting of 1, and a minimum of 1 scan per group. The NCBI non-redundant database 
(version 20110722, restricted to mammals) was searched by using MASCOT 2.2.06 
(Matrix Science, Oxford, U.K.) with the following settings: enzyme, none; MS tolerance, 
10 ppm; MS/MS tolerance, 0.8 Da; maximum number of missed cleavages, 3; peptide 
charge of 1+, 2+ and 3+; variable oxidation of methionine. 
4.3.7 Data analysis 
The uptake of deuterium was determined by the mass-to-charge differences 
between the centroid of the isotopic distribution of the deuterated peptide and the 
undeuterated peptide, or the average mass differences between the masses of the 
deuterated protein and the undeuterated protein. No correction for back exchange was 
applied because the time between sample quench and the measurement with the mass 
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spectrometer was less than 6 min, and all data were treated consistently. For global 
protein analysis, MaxEnt1 algorithm (MassLynX version 4.0) was used to generate 
decharged spectra. The parameter settings were: resolution, 1.00 Da/channel; uniform 
Gaussian width at half height, 1.00 Da; minimum intensity ratios, 33% for left peaks and 
right peaks. For peptide analysis, the centroid of the peptide isotopic distribution was 
analyzed using HDExaminer 1.0 (Sierra Analytics, Modesto, CA). 
4.3.8 Kinetic modeling 
The global protein kinetic data were fitted with a fixed-rate-constant binning 
model by using MathCAD (Math-Soft. Inc. Cambridge, MA) as described previously (29, 
32). Briefly, all e changeable H’s were separated into four fi ed rate-constant bins (k = 
10, 1, 0.1, 0.01 min
-1
), and the root-mean-square (RMS) was minimized during the fitting 
process. Three trials were fit separately, and the results were averaged and reported with 
standard deviations.  
4.3.9 PLIMSTEX titration 
To obtain the binding affinity between TnC and TnI and to examine whether TnT 
could affect the interaction between them, the TnC alone and TnC-TnT (1:1) complex 
were first incubated at 20 μM protein concentration in HEPES buffer (10 mM HEPES, 
150 mM KCl) in the presence of 1 mM CaCl2 for 1 h at 25 °C. The two complex samples 
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were than incubated with various TnI concentrations (from 8 μM to 300 μM) for 1 h at 25 
°C in the same buffer system. The H/DX experiment was then started, as described in 
previous section. The H/DX time was 30 min, chosen because the extent of H/DX had 
become relatively constant at that time, and small errors in sampling time would have 
minimal impact on the titration accuracy. The method for fitting the titration curve was 
described previously (29, 32). A 1:1 protein-ligand binding system was used invoking  
three fit parameters: Ka1, D0, ΔD1; where Ka1 is the binding constant; D0 is the deuterium 
uptake of protein in the absence of ligands (apo form); and ΔD1 is the difference between 
the average of deuterium uptake of the complex in the presence of ligand and that of the 
apo form. The parameters were optimized in the searching process to minimize the root 
mean square (RMS) of all inputs. MathCAD (Math-Soft. Inc. Cambridge, MA) was used 
in this fitting process. Three trials of experiments were fitted separately, and the results 
were averaged and reported with standard deviations.         
4.4 RESULTS AND DISCUSSION 
4.4.1 H/DX kinetics of TnC within the Tn complex 
   Troponin C (TnC) acts as a calcium sensor in the troponin complex. Two Ca
2+
 
binding sites (EFIII and EFIV) with high binding affinities (~10
7
M
-1
), located at the C-
terminal domain, are often saturated with Ca
2+
 and stabilize the three-part complex. The 
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other two binding sites, located at the N-terminal domain, have lower Ca
2+
binding 
affinities (~10
6 
M
-1
) (3, 21). Once the four sites are saturated with Ca
2+, a “hydrophobic 
pocket” forms near the N-terminal region of TnC, providing the location for interaction 
with the “inhibitor region” of TnI to initiate muscle contraction. 
The solvent accessibility and the hydrogen bonding of TnC are affected 
significantly by interacting with Ca
2+
 as revealed by our earlier H/DX study (21). Most of 
the changes occur at the four Ca
2+
 binding regions (EF-hands). The additional presence of 
TnI and TnT are likely to have significant influence on the physical properties of TnC 
and its dynamics in solution. Marshall and coworkers (27) studied the conformational 
changes of cardiac TnC (cTnC), cTnI and cTnT in the binary (cTnC-cTnI) and ternary 
complexes (cTnC-cTnI-cTnT) in the presence and absence of Ca
2+
 by using H/DX 
FTICR MS. They concluded that the amide exchange rates of C-terminal regions of cTnC 
are largely affected by the interaction with cTnI and cTnT and that the N-terminal regions 
of cTnC are mainly affected by cTnI. Although skeletal troponin is structurally similar to 
cardiac troponin, the binding properties between each subunit might be different. 
To address how TnI and TnT affect the dynamics and conformation of TnC, we 
designed a different H/DX kinetics experiment to study global TnC in the presence or 
absence of TnI and TnT (Figure 4-2). We added excess amounts of Ca
2+
 in the solution 
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(1 mM) to stabilize the binary (TnC-TnI; TnC-TnT) and the ternary (TnC-TnI-TnT) 
complexes. The ratio for each subunit in solution was 1:1 and the complexes were 
equilibrated for 1 h at 25 °C before initiating the H/DX. 
 
 
Figure 4-2. Kinetics of H/D exchange for rabbit skeletal TnC. Apo-TnC in 3 mM EGTA 
(diamonds, red) shows the most extensive D uptake. Ca
2+
 loaded TnC (squares, green) 
and Ca
2+
 loaded TnC-TnT complexs (squares, blue) show similar D uptake. Ca
2+
 loaded 
TnC-TnI complex (squares, gray) and Ca
2+
 loaded TnC-TnI-TnT complex (squares, 
black) show further decrease of D uptake. The fitted curves are shown as solid lines.   
It is obvious that the presence of Ca
2+ 
(green line) affects the conformation of 
TnC significantly, as is well known and consistent with the H/DX results reported in the 
previous chapter (21). Interestingly, the addition of TnT to TnC has minor impact on the 
hydrogen bonding of TnC (blue line); only approximately five amide hydrogens on TnC 
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are affected when TnT binds. Thus, the binding of TnT affects in a minor way the solvent 
accessibility of TnC, indicating that the interaction between these two subunits is either 
weak or highly localized. The addition of TnI to TnC further increases H-bonding, 
decreasing the solvent accessibility of TnC (gray line; ~20 D lower than the D uptake of 
TnC alone). The decrease shows that the N-terminal regions of TnC can interact with the 
inhibitor region of TnI in the presence of Ca
2+
. Again underscoring the minor effects of 
TnT, we find its addition to the TnC-TnI binary complex (black line) produces only 
minor effects on TnC.   
To probe more deeply how TnI and TnT
 
binding in the complex affects the 
exchange kinetics, we fit the kinetic curve with four exchange rate-constant bins (k = 10, 
1, 0.1, 0.01 min
-1
) (Table 4-1). The results are consistent with those reported previously 
(21). Ca
2+
 binding affects 48 fast-exchanging amides of TnC; TnC in the absence of Ca
2+
 
exchanges 96 ± 1 amides with a rate constant of 10 min
-1
, whereas when loaded with Ca
2+
, 
48 ± 2 amides exchange with the same rate constant.  
Although the overall kinetics is affected by the addition of TnI and TnT, there is no 
significant effect on the number of fast-exchanging amides. There are slower exchanging 
amides (k = 1 min
-1
) that are affected upon TnT binding. Ca
2+
-loaded TnC has 32 amides 
whereas TnC in the Ca
2+
-loaded TnC-TnT complex has 24 amides that exchange with 
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this rate constant. The addition of TnI further affects the number of amides that exchange 
with this rate constant: 8 TnC amides in the Ca
2+
-loaded TnC-TnI complex exchange 
with a rate constant of 1 min
-1
, whereas 12 TnC amides in the ternary complex (TnC-TnI-
TnT) that exchange with this rate constant. The effect of TnI binding on TnC is 
principally to slow down the exchange of amides in the k = 1 min
-1
 rate constant regime, 
whereas there is little effect on exchange for TnT binding.   
pKinetic Fit # of H's per fixed-rate bin Total 
k ( min
-1
 ) 10 1 0.1 0.01  
TnC-EGTA 96 ± 1 7 ± 1 19 ± 1 13 ± 1 135 
TnC-CaCl2 48 ± 2 32 ± 6 14 ± 2 28 ± 4 122 
TnC-TnT-CaCl2 49 ± 1 24 ± 1 18 ± 2 26 ± 4 117 
TnC-TnI-CaCl2 54 ± 1 8 ± 1 16 ± 1 20 ± 3 98 
TnC-TnT-TnI-CaCl2 50 ± 4 12 ± 6 13 ± 2 20 ± 2 95 
Table 4-1. The numbers of exchangeable amide hydrogens of five TnC complexes with 
respect to four fixed exchange rate constants.    
Binding with TnI, on the other hand, reduces further the number of amides 
exchanging at k = 1 min
-1
, producing more hydrogen bonds and presumably reducing 
solvent accessibility for a portion of TnC. There are no significant differences for amides 
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of TnC that exchange with smaller rate constants (k = 0.1 and 0.01 min
-1
) as a function of 
binding to TnI or TnT. Thus, TnC binding to Ca
2+
 reduces significantly the number of 
fast exchanging amides, and TnI binding reduces further the number of amides 
exchanging with k = 1 min
-1
. The affected amides apparently shift to a very slow 
exchange regime where k < 0.01 min
-1
. We find little effect for the binding of TnT. 
4.4.2 PLIMSTEX study of TnI binding of TnC and TnC-TnT complex 
TnC-TnI interaction is known to be the key factor in muscle contraction (2, 3, 33). 
Swenson and coworkers (19, 20) studied the affinities between skeletal TnC and TnI in 
the presence of different metal cations (Ca
2+
 and Mg
2+
) by inserting specific fluoros-
probes and measured the changes of fluorescence. Given that our global H/DX 
measurement on TnC shows significant decrease of deuterium uptake in the presence of 
TnI, it is of interest to investigate the TnC-TnI interactions by applying PLIMSTEX (28, 
29).  
To do this, we titrated TnC, at a concentration of 20 μM, with TnI at 
concentration ranging from 8 to 300 μM (Figure 4-3, blue curve) in the presence of 1 
mM CaCl2. H/DX was initiated by twenty-fold dilution of the mixtures into D2O buffer 
as described in the experimental section. We further examined the influence of TnT on 
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the TnC-TnI interaction by first making the TnC-TnT complex in 1:1 ratio, as described 
in the experimental section, and titrated with TnI (Figure 4-3, pink curve). 
 
Figure 4-3. PLIMSTEX curve of Ca
2+
-loaded TnC (blue) and Ca
2+
-loaded TnC-TnT 
complex (34) titrated with TnI. The concentration of the protein for the titration was 1 
μM. 
 
Table 4-2. TnC-TnI affinities obtained by PLIMSTEX strategy. The fitting process 
utilizes 1:1 binding model and three search parameters (Ka1, D0, ΔD1).      
Given that the two curves are similar, we conclude that the presence of TnT has 
minor impact on the TnC-TnI interaction. To have a quantitative understanding on the 
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strength of the interactions, we fitted the curves to obtain affinities by using 1:1 binding 
model in MathCAD, in which three variants were optimized in the searching process 
(Ka1, D0, ΔD1) (Table 4-2). The fitted results of ΔD1 are 28 for the TnC-TnI interaction 
and 23 for (TnC + TnT)-TnI interaction, which are in good agreement to the experimental 
results of 27 and 23, respectively. The values of D0, which are 112 for TnC-TnI 
interaction and 109 for (TnC+TnT)-TnI interaction also agree with the experimental 
results of 111 and 110, respectively. Fitting the titration curves also afford the affinities 
(Ka1). They are (1.9 ± 0.4) x 10
6 
M
-1 
for the interaction of  Ca
2+
-loaded TnC interacting 
with TnI, and (2.4 ± 0.2) x 10
6 
M
-1 
for Ca
2+
-loaded TnC-TnT complex interacting with 
TnI. When compared to the Swenson fluorescence results (19, 20) for the affinity of 
Ca
2+
-loaded TnC interacting with 5-(iodoacetamido)-eosin (IAE) labeled TnI (1.7 x 10
9 
M
-1
), our affinity values are three magnitudes smaller. Given that they titrated TnI with 
TnC at 25 nM TnI concentration under similar buffer condition (10 mM Pipes, 0.3 M 
KCl, 0.01% NaN3, 1 mM CaCl2, pH 7.0) to ours but having the presence of 0.5 mM 
dithiothreitol (DTT) or 2-mercaptoethanol (β-ME) and at lower temperature (0 ºC), these 
differences may change the stability of the TnC-TnI complex and cause the discrepancy 
between our results. The use of reducing agents (DTT and β-ME), for example, reduces 
three cysteine residues (Cys-48, 64, and 133) of TnI and one cysteine of TnC (Cys-98), 
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making them feasible for fluoros-probes labeling. This cysteine reduction, however, may 
affect the physical properties of TnC-TnI complex from stability and conformational 
point of views.         
Swenson also measured the affinity of Ca
2+
-loaded TnC interacting, with a TnI 
inhibitor peptide (residues 104-115, RGKFKRPPLRR) in addition to full-length TnI, and 
they obtained a value of (6 ± 1) x 10
5 
M
-1
. Our H/DX results on the TnC-TnI inhibitor 
peptide at a TnC concentration of 20 μM, and peptide-to-TnC ratio of 5:1, however, show 
no uptake differences between apo TnC and holo TnC (TnI inhibitor peptide loaded) 
(Figure 4-4). This suggests that the interaction between TnC and TnI inhibitor peptide 
104-115 is weak and that the presence of full length TnI is essential for the interaction. In 
any event, our PLIMSTEX results show that TnT has no significant impact on the TnC-
TnI interaction, in agreement with our H/DX kinetics measurements.    
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Figure 4-4. D uptake of TnC with or without the presence of TnI inhibitor peptide 
(residues 104-115, RGKFKRPPLRR). The ratio of peptide to TnC is 5:1. The extent of D 
uptake at 30 s exchange time (19) and 30 min exchange time (green) show no detectable 
differences between the apo and holo states.  
4.4.3 H/DX reveals structural changes of TnC, TnI and TnT within the 
complex 
 To expand the global studies of TnC-TnI, TnC-TnT, and TnC-TnI-TnT 
interactions, we followed the conformational changes of each subunit in the presence of 
additional subunits with site specificity by conducting pepsin digestion and examining 
the H/DX of the released peptides. Eight different protein mixtures were prepared: TnC-
EGTA; Ca
2+
 loaded TnC; TnI alone; TnT alone; TnI-TnT; Ca
2+
 loaded TnC-TnI; Ca
2+
 
loaded TnC-TnT; and  Ca
2+
 loaded TnC-TnI-TnT. Each subunit was mixed with 1:1 ratio 
at 20 μM protein concentration and equilibrated for 1 h at 25 °C before conducting the 
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H/DX for 30 min and then digesting with pepsin. The extent of D uptake on each subunit 
was analyzed separately and plotted as a function of peptide regions from N to C-terminal 
domain (Figure 4-5). 
 
Figure 4-5. Peptide level D uptake diagrams. Each diagram shows the relative D uptake 
(%) with respect to peptide sequence from N-terminal to C-terminal (Left to right). (A) 
Peptide level D uptake of TnC, (B) peptide level D uptake of TnI, (C) peptide level D 
uptake of TnT. The deuterium exchange time was 30 min. 
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For TnC, it is obvious that the addition of Ca
2+
 alters the H-bonding and solvent 
accessibility of the four EF hands (Figure 4-5A, blue curve). In the presence of TnI, 
regions comprising EFI and EFIII show significant increases in protection (Figure 4-5A, 
gray and black curves). These D uptake differences indicate that the interface between 
TnC and TnI involves these EF hands. Swenson and coworkers (19) also studied the 
interactions of TnI to TnC fragments, and they concluded that TnI interacts to both N and 
C-terminal domain of TnC. Our results provide a more detailed picture of their 
interaction. The addition of TnT to make a three-part complex, however, doesn’t have 
structural impact on the TnC exchange, which agrees well with our global measurement 
(Figure 4-5A, green curve). 
For TnI, the binding with TnC imparts major protection to two regions of TnI, the 
N-terminal region (23-30) and the C-terminal region (101-119). The latter is known to be 
the inhibitor region (Figure 4-5B, blue and black curves). Interestingly, two regions, the  
N-terminal region (13-22) and the middle regions of TnI (71-83), show more D uptake or 
more solvent exposure in the presence of TnC. This structural protrusion of TnI could be 
an outcome of the TnC-TnI interactions located at the N and C-terminal domains. The 
presence of TnT only imparts protection on residues 84-100 of TnI (Figure 4-5B, green 
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and black curves). These results are consistent with the view that this region is the TnI-
TnT coiled-coil interface (2). 
For TnT, the presence of TnC has only minor effects in the extent of H/DX, 
further confirming that there are no significant interactions between TnC and TnT. The 
addition of TnI to TnC and TnT, however, shows a significant decrease of in H/DX 
extent in the region 229-268 of TnT (Figure 4-5C, green and black curves). This region 
is also known to be the TnI-TnT coiled-coil interface. 
 To afford a structural view of the conformational changes of each subunit in the 
various complexes, we mapped our peptide level H/DX results onto the X-ray crystal 
structure of chicken skeletal troponin (PDB: 1YTZ) (2) (Figure 4-6). Given that the 
sequence homology of skeletal troponin between rabbit and chicken is high (>82%), we 
mapped our H/DX results in regions where there is amino-acid sequence identity. The 
interfaces between each subunit, as determined by H/DX, agree well with the crystal 
structure (Figure 4-6, regions shown in gray or black). Moreover, our studies show that 
regions 13-22 and 71-83 of TnI protrude more when bound to TnC.  
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Figure 4-6. A map of the peptide-level H/DX onto X-ray crystal structure of chicken 
skeletal troponin complex (PDB: 1YTZ). Different colors represent different extents of 
H/DX or protection—see figure legend. “Protection” was defined as the relative D uptake 
differences (%) between two states. A decrease of relative D uptake was defined as 
positive protection.    
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4.5 CONCLUSIONS 
Improving our knowledge of TnC-TnI-TnT interactions is important in 
understanding the detailed mechanism of muscle contraction. We began our study, as 
shown in the previous chapter, of the skeletal TnC-Ca
2+
 interactions and the binding 
orders of Ca
2+
 to TnC by conducting H/DX-MS and PLIMSTEX (21). We then extended 
our H/DX study to the dynamics of skeletal TnC within the whole complex and their 
interactions for two reasons: to improve our understanding of the TnC-TnI-TnT 
interactions and to test further the ability of H/DX and PLIMSTEX to provide insight into 
protein complexes. Although H/DX is now established as a structural tool for protein 
dynamics, protein-ligand, protein-protein interactions (24), its applications to complexes 
are limited. Here is an area where NMR and X-ray crystallography may not succeed. 
Unlike other covalent labeling strategies, H/DX can “mark” all amide hydrogens except 
proline and reveal changes of H-bonding at the peptide level, many of which are related 
to solvent accessibility-associated, even for proteins in complexes. The potential of H/DX 
has been successfully applied to study the biophysical properties of the whole cardiac 
troponin complex (26) and that of the individual subunit in the skeletal troponin complex, 
as shown here.  
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By utilizing H/DX on the rabbit skeletal troponin complex, we conclude that TnC 
is largely affected by TnI but not by TnT within the complex. We further examined the 
TnC-TnI binding affinities with or without the presence of TnT. Our results show that the 
affinities are in the range of 10
6 
M
-1
, which, when compared to previous fluorescence 
measurements (19, 20), show a discrepancy of three orders of magnitude. This difference 
may be an outcome of the different stability of protein complex in different 
environments. The minor influence of TnT on the TnC-TnI interaction, however, agrees 
with our global H/DX measurements and with previous X-ray crystallography. 
By the addition of enzymatic digestion in the H/DX work flow, we can refine the 
spatial resolution to the peptide level and reveal the interfaces between each subunit. This 
provides more detailed information on the conformational changes of each subunit within 
the complex in a systematic way. This high-resolution information is difficult to achieve 
by X-ray crystallography.           
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Chapter 5* 
Hydrogen/Deuterium Exchange and Electron-Transfer Dissociation 
Mass Spectrometry Determine the Interface and Dynamics of 
Apolipoprotein E Oligomerization  
 
 
 
 
 
 
 
 
 
* 
This chapter is based on recent publication: Reproduced with permission from Huang, R. 
Y. C., Garai, K., Frieden C., and Gross, M. L. Hydrogen/Deuterium Exchange and 
Electron-Transfer Dissociation Mass Spectrometry Determine the Interface and 
Dynamics of Apolipoprotein E Oligomerization. Biochemistry, 2011, 50, 9273-9282. 
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5.1 ABSTRACT   
Apolipoprotein E, a 34 kDa protein, plays a key role in triglyceride and 
cholesterol metabolism. Of the three common isoforms (ApoE2, 3 and 4), only ApoE4 is 
a risk factor for Alzheimer’s Disease. All three isoforms of wild-type ApoE self-associate 
to form oligomers, a process that may have functional consequences. Although the C-
terminal domain, residues 216-299, of ApoE is believed to mediate self-association, the 
specific residues involved in this process are not known. Here we report the use of 
hydrogen/deuterium exchange (H/DX) coupled with enzymatic digestion to identify those 
regions in the sequence of full-length apoE involved in oligomerization. For this 
determination, we compared the results of H/DX of the wild-type proteins and those of 
monomeric forms obtained by modifying four residues in the C-terminal domain. The 
three wild type and mutant isoforms show similar structures based on their similar H/DX 
kinetics and extents of exchange. Regions of the C-terminus (residues 230-270) of the 
ApoE isoforms show significant differences of deuterium uptake between oligomeric and 
monomeric forms, confirming that oligomerization occurs at these regions. To achieve 
single amino acid resolution, we examined the extents of H/DX by using electron transfer 
dissociation (ETD) fragmentation of peptides representing selected regions of both the 
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monomeric and the oligomeric forms of ApoE4. From these experiments, we could 
identify the specific residues involved in ApoE oligomerization. In addition, our results 
verify that ApoE4 is composed of a compact structure at its N-terminal domain. Regions 
of C-terminal domain, however, appear to lack defined structure.  
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5.2 INTRODUCTION 
Apolipoprotein E (ApoE), a 299-residue, 34 kDa protein, a major lipid transporter 
in plasma and the central nervous system (1-3), is intimately involved in triglyceride and 
cholesterol metabolism (2). There are three major isoforms, ApoE2, ApoE3 and ApoE4, 
that differ only by single amino acid changes (3). ApoE3 has a cysteine at position 112 
and an arginine at 158, whereas ApoE2 has cysteines, and ApoE4 has arginines at these 
two positions. These single amino acid differences cause significant differences in their 
biochemical and functional properties (2, 3). For example, ApoE4 is a major risk factor 
for Alzheimer’s disease and cardiovascular diseases, whereas ApoE2 serves a protective 
role (4). 
Lipid-free ApoE consists of a 22 kDa N-terminal domain (1-191), which harbors 
the LDL receptor binding site, and a 10 kDa C-terminal domain (216-299), which has 
high affinity for lipids (5-7), linked by a protease-sensitive hinge region (3, 8). Structures 
of full length, wild-type ApoE are unknown, although x-ray crystallography of the N-
terminal domain shows it is a monomer comprised of a four-helix bundle (9). The lack of 
structure of the wild-type proteins is probably due to a high tendency for them to 
aggregate at the high concentrations needed for crystallization (8, 10) and the likely 
presence of amphipathic helices in the full length protein (11, 12). Recently, however, an 
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NMR structure of a monomeric mutant of ApoE3 was determined (13). Lipid-free ApoE 
e ists predominantly as a tetramer at μM concentrations and dissociates to dimers and  
monomers at nM concentrations (1, 2, 10, 14-17). A form of ApoE3 that remains 
monomeric at 600 μM can be obtained by making four or five substitutions in the C-
terminal region without apparently affecting the overall secondary structure or function 
(18). This monomeric form is a reference point for our study to analyze the structure and 
oligomerization properties of ApoE isoforms.  
We chose hydrogen/deuterium exchange (H/DX) coupled with mass spectrometry 
(MS) (19-22) as a structural tool to measure the relative rates of exchange of amide 
hydrogens with deuteriums from D2O and draw conclusions based on the measured m/z 
and their changes, rather than ion abundances. The experimental outcome allows 
inferences on the stability of the hydrogen bonding, the extent of which is inverse to 
relative solvent accessibilities. To achieve a high-resolution comparison of the three 
isoforms of ApoE and their monomeric mutants, we coupled H/DX with enzymatic 
digestion and analyzed the exchanged peptides.   
 H/DX with digestion affords spatial resolution at the “peptide level” (i.e., to 
regions of the protein that are 6-10 amino-acid residues in length (23)) Although one can 
sometimes incorporate multiple enzymatic digestions to generate overlapping peptide 
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fragments and improve the resolution to one or a few amide sites, we chose gas-phase 
fragmentation of the deuterated peptides released upon pepsin digestion because it has 
greater potential to achieve resolution at the amino-acid level. Fragmentation cannot be 
collisionally induced dissociation (CID) (collision-activated dissociation (CAD)), as 
indicated in chapter 1, because it causes scrambling of H and D (24-29). To overcome 
this, we fragmented the peptides with electron-transfer dissociation (ETD) (30) under 
experimental conditions that we determined to be sufficiently “gentle” to avoid 
scrambling.  
To insure minimal scrambling, we followed Jørgensen, who established a set of 
standard peptides as tests (several other methods were also established for the same 
purpose (31, 32)), using a bottom-up H/DX (23) to afford resolution at a single-amide site. 
The latter allowed us to improve the resolution to the single amide level so that we can 
identify those residues involved in self-association. This approach also affords an 
opportunity to continue the development of a structural model for the full-length, wild-
type ApoE proteins. 
5.3 EXPERIMENTAL PROCEDURES 
5.3.1 Protein expression 
Apolipoprotein E was expressed in E. coli and purified as described previously by 
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Garai et al. (33). Briefly, ApoE proteins were expressed in Escherichia coli (Strain BL21, 
DE3 competent cells, Stratagene), which was grown in LB media to OD600 = 0.6. 
Mutations were introduced into the c-DNA of ApoE using the QuikChange site-directed 
mutagenesis kit (Stratagene). All sequences were verified by using DNA sequencing. In 
all cases, the monomeric mutants contained the following four substitutions: 
F257A/W264R/L279Q and V287E. 
5.3.2 Materials 
Potassium chloride, HEPES hemisodium salt [N-(2-hydroxyethyl)piperazine-N′-
(2-ethanesulfonic acid) hemisodium salt], tris(2-carboxyethyl)phosphine hydrochloride 
(TCEP), porcine pepsin, citric acid, sodium citrate, sodium chloride, and ethanolamine 
were purchased from Sigma-Aldrich (St.Louis, MO). The synthetic peptide 
HHHHHHIIKIIK used to test the extent of H/D scrambling was purchased from 
Genscript (Piscataway, NJ). D2O was from Cambridge Isotope Laboratories Inc 
(Andover, MA), and high purity guanidine hydrochloride was from Pierce (Rockford, 
IL). 
5.3.3 Preparation of ApoE stock solution 
ApoE, dissolved in 4 M GdnCl, 0.1  β-mercaptoethanol, was dialyzed against 10 
mM HEPES and 150 mM KCl containing 100 μM TCEP disulfide reductant by using 
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Slide-A-Lyzer Dialysis Cassettes 7000 MWCO (Pierce, CA) for 2 h. The buffer was 
exchanged for fresh buffer, and the solution was dialyzed overnight at 4 °C. The 
concentration of the final protein solution was established by absorbance at 280 nm (ε = 
44950 cm
-1
M
-1
) (34). The protein solutions were stored at -80 °C as 50 L aliquots.          
5.3.4 H/D Exchange (H/DX) Protocol 
The protein stock solution was first diluted in buffer (10 mM HEPES, 150 mM 
KCl, pH 7.4) to prepare a 4 μM final analytical concentration and equilibrated at 25 °C 
for 2 h. H/DX was initiated by diluting the protein solution 1:10 into D2O buffer (10 mM 
HEPES, 150 mM KCl, pD 7.4) at 25 °C. At varying times, the H/DX was quenched by 
adding sufficient 1 M HCl at 0 °C to give a final pH of 2.5. 
For peptide-level H/DX experiments, the quenched solution was injected into an 
on-line pepsin-digestion device (Figure 5-1) containing  immobilized pepsin in a 1 mm 
diameter × 2 cm length guard column (Upchurch Scientific, Oak Harbor, WA), which 
was prepared as described previously (35). The quenched solution was injected into the 
pepsin column in 0.1% formic acid via an Agilent 1100 HPLC (Santa Clara, CA) 
operated at 50 μL/min flow rate for 3 min. The digested protein solution was trapped on a 
C18 guard column (1 mm diameter x 1.5 cm length, Optimize Technologies, Oregon 
City, OR). The peptide mixture was then eluted from the trap column and separated with 
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a C18 analytical column (1 mm diameter x 5 cm length, Dionex, Bannockburn, IL) via an 
Agilent 1200 HPLC (Santa Clara, CA) with a gradient operated at 50 μL/min flow rate. 
Solvent A was water containing 0.1% formic acid, and solvent B was 80% acetonitrile, 
20% water containing 0.1% formic acid. The gradient settings were: 5% to 15% solvent 
B in 0.3 min, 15% to 50% solvent B in 5.2 min, 50% to 100% solvent B in 0.5 min, and 
isocratic flow at 100% solvent B for 1.5 min, then returned to 5% solvent B in 0.1 min. 
All LC connection lines were immersed in a water-ice (0 °C) bath.  
 
Figure 5-1. Diagram for on-line pepsin digestion device. 
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5.3.5 LC-ESI/MS Analysis with a Q-TOF Mass Spectrometer 
Peptide-level H/DX results were acquired on a Maxis (Bruker, Bremen, Germany) 
quadrupole time-of-flight (Q-TOF) mass spectrometer. The settings were: capillary 
voltage, 3.8 kV; nebulizer gas, 0.4 bar; drying gas flow rate and temperature, 4.0 L/min 
and 180 °C, respectively; funnel RF, 400 V(pp).  
 
Figure 5-2. ETD product ion spectrum of standard peptide HHHHHHIIKIIK. 
5.3.6 Test of hydrogen scrambling 
In the test procedure, described previously by Jørgensen and coworkers (30), 100 
μM of synthetic peptide, HHHHHHIIKIIK (Figure 5-2), was prepared in D2O and kept at 
4 °C overnight to allow complete deuterium exchange. The solution was diluted 50-fold 
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with cold H2O buffer (50% MeOH, 0.5 M acetic acid, pH 2.5) and frozen on dry ice to 
quench the exchange reaction. When needed for analysis, the peptide solution was 
manually thawed and injected into the ESI source via a pre-cooled 500 μL syringe 
(Hamilton, Reno,  V) operated at 50 μM/min flow rate.  
Three instrumental conditions were chosen: (1) capillary temperature, 50 °C; 
capillary voltage, 20 V; tube lens, 50 V; (2) capillary temperature, 100 °C; capillary 
voltage, 50 V; tube lens, 50 V, and (3) capillary temperature, 200 °C; capillary voltage, 
100 V; tube lens, 100 V. The active hydrogens of the test peptide were exchanged with 
deuterium and submitted to back exchange for approximately 1 min. The maximum 
number of deuteriums remaining in the peptide was approximately 4.5, which agreed 
with Jørgensen’s results under similar conditions (29). Upon fragmenting the peptide by 
ETD, we found the deuterium content for the c5 ion to be low (~0.6 D) under the first 
condition, indicating low H/D scrambling. As the capillary temperature and voltage were 
increased, increasing deuterium content was found in the N-terminal c5 ion (deuterium 
uptakes for the c ions are in Figure 5-3), indicating that the first set of instrument 
parameters were optimum. Another advantage for tuning the experiment by using this 
standard peptide was that the solution flow rate and other instrument parameters were 
easily optimized to afford good peptide ion signals. 
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Figure 5-3. The deuterium uptake of C ions of the standard peptide HHHHHHIIKIIK 
after performing the H/DX-ETD. Three different ESI conditions were marked in different 
colors (blue, pink, and green). 
5.3.7 LC-ESI/MS/MS Analysis with an Orbitrap-ETD Mass Spectrometer 
To confirm the sequence for each peptic peptide, the protein was digested as 
described previously and analyzed on a Thermo LTQ XL Orbitrap (Thermo Fisher, San 
Jose, CA). The settings were: spray voltage, 3.5 kV; sheath gas flow rate, 8 (arbitrary 
units); capillary temperature, 275 °C; capillary voltage, 35 V; and tube lens, 110 V. One 
full mass spectral acquisition triggered three scans of MS/MS (precursor ion activation to 
give CID) whereby the most abundant precursor ions were activated for sequencing. The 
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peaks observed in the product-ion spectra (MS/MS) were centroided for each peptide 
during the acquisition. 
H/DX-ETD MS was performed on a Thermo LTQ XL Orbitrap (Thermo Fisher, 
San Jose, CA), using the fluoranthene radical anion to cause ETD. One full mass-
spectrum acquisition was used to trigger three scans of ETD. The parameters were: spray 
voltage, 3.5 kV; sheath gas flow rate, 8 (arbitrary units); capillary temperature, 50 °C; 
capillary voltage, 20 V; tube lens, 50 V; tandem MS selection threshold, 1000 counts; 
activation time, 100 ms for ETD.  For ETD, the isolation width was 6.0 m/z, and the 
reaction time was “charge-state” dependent. A precursor mass list was generated based 
on the deuterated peptides’ centroid m/z, and MS/MS data were centroided during 
acquisition.  
5.3.8 Mascot database search 
Thermo RAW files were processed by using extract_msn (2007 version 4.0, 
Thermo Fisher, San Jose, CA) with a grouping tolerance of 0.8 Da, an intermediate scan 
setting of 1, and a minimum of 1 scan per group. The NCBI nonredundant database 
(version 20101004, restricted to human) was searched by using MASCOT 2.2.06 (Matrix 
Science, Oxford, U.K.) employing the following settings: enzyme, none; MS tolerance, 
- 180 - 
 
10 ppm; MS/MS tolerance, 0.8 Da; maximum number of missed cleavages, 3; peptide 
charge of 1+, 2+ and 3+; oxidation of methionine was set as variable modification. 
5.3.9 Data analysis 
For peptide-level H/DX, the uptake of deuterium for each peptide was measured 
as the average differences between the centroid masses of the deuterated peptide and the 
undeuterated peptide. The back-exchange was measured to be one deuterium loss per 
minute. No correction for back exchange was applied because the time between sample 
quench and the measurement with the mass spectrometer was less than 6 min, and all data 
were treated consistently. The centroid and width of the deuterium containing isotopic 
distribution for each peptide was analyzed using HX-Express software (36). 
For H/DX-ETD, the centroid of the deuterium-containing isotopic distribution for 
each product ion was obtained through MagTran 1.03 (Amgen, Thousand Oaks, CA). A 
minimum of 10% relative ion abundance threshold was applied in the data processing. 
The deuterium uptake for n
th
 amino acid was determined as the difference between the 
centroid of cn-1 and cn-2 ions or the difference between the centroid of zn+1 and zn ions. All 
experiments were performed in at least triplicate. 
5.4 RESULTS AND DISCUSSION 
5.4.1 Regions involved in ApoE self-association revealed by H/DX kinetics study  
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Apolipoprotein E isoforms e ist predominantly as tetramers at μM concentrations 
and dissociate into dimers and monomers at nM concentrations (17). The C-terminal 
domain seems to play the major role in this self-association (10). At analytical 
concentrations higher than M, the protein tends to aggregate (17, 37), hindering the 
elucidation of the full-length structure. Wang and coworkers (18) showed that a 
monomeric form of ApoE3 could be generated by substituting in the C-terminal region 
four to five bulky hydrophobic residues with either smaller hydrophobic or polar/charged 
residues. Although these substitutions prevent oligomerization, an understanding of the 
key residues involved in the self-association process and the differences between the 
ApoE isoforms remains to be achieved. 
In this study, we performed peptide-level H/DX kinetic measurements at seven 
different exchange times (0.5, 1, 3, 5, 10, 30, 60 min) on all three isoforms of ApoE 
including the wild-type proteins and their monomeric mutants. Starting with protein 
solutions for which the analytical concentration was 4 μM (where ApoE e ists 
predominantly as tetramer), the proteins were equilibrated at 25 °C for 2 h followed by 
introduction of D2O to initiate exchange and MS analysis to afford the kinetics of 
exchange at the peptide level for ApoE4 (Figure 5-4). Although the extents of H/DX for 
all regions of the wild-type proteins and the monomeric mutants located in the N-terminal 
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domain are similar, as revealed by peptic peptides, significant differences between the 
wild type and monomeric mutant occur in the C-terminal region for peptides 230-243 and 
262-270, and small differences for peptide 271-279. These differences are most obvious 
at early exchange times (0.5-1 min). We suggest that this behavior is a consequence of 
the time-dependent dissociation of tetramer to monomer as discussed below. Interestingly, 
two substitution sites used to produce the monomeric mutant are located in two of these 
regions (W264R and L279Q) (18). Information for the peptide containing residue F257A 
(Peptide 257-261) was missing because the peptide signal intensity was low, and the 
signal dropped even more caused by further dispersion of signals by uptake of deuterium. 
Peptide 230-243 showed a dramatic decrease in deuterium uptake for this region of the 
wild type compared to the monomer. Overall, the regions that are affected by self-
association are near the C-terminus, and this is consistent with previous findings that the 
C-terminal domain contains the residues important for ApoE oligomerization.  
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Figure 5-4. Peptide-level H/DX kinetics of ApoE4. A comparison between wild type 
(blue) and monomeric mutant (pink) shows significant differences in H/DX only for 
peptides 230-243 and 262-270 and small difference for peptide 271-279.   
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Figure 5-5. Comparison of H/DX kinetics of peptide 230-243 and 262-270 among all 
three isoforms (ApoE2, ApoE3, and ApoE4). An example of the mass spectra of peptide 
262-270 of ApoE4 as a function of  H/DX time is shown on the right (the red, dotted line 
is a reference to guide the eye). 
The deuterium uptake of the two regions represented by peptides 230-243 and 
262-270 of all the wild-type isoforms are time-dependent as shown in Figure 5-5. This 
slow H/DX of the C-terminal peptide fragments (residues 230-243 and 262-270) of the 
wild-type ApoE isoforms may be consistent with the slow dissociation of the ApoE 
oligomers. Garai and Frieden (17) showed that association-dissociation of ApoE isoforms 
fit a monomer-dimer-tetramer model and that the rate for dissociation at neutral pH is 
slow. The H/DX experiments were carried out by diluting ApoE from 4 µM to 400 nM  
analytical concentration in the D2O buffer; the result is dissociation of the tetramers to 
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monomers. Although wild-type ApoE exists as a mixture of monomers, dimers and 
tetramers at 400 nM (17), deuterium uptake by the wild-type ApoE at this concentration 
reaches completion owing to the reversibility of the monomer-dimer-tetramer process. 
The dissociation rate constants for the isoforms, as measured by Garai and Frieden, are 
approximately 10
-4
 s
-1 
for dimer-monomer and 10
-3
 s
-1
 for tetramer-dimer conversion, the 
equilibrium constants for both processes are in the range of 10
7
 M
-1
 (17). We fit the 
H/DX kinetic data with a fixed-rate-constant binning model by using MathCAD (Math-
Soft. Inc. Cambridge, MA), as previously described (38, 39), whereby iterations were 
continued until the root mean square (RMS) was minimized. We chose three fixed rate-
constant bins (k = 10, 1, 0.1 min
-1
); the latter bin on the basis of the time needed to effect 
nearly complete exchange (Table 5-1). According to the model, nearly all the amide 
hydrogens in these two regions of the wild-type ApoE exchange in 0.1 min
-1 
(1.6 x 10
-3
 s
-
1
) rate-constant bin, whereas all amide hydrogens of the monomeric mutants undergo fast 
exchange rate (k = 10 min
-1
), indicating that the mutants are flexible in these two regions.  
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 Kinetic Fit # of H's per fixed-rate bin 
Peptide 230-243 k ( min
-1
 ) 10 1 0.1 
WT 
ApoE2  0 ± 0 2 ± 1 8 ± 1 
ApoE3 0 ± 0 3 ± 1 7 ± 1 
ApoE4 1 ± 0 1 ± 0 8 ± 1 
MM 
ApoE2  9 ± 1 0 ± 0 0 ± 0 
ApoE3 10 ± 1 0 ± 0 0 ± 0 
ApoE4 10 ± 1 0 ± 0 0 ± 0 
Peptide 262-270 k ( min
-1
 ) 10 1 0.1 
WT 
ApoE2  1 ± 0 0 ± 0 2 ± 0 
ApoE3 0 ± 0 1 ± 0 3 ± 1 
ApoE4 1 ± 0 1 ± 0 2 ± 1 
MM 
ApoE2  4 ± 1 0 ± 0 0 ± 0 
ApoE3 4 ± 1 0 ± 0 0 ± 0 
ApoE4 4 ± 1 0 ± 0 0 ± 0 
Table 5-1. Numbers of amide hydrogen undergoing H/D exchange for wild-type (WT) 
and monomeric-mutant ApoE’s isoforms. The kinetic modeling used three fi ed 
e change rate constants and “binned” the number of amides with respect to the rate 
constants. 
The H/DX kinetics do not reveal the two-step behavior observed by Garai et al. 
(17) but instead are an integrated view of the various states of the protein. Given that the 
peptide-level H/DX kinetics for the wild-type ApoE’s C-terminal regions (~10-3 s-1) 
agrees well with the average dissociation constant determined for tetramer-dimer-
monomer process (17), we suggest that the oligomeric proteins must first dissociate to 
monomers and then undergo H/DX in the two C-terminal regions. 
ApoE2 and ApoE3 show similar H/DX behavior (Figures 5-6 and 5-7). A 
comparison of the H/DX kinetics for monomeric mutant of all three isoforms (Figure 5-8) 
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reveals that some regions have minor differences among the three isoforms (peptide 15-
30, 116-123, and 271-279) where ApoE4 takes up slightly more deuterium than ApoE2 
and ApoE3. Overall, the three isoforms must share similar structures and properties with 
respect to oligomerization. These properties as revealed by H/DX are also consistent with 
the differences found in our study using fast photochemical oxidation (FPOP) (40).    
 
 
Figure 5-6. Peptide-level H/DX kinetics of ApoE2. The extent of deuterium uptake is 
plotted as a function of exchange time. Wild type is marked in blue and monomeric 
mutant is marked in pink. 
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Figure 5-7. Peptide-level H/DX kinetics of ApoE3. The extent of deuterium uptake is 
plotted as a function of exchange time. Wild type is marked in blue and monomeric 
mutant is marked in pink. 
 
Figure 5-8. Peptide-level H/DX kinetics of ApoE2, ApoE3 and ApoE4 monomeric 
mutant. The extent of deuterium uptake is plotted as a function of exchange time. ApoE2 
is marked in blue, ApoE3 is marked in pink, and ApoE4 is marked in green. 
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5.4.2 H/DX-ETD reveals residues involved in self-association of ApoE4  
Peptide-level H/DX kinetics, as shown in this study, can reveal not only those 
regions that are involved in protein:protein interactions but also the dynamics of the 
interactions. To improve the resolution of the H/DX experiments, we chose a bottom-up 
strategy whereby, following H/DX of the protein and proteolysis, we subjected the 
peptide to ETD fragmentation (Figure 5-9). This approach is more appropriate than a 
top-down one because our ApoE samples contain several post-translational oxidations 
that disperse the signal and increase the difficulty of the top-down H/DX experiment. 
Furthermore, extensive sequence coverage for any 34 kDa protein is difficult to achieve 
in a top-down experiment.  
 
Figure 5-9. A diagram of the H/DX-ETD procedure. A peptide of interest produced from 
on-line pepsin digestion is subjected to ETD fragmentation. Peptide coverage (~89%) of 
ApoE4 by applying this strategy is shown in right (four substitution sites to achieve the 
MM are marked in red).   
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Bottom-up H/DX-ETD experiments were performed under the same conditions as 
for peptide-level H/DX e periments in which a 4 μM (analytical concentration) protein 
solution was equilibrated at 25 °C for 2 h followed by diluting the protein solution 1:10 
into D2O buffer for 1 min, a time at which there is a large difference in H/DX between 
wild types and the monomeric mutants of ApoE. After quenching the exchange, the 
protein solution was submitted to on-line pepsin digestion, and the peptides were 
analyzed by MS and ETD whereby the selection of the precursor ion was directed by a 
precursor-mass list containing the peptides of interest. This list utilized the centroid m/z 
of the deuterium-containing isotopic distribution of the peptides of interest. ETD usually 
generates a product-ion spectrum of good signal-to-noise for those peptides that are 
doubly or more highly charged. Peptides that are +4 or higher, however, will show 
increased H/D scrambling due to the more energetic collisions they undergo upon 
acceleration in the ESI declustering field than do lower charged ions (30). Therefore, we 
selected doubly and triply charged peptides that had sufficient ion signal for ETD 
fragmentation.  
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Figure 5-10. ETD product-ion spectra of peptide 206-214 of ApoE4 after H/DX. The 
centroid of the distribution of C ions from MM is shown as red dotted line, showing there 
are no significant differences in H/DX between WT and MM. 
 
Figure 5-11. ETD product-ion spectra of peptide 262-270 of ApoE4 after H/DX. The 
centroid of the distribution of c ions from monomeric mutant shows there are significant 
differences in the extent of H/DX between WT and MM  for this region. 
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Although the c ions of peptides 206-214 show no significant differences in H/DX 
for wild type ApoE4 and monomeric mutant forms after 1 min (Figure 5-10), the region 
262-270 (Figure 5-11) undergoes significantly different H/DX. We measured the extent 
of deuteration at each amide site, using the difference of the isotopic-distribution centroid 
between two adjacent product ions (c or z ions). For example, the extent of deuterium on 
the n
th
 amino acid is the difference between the centroid of cn-1 and cn-2 ions or between 
the centroid of zn+1 and zn ions. The outcome is a deuterium-uptake diagram for each 
amide of each residue of the ApoE4 wild type and its monomeric mutant. We analyzed 
132 out of 274 amides with exchangeable backbone hydrogens (excluding proline and the 
N-terminal amine hydrogens for each peptide), giving a coverage of ~ 50%. The coverage 
depends highly on the quality of the product-ion spectra; that quality was reduced when 
working under ESI conditions that minimize scrambling. No correction for back 
exchange was made because all experiments were treated consistently. Although three of 
four substitution sites of the ApoE4 monomeric mutant are located on C-terminal peptic 
peptides, which we selected for ETD fragmentation, these sites are located separately on 
different peptides; thus, the extents of back exchange should be similar for the same set 
of peptides from the two protein isoforms and will not affect conclusions about the 
relative differences of H/DX. 
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Figure 5-12. The extent of deuterium uptake of various amino-acid residues in the C-
terminal domain of ApoE4 (Residue 220-299). Several residues of wild type (blue) have 
lower level (<0.3D) of deuterium uptake compared to the monomeric mutant (pink). 
Note: The gaps correspond to missing information. 
There are clearly no significant differences for all the amides examined in the N-
terminal region of the wild type and the monomeric mutant form of ApoE4 (the complete 
extents of deuteration are in Table 5-2). Not surprisingly, several amides in the C-
terminal region underwent relatively low deuterium uptake (< 0.3 D) for the wild type 
ApoE4 whereas they exchanged more deuterium (> 0.7 D) for the monomeric mutant 
(Figure 5-12). The residues associated with these amides are: Val232, Lys233, Gln235, 
Glu238, Val239, Arg240, Ala241, Leu243, Gln246, Ser263, Trp264 (Arg in the 
monomeric mutant form), Phe265, Leu268, Glu270, and Leu279 (Gln in the monomeric 
mutant form). Interestingly, two of the substitution sites (Trp264Arg and Leu279Gln) are 
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on the list, indicating the important roles played by the two residues in the self-
association process. Several residues (e.g., Glu234 and Lys242) showed no significant 
differences in deuterium uptake between the wild-type and monomeric-mutant forms, 
indicating that these two residues are minimally affected by the self association of ApoE4. 
Weisgraber and coworkers (10), who studied the ApoE oligomerization by truncating 
various sites in the C-terminal region, found that residues within 267-299 are critical for 
tetramerization. Our study, using the full-length protein, show that three residues within 
this region are important in the ApoE self asoociation. Moreover, 12 additional residues, 
which are close to this region, also play a role in self association. A potential spinoff of 
this work is the use of H/DX results as a basis for designing future mutation studies in 
ApoE and other proteins. 
5.4.3 The structure of ApoE4  
Before mapping the H/DX-ETD results onto a structure of ApoE that contains the 
X-ray crystal structure of the N-terminal domain (PDB: 1GS9) (41), we wished to 
establish that a low extent of deuteration for a specific amide indicated low solvent 
accessibility and not extensive back exchange. Thus, we prepared a nearly 100% 
deuterium-exchanged ApoE4 monomeric mutant by diluting the protein solution into 
D2O buffer at 25 °C and exchanging for 24 h. After submitting the protein to on-line 
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pepsin digestion and ETD-MS analysis (42), we found that the average percent back 
exchange was (13 ± 4)%. (Each deuterium uptake for a single amide was normalized to 
its corresponding D100% value, and the normalization was treated separately for each trial 
of experiments—see table 5-2). 
 
Figure 5-13. The extent of deuterium uptake of each amide of ApoE4 monomeric mutant 
after correcting for back exchange (pink). Most of the amides in the C-terminus have 
high extent of deuterium uptake, indicating a flexible structure in this region. The extent 
of deuterium uptake in N-terminal region are consistent with the known secondary 
structure (top). (flexible loop, black line; flexible helix, gray box; rigid helix, black box).  
Note: The gaps correspond to missing information.  
The deuterium uptake at a single amide of the ApoE4 monomeric mutant (Figure 
5-13), show that the ApoE4 structure is primarily compact in the N-terminal region and 
more flexible in the C-terminal region, as previously assumed (43). Previous studies 
indicated that the C-terminal domain should contain amphipathic helices and several 
flexible loop regions (11, 12). Four possible helices, represented by peptide regions 190-
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199, 210-223, 238-266, and 271-276, exist in the C-terminal domain, as determined by 
Wang and coworkers (5). Their recent NMR structure of ApoE3 monomeric mutant 
shows that these helices are in the middle of long, unstructured regions (44). Our amide-
level H/DX results, when mapped onto a schematic secondary structure of the C-terminal 
domain of ApoE (Figure 5-14), show that peptide regions 190-199 and 271-276 undergo 
extensive H/DX, consistent with being flexible helices. Although deuterium uptake 
information is missing for peptide regions 215-222 and 249-262, those regions adjoin 
those helices in C-terminal domain that also undergo extensive H/DX and should be 
flexible.  
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Figure 5-14. Structure of ApoE4 on which residue-level H/DX of ApoE4 monomeric 
mutant is mapped. Left: X-ray crystal structure of N-terminal region of ApoE4 (PDB: 
1GS9). Right: Proposed secondary structure of C-terminal region of ApoE (5). Possible 
helices are shown in dotted boxes. Different colors represent different levels of deuterium 
uptake for each residue (lower left).   
In another peptide-level H/DX e periment, we treated the three ApoE’s isoforms 
with 0.5 M guanidine hydrochloride (GdnCl) (Figure 5-15), a concentration at which the 
protein could lose some tertiary/quaternary structure while maintaining its secondary 
structure (43). The results show that this low concentration of denaturant has more impact  
on the C-terminal than the N-terminal region of ApoE. This is additional evidence that 
ApoE is composed of a flexible C-terminal region, making it susceptible to denaturation. 
Morrow and coworkers (45), who studied the denaturation of ApoE at various 
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concentrations of GdnCl, showed that the regions nearby the C-terminus and in the 
presence of low concentration of GdnCl, unfold prior to those close to the N-terminal 
domain. Our results are consistent with their findings. 
 
Figure 5-15. Peptide-level H/DX of ApoE2, ApoE3, and ApoE4 with or without the 
presence of 0.5 M GdnCl. The relative deuterium uptake difference is plotted as different 
peptide regions. The large difference indicates the regions (red) having less stable H-
bonding or more relative solvent accessibilities in the presence of denaturant. 
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The structure of the N-teminal domain of ApoE was determined by X-ray 
crystallography and NMR to be a four helix-bundle (5, 9, 41). Our results, when 
compared to the X-ray crystal structure of N-terminal domain (Figure 5-14), show that 
amides in the regions of residues 6-25, 76-91, 124-125, and 165-191 undergo extensive 
deuterium uptake, consistent with their location at or near the flexible-loop regions and as 
part of the flexible-helix region (170-180). The amides in regions 70-75 and 92-103, 
which are located in a rigid helix, undergo low extents of deuteration, in accord with the 
strong H-bonding in that region of the protein.  
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Table 5-2. A complete list of deuterium uptake for 132 residues in ApoE4. 
Amino 
acid 
WT STD MM STD D 100% 
Normalized 
MM 
STD 
V6 0.76  0.11  0.79  0.08  0.78  1.01  0.10  
E7 0.78  0.07  0.88  0.10  0.93  0.95  0.11  
T8 0.87  0.06  0.87  0.08  0.82  1.06  0.10  
E9 0.15  0.14  0.22  0.18  0.31  0.71  0.11  
E11 0.98  0.02  0.76  0.11  1.01  0.75  0.11  
E13 0.99  0.12  0.82  0.07  0.98  0.84  0.07  
L14 0.99  0.02  0.90  0.03  1.00  0.90  0.03  
Q16 1.01  0.09  0.94  0.02  0.99  0.95  0.02  
Q17 0.84  0.04  0.79  0.08  0.80  0.99  0.10  
T18 1.00  0.17  0.83  0.11  0.88  0.94  0.13  
E19 0.90  0.05  0.93  0.07  0.95  0.98  0.07  
W20 0.20  0.08  0.08  0.03  0.11  0.73  0.02  
Q21 0.77  0.03  0.90  0.07  0.93  0.97  0.08  
S22 0.83  0.13  0.97  0.04  0.98  0.99  0.04  
R25 0.97  0.12  0.93  0.07  1.00  0.93  0.07  
W26 0.94  0.05  0.90  0.02  0.98  0.92  0.02  
E45 0.09  0.02  0.01  0.02  0.98  0.01  0.02  
E70 0.10  0.02  0.06  0.02  0.94  0.06  0.02  
L71 0.10  0.04  0.06  0.06  1.08  0.05  0.06  
K72 0.17  0.01  0.18  0.04  0.89  0.20  0.05  
A73 0.16  0.05  0.15  0.02  1.00  0.15  0.02  
Y74 0.13  0.07  0.16  0.03  1.02  0.16  0.03  
K75 0.05  0.07  0.17  0.02  1.00  0.17  0.02  
S76 0.95  0.02  0.98  0.02  0.97  1.01  0.02  
E77 0.88  0.09  0.92  0.08  0.99  0.93  0.08  
L78 0.89  0.10  0.95  0.03  0.98  0.97  0.03  
E80 0.95  0.05  0.99  0.03  0.99  1.00  0.03  
Q81 0.20  0.08  0.16  0.02  1.00  0.16  0.02  
T83 0.92  0.04  0.97  0.05  0.98  0.99  0.05  
V85 0.86  0.14  1.09  0.02  0.99  1.10  0.02  
A86 0.18  0.07  0.15  0.04  1.02  0.15  0.04  
E87 0.79  0.04  0.80  0.08  0.95  0.84  0.08  
E88 0.92  0.04  0.87  0.13  0.85  1.02  0.15  
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T89 0.98  0.06  0.94  0.03  0.95  0.99  0.03  
R90 0.89  0.14  0.91  0.05  0.92  0.99  0.05  
A91 0.95  0.02  0.96  0.02  0.93  1.03  0.02  
R92 0.10  0.08  0.06  0.07  1.02  0.06  0.07  
L93 0.08  0.04  0.16  0.08  1.03  0.16  0.07  
L97 0.17  0.01  0.12  0.04  0.99  0.12  0.04  
Q98 0.07  0.11  0.08  0.06  0.98  0.08  0.06  
R103 0.72  0.02  0.79  0.02  1.00  0.79  0.02  
L104 0.92  0.08  1.05  0.05  0.99  1.06  0.05  
Q117 0.18  0.01  0.15  0.03  0.98  0.15  0.03  
Y118 0.13  0.08  0.04  0.11  0.78  0.05  0.14  
R119 0.76  0.07  0.73  0.03  1.04  0.71  0.03  
E121 0.14  0.10  0.15  0.08  0.89  0.17  0.09  
V122 0.15  0.04  0.13  0.02  0.88  0.15  0.02  
Q123 0.13  0.02  0.11  0.03  0.66  0.17  0.05  
A124 1.01  0.07  1.00  0.05  0.99  1.02  0.05  
M125 0.75  0.04  0.75  0.08  0.72  1.05  0.11  
L133 0.83  0.08  0.87  0.02  0.89  0.98  0.02  
Q163 0.02  0.01  0.01  0.01  0.77  0.01  0.01  
A164 0.99  0.01  1.07  0.00  0.99  1.08  0.00  
G165 0.96  0.10  0.91  0.06  1.00  0.91  0.06  
A166 0.77  0.12  0.78  0.03  0.81  0.96  0.04  
R167 0.77  0.02  0.74  0.03  0.70  1.06  0.04  
E168 0.88  0.01  0.89  0.07  1.01  0.88  0.06  
G169 0.89  0.10  0.90  0.03  1.00  0.90  0.03  
A170 0.74  0.04  0.71  0.08  0.74  0.96  0.11  
E171 0.86  0.02  0.84  0.12  0.93  0.91  0.13  
R172 0.91  0.06  0.93  0.11  0.97  0.96  0.11  
G173 0.92  0.04  0.97  0.08  0.99  0.98  0.08  
L174 0.70  0.08  0.99  0.11  1.00  0.99  0.11  
S175 0.07  0.06  0.08  0.03  0.33  0.24  0.10  
A176 0.84  0.01  0.86  0.03  0.88  0.98  0.04  
E179 0.89  0.02  0.89  0.06  0.99  0.90  0.06  
R180 0.23  0.07  0.22  0.02  0.31  0.71  0.06  
G182 0.88  0.13  0.80  0.02  0.84  0.95  0.02  
V185 0.74  0.08  0.99  0.06  0.97  1.02  0.06  
Q187 1.01  0.05  0.98  0.03  0.93  1.05  0.03  
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G188 0.82  0.07  0.85  0.08  0.99  0.86  0.08  
R189 0.76  0.11  0.83  0.11  0.88  0.94  0.12  
V190 0.94  0.02  0.97  0.05  0.98  0.99  0.05  
R191 0.74  0.10  1.00  0.02  1.02  0.99  0.01  
T194 0.28  0.06  0.32  0.01  0.47  0.69  0.02  
S197 0.98  0.04  0.77  0.05  0.98  0.79  0.05  
L198 0.91  0.03  0.90  0.02  0.96  0.93  0.02  
A199 0.08  0.05  0.14  0.04  0.91  0.15  0.05  
G200 0.08  0.04  0.03  0.02  0.76  0.04  0.03  
Q201 0.16  0.12  0.08  0.04  0.98  0.08  0.04  
L203 0.86  0.06  0.88  0.03  1.02  0.87  0.03  
Q204 0.41  0.09  0.35  0.01  0.35  1.00  0.03  
E205 0.85  0.03  0.99  0.06  1.01  0.98  0.06  
Q208 0.33  0.03  0.31  0.01  0.33  0.94  0.03  
A209 0.75  0.08  0.66  0.06  0.94  0.70  0.06  
W210 0.01  0.02  0.04  0.01  0.05  0.80  0.10  
G211 0.97  0.11  0.41  0.03  0.58  0.71  0.05  
E212 0.40  0.01  0.32  0.02  0.32  1.00  0.06  
R213 0.73  0.04  0.67  0.07  0.88  0.76  0.08  
L214 0.99  0.08  0.98  0.10  1.01  0.97  0.10  
S223 0.02  0.05  0.06  0.04  0.93  0.06  0.04  
R224 0.19  0.05  0.05  0.01  0.89  0.05  0.01  
T225 0.79  0.09  1.00  0.04  1.00  1.00  0.04  
R226 0.97  0.05  0.77  0.13  0.95  0.81  0.13  
D227 0.91  0.03  0.99  0.08  1.02  0.97  0.08  
L228 0.94  0.08  0.80  0.11  0.98  0.82  0.11  
V232 0.02  0.01  0.90  0.10  1.02  0.88  0.10  
K233 0.11  0.02  0.91  0.10  0.96  0.95  0.10  
E234 0.83  0.02  0.86  0.03  0.96  0.90  0.03  
Q235 0.10  0.04  0.92  0.10  1.01  0.91  0.10  
E238 0.09  0.03  0.83  0.05  0.95  0.88  0.05  
V239 0.08  0.04  0.85  0.09  0.85  1.01  0.11  
R240 0.03  0.01  0.78  0.06  0.92  0.85  0.07  
A241 0.13  0.03  0.82  0.05  1.00  0.82  0.05  
K242 0.87  0.01  0.82  0.03  0.93  0.88  0.03  
L243 0.03  0.01  0.97  0.04  1.02  0.95  0.04  
E244 0.97  0.10  0.95  0.12  1.00  0.95  0.12  
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E245 0.15  0.04  0.10  0.01  0.16  0.64  0.06  
Q246 0.09  0.07  0.98  0.10  0.99  1.00  0.10  
A247 0.90  0.06  1.01  0.04  0.95  1.07  0.04  
Q248 0.06  0.05  0.12  0.02  0.31  0.39  0.07  
S263 0.14  0.03  0.87  0.06  0.92  0.95  0.07  
W264R 0.13  0.02  0.94  0.03  0.99  0.95  0.03  
F265 0.09  0.01  0.77  0.03  0.89  0.87  0.03  
L268 0.05  0.01  0.32  0.01  0.45  0.71  0.03  
V269 0.08  0.03  0.10  0.01  0.10  1.00  0.10  
E270 0.03  0.03  1.01  0.05  0.99  1.02  0.05  
Q275 0.78  0.05  0.98  0.04  0.99  0.99  0.04  
W276 0.82  0.06  0.73  0.06  0.81  0.90  0.07  
A277 0.31  0.08  0.89  0.06  0.93  0.96  0.06  
G278 0.94  0.02  0.89  0.01  0.92  0.97  0.01  
L279Q 0.07  0.06  0.95  0.04  1.02  0.93  0.04  
A285 0.95  0.08  0.83  0.10  0.89  0.93  0.11  
G288 0.70  0.02  0.99  0.10  0.93  1.06  0.10  
T289 1.08  0.03  0.70  0.03  0.71  0.98  0.04  
S290 0.84  0.10  1.05  0.03  1.01  1.04  0.03  
A291 0.42  0.07  0.82  0.05  0.81  1.01  0.06  
A292 0.91  0.06  0.81  0.04  0.89  0.90  0.04  
V294 0.87  0.06  0.87  0.03  0.92  0.95  0.03  
D297 0.63  0.10  0.44  0.05  0.58  0.76  0.09  
N298 0.93  0.04  0.82  0.03  0.89  0.92  0.03  
H299 0.79  0.04  0.76  0.04  0.99  0.77  0.04  
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5.5 CONCLUSIONS 
 The observation that ApoE has a high tendency to aggregate has hindered 
determination of the full-length structures of the three wild-type isoforms. We are 
approaching structure analysis of the three isoforms and their monomeric mutants by 
chemical footprinting (46) including H/DX coupled with MS. Unlike other covalent 
protein footprinting methods, H/DX is general, marking all the amino acids except 
proline and covering nearly the entire protein backbone, provided the proteolysis and 
LC/MS efficiencies are high.  
 Our H/DX results not only confirm the role of the C-terminal domain in the 
oligomerization process but also reveal the dissociation rate of oligomers to give 
monomers. We found that the three wild-type isoforms largely share oligomerization 
properties. A bottom-up H/DX-ETD experiment also located deuterium on lipid-free 
ApoE4 including its wild type and monomeric mutant form and afforded information on 
approximately 50% of the amides. We obtained clear, single-amide-level H/DX results 
for ApoE4, identified the residues involved in self-association, and showed they are 
located in the C-terminal domain (i.e., residues 232-272).  
The region of apoE that shows differential H/DX between the wild-type protein 
and the monomeric mutant includes the residues 244-272, which harbor the lipid-binding 
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site (47) and are involved in A binding, with implications for understanding 
Alzheimer’s Disease (47). In addition, residues 241-272 mediate the toxic effects of 
ApoE4 in neuroblastoma cells (48). Thus, the residues 232-272 in the C-terminal domain 
seem to be involved in the multiple processes that are crucial for biological function and 
that mediate toxicity. Additional studies along these lines should increase our 
understanding of ApoE interactions with itself and with various ligands, an understanding 
that will be difficult to obtain by NMR and X-ray crystallography. Furthermore, H/DX 
and other footprinting strategies should not only provide information for the design of 
other ApoE monomeric mutants that contain a minimum number of mutation sites but 
also be a means for evaluating their equivalency.      
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Chapter 6 
Hydrogen/Deuterium Exchange Mass Spectrometry Probes the 
Apolipoprotein E-Amyloid-β (Aβ 40) Interactions  
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6.1 ABSTRACT   
Apolipoprotein E (ApoE), which may be involved in the clearance of amyloid-
 from the brain, is an important factor in various diseases including Alzheimer’s 
Disease (AD). It is a 34 kDa protein consisting of two domains separated by a region of 
random structure. Each domain has a distinct function and structure. The N-terminal 
domain, for example, contains receptor-binding and heparin (proteoglycan)-binding 
regions, whereas the C-terminal domain contains the major lipid-binding site. Although 
the C-terminal domain (residues 216-299) of ApoE is believed to be the potential region 
that binds to, the specific regions involved in this interaction are not yet known. Here 
we report the use of hydrogen/deuterium exchange (H/DX) coupled with mass 
spectrometry to identify those regions that are involved in ApoE-interactions. Given 
that the C-terminal regions of ApoE contain the interfaces for its oligomerization, the 
interaction between ApoE and  may be shifted to other sites.Our results suggest, 
however, that oligomerization of ApoE does compete with the interaction with 
Interestingly, region 52-60 of ApoE, located at the N-terminal domain, show some 
decrease of deuterium uptake in the presence of  This finding  provides additional 
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support for the importance of the N-terminal region of ApoE in the ApoE-complex 
formation. 
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6.2 INTRODUCTION 
The aggregation and deposition of  as plaques in the brain may be key to 
understanding the early processes causing Alzheimer’s Disease (AD) (1). Amyloid-
is formed after sequential cleavage of the amyloid precursor protein (2) by α-, β-
 and γ-secretases. The propensity of  aggregation is different for different sequence 
lengths of the cleavage products. For example,  has higher tendency to form 
oligomers in solution than (3). Recently, an NMR structure of shows 
it has a helix in the middle region (residue 12-23) whereas the N and C-terminal regions 
of are unstructured (4). Understanding the processes of aggregation so that one 
can modulate the population of the various aggregation states of in the brain may be 
crucial for the treatment of Alzheimer’s Disease. 
Apolipoprotein E (ApoE), a major lipid transporter in plasma and the central 
nervous system (5-7), may affect both the deposition and clearance of  from the brain 
and, hence, play a role in the pathogenesis of Alzheimer’s Disease (1). There are three 
major isoforms, ApoE2, ApoE3 and ApoE4, differing in the progression by only single 
amino-acid substitutions (7). These small differences alter significantly their biochemical 
properties. For example, ApoE4 is a major risk factor for Alzheimer’s disease and 
cardiovascular diseases. In fact, the expression of ApoE4 in humans results in greater  
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and amyloid deposition than for expression of ApoE3 (1). ApoE2, on the other hand, 
seems to play a protective role (8). 
The ApoE proteins consist of a 22 kDa N-terminal domain and a 10 kDa C-
terminal domain (9-11), linked by a protease-sensitive hinge region. Each domain has a 
unique function. Whereas the N-terminal domain harbors the LDL receptor binding site, 
the C-terminal domain binds to lipids with high affinity and forms oligomers through 
self-interactions in this region (6, 7, 12).  
ApoE may mediate the level of free in the brain by forming ApoE-
complexes. Complex formation, however, is different among different isoforms of 
ApoE and under different conditions (i.e., temperature, pH). Lipidated ApoE4, for 
example, binds preferentially to an intermediate aggregation form of with 2-3 fold 
higher affinity than do ApoE2 and ApoE3 under the same conditions (13). Lipid-free 
ApoE3, on the other hand, forms an ApoE-complex with apparent higher affinity with 
respect to ApoE4 (14). The C-terminal regions of ApoE (244-272) and the N-terminal 
regions of (1-28) are believed to be involved in the ApoE- interactions (15, 16).  
These same regions of are likely to be involved also in self-association (17). A recent 
study of the ApoE- interactions by MD simulation, however, suggests the interactions 
occur on helix I and IV of the N-terminal domain of ApoE (18). Although these studies 
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led to controversial conclusions on the regions of ApoE that are involved in ApoE- 
complex formation, the importance of ApoE in the etiology of Alzheimer’s disease is 
certain. Therefore, understanding the interactions between ApoE and  is essential for 
the study of this disease.  
The oligomerization properties of ApoE were recently studied in our group, as 
shown in chapter five, by using hydrogen/deuterium exchange (H/DX) and fast 
photochemical oxidation of proteins (FPOP), both in combination with MS (19, 20). The 
results show that the interfaces for ApoE oligomerization are mainly located at the C-
terminal region of ApoE. Given that this region contains potential binding sites with  
as shown in the previous study (15), it is our interest to extend the H/DX MS strategy to 
the study of ApoE- complex formation.  
 H/DX coupled with MS (21-24) has become a powerful tool that can probe both 
protein conformational changes associated with protein-ligand interactions (ligand: 
protein, DNA, peptide, drug etc) and also protein dynamics. Given that ApoE3 appears to 
form a stable complex with  in a lipid-free environment and that 40 has lower 
tendency to self-aggregate in solution, we chose these two as our first target in this study. 
The outcomes may lead to an improved understanding of the ApoE- complex 
formation and serve as a useful reference point for future studies of A and ApoE.  
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6.3 EXPERIMENTAL PROCEDURES 
6.3.1 Protein expression 
Wild type apolipoprotein E3 (ApoE3WT) was expressed in E. coli and purified as 
described previously by Garai et al. (25). Briefly, ApoE proteins were expressed in 
Escherichia coli (Strain BL21, DE3 competent cells, Stratagene), which was grown in 
LB media to OD600 = 0.6.  
6.3.2 Materials 
HEPES hemisodium salt [N-(2-hydroxyethyl)piperazine-N′-(2-ethanesulfonic 
acid) hemisodium salt], Tris(2-carboxyethyl)phosphine hydrochloride (TCEP), porcine 
pepsin, citric acid, sodium citrate, sodium chloride, potassium chloride, and ethanolamine 
were purchased from Sigma-Aldrich (St.Louis, MO).40 was from Keck 
biotechnology resource laboratory (Yale University, New Haven, CT). D2O was 
purchased from Cambridge Isotope Laboratories Inc (Andover, MA).  
6.3.3 Preparation of ApoE3-40  complex 
40 was dissolved in 3 mM NaOH, 150 mM NaCl, 1 mM TCEP, and the 
monomeric 40 was purified by using size-exclusion chromatography. ApoE3WT-
40 complex was made by mixing ApoE3 and 40 in a ratio of 1:5, a ratio that 
ensures the interaction was saturated and the ion intensity of ApoE3 was not suppressed 
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by 40, at 0.5 µM analytical concentration of ApoE3WT in HEPES buffer (10 mM 
HEPES, 150 mM NaCl, 100 µM TCEP, pH 7.4). The mixture was incubated at 25 °C for 
various times (30 s, 5 min, 20 min, 1 h, 8 h, 24 h, 52 h) prior to submitting the system to 
H/DX.        
6.3.4 H/D Exchange (H/DX) Protocol 
For global H/DX pulse labeling experiments, the ApoE3WT-40 complex was 
diluted 1:4 in D2O buffer (10 mM HEPES, 150 mM NaCl, pD 7.4) at 25 °C for 1 min. 
The H/DX was quenched by adding sufficient 1 M HCl at 0 °C to give a final pH of 2.5. 
The quenched protein solution was then loaded onto a C8 guard column (1 mm x 15 mm, 
Optimize Technologies, Oregon, City, OR) via an Agilent 1100 HPLC (Santa Clara, CA) 
operated at 50 μM/min flow rate with 0.1  TFA for 3 min. The protein was eluted by 
using a Waters nanoACQUITY UPLC (Manchester, U.K) with the following gradient 
settings: 5% to 50% solvent B in 0.3 min, 50% to 100% solvent B in 5.2 min and 
isocratic flow at 100% solvent B for 0.5 min, then back to 5% solvent B in 0.1 min at 50 
μM/min flow rate. All LC connection lines were immersed in a water-ice (0 °C) bath. 
(solvent A, water containing 0.1% formic acid; solvent B, acetonitrile containing 0.1% 
formic acid). 
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For peptide level H/DX experiments, the ApoE3WT-40 complex was diluted 
1:3 in D2O buffer (10 mM HEPES, 150 mM NaCl, pD 7.4) at 25 °C. At various times (30 
s, 3 min, 5 min, 10 min, 30 min, 1 h), the H/DX was quenched as described above. The 
quenched solution was then injected into an on-line pepsin-digestion device containing 
immobilized pepsin in a 1 mm diameter × 2 cm length guard column (Upchurch 
Scientific, Oak Harbor, WA), which was prepared as described previously (26). The 
quenched solution was injected into the pepsin column in 0.1% formic acid via an 
Agilent 1100 HPLC (Santa Clara, CA) operated at 50 μL/min flow rate for 6 min. The 
digested protein solution was trapped on a C18 guard column (1 mm diameter x 1.5 cm 
length, Optimize Technologies, Oregon City, OR). The peptide mixture was then eluted 
from the trap column and separated with a C18 analytical column (1 mm diameter x 5 cm 
length, Dionex, Bannockburn, IL) via a Waters nanoACQUITY UPLC (Manchester, U.K) 
with a gradient operated at 50 μL/min flow rate. Solvent A was water containing 0.1% 
formic acid, and solvent B was 80% acetonitrile, 20% water containing 0.1% formic acid. 
The gradient settings were: 5% to 15% solvent B in 0.3 min, 15% to 50% solvent B in 5.2 
min, 50% to 100% solvent B in 0.5 min, and isocratic flow at 100% solvent B for 1.5 min, 
then returned to 5% solvent B in 0.1 min. All LC connection lines were immersed in a 
water-ice (0 °C) bath.  
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6.3.5 LC-ESI/MS Analysis with a Q-TOF Mass Spectrometer 
All H/DX results were acquired on a MaXis (Bruker, Bremen, Germany) 
quadrupole time-of-flight (Q-TOF) mass spectrometer. The settings were: capillary 
voltage, 3.8 kV; nebulizer gas, 0.5 bar; drying gas flow rate and temperature, 8.0 L/min 
and 200 °C, respectively; funnel RF, 400 V(pp).  
6.3.6 LC-ESI/MS/MS Analysis with an Orbitrap Mass Spectrometer 
The sequence of each peptic peptide was confirmed by analyzing the digested 
peptides on a Thermo LTQ XL Orbitrap (Thermo Fisher, San Jose, CA). The settings 
were: spray voltage, 3.2 kV; sheath-gas flow rate, 8 (arbitrary units); capillary 
temperature, 275 °C; capillary voltage, 35 V; and tube lens, 110 V. One full mass spectral 
acquisition triggered three scans of MS/MS (CID fragmentation) whereby the most 
abundant precursor ions were activated for sequencing. The peaks observed in the 
product-ion spectra were centroided to provide the mass for each peptide during the 
acquisition. 
6.3.7 Mascot database search 
Thermo RAW files were processed by using extract_msn (2007 version 4.0, 
Thermo Fisher, San Jose, CA) with a grouping tolerance of 0.8 Da, an intermediate scan 
setting of 1, and a minimum of 1 scan per group. MASCOT 2.2.06 (Matrix Science, 
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Oxford, U.K.) was used to analyze the results by searching through the NCBI 
nonredundant database (version 20101004, restricted to human). The MASCOT settings 
were: enzyme, none; MS tolerance, 10 ppm; MS/MS tolerance, 0.8 Da; maximum 
number of missed cleavages, 3; peptide charge of 1+, 2+ and 3+; oxidation of methionine 
was set as variable modification. 
6.3.8 Data analysis 
The uptake of deuterium for each protein or peptide was measured as the average 
mass differences between the masses of the deuterated protein and the undeuterated 
protein, or the average differences between the centroid of all the mass peaks of the 
deuterated peptide and the undeuterated peptide. Back-exchange was measured to be one 
deuterium loss per minute. No correction for back exchange was applied because the time 
between sample quench and the measurement with the mass spectrometer was within 10 
min  and conclusions were drawn based on comparisons of data taken consistently. The 
deconvoluted protein mass spectrum was generated with MagTran 1.03 (Amgen, 
Thousand Oaks, CA). The centroid of the peptide isotopic distribution was analyzed 
using HDExaminer 1.0 (Sierra Analytics, Modesto, CA). All experiments were 
performed in at least triplicate. 
6.4 RESULTS AND DISCUSSION 
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6.4.1 Examination of the ApoE3-40 complex formation by H/DX pulse labeling  
Apolipoprotein E isoforms exist predominantly as tetramers at low μM 
concentrations and dissociate into dimers and monomers at high nM concentrations (27). 
At analytical concentrations higher than M, the protein starts to aggregate (27, 28). It is 
known that the C-terminal domain plays a major role in this self-association (29). An 
important question is whether self association competes with the ApoE- interactions. 
To monitor the formation of ApoE3WT- complex, we first measured global H/DX 
kinetics in which the ApoE3WT was mixed with  in 1 to 5 ratio at 25 °C for 1 h 
followed by allowing H/DX for various times (30 s to 24 h) (Figure 6-1). The outcome, 
however, is no significant differences in deuterium uptake of ApoE3WT in the absence or 
presence of  This suggests that these two proteins do not form a stable complex 
under these conditions.  
 
Figure 6-1. Global H/DX kinetics of ApoE3WT. A comparison between apo-ApoE3WT 
(Aβ40 free, blue) and holo-ApoE3WT (Aβ40 bound, red) shows no differences in H/DX.   
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One explanation of the above is that the kinetics of complex formation are too 
slow to allow detection of a complex under those conditions. If so, a more informative 
way may be to monitor complex formation as a function of the incubation times for these 
two proteins by using a pulsed H/DX labeling strategy. In this experiment, we mixed 
ApoE3WT with  under same conditions as described above and incubated the 
resulting solution for various times (30 s to 52 h). The resulting solution was then 
submitted to pulsed H/DX for 1 min. Pulsing the H/DX allowed it to be a reporter and 
present a “snapshot” of  any slow-forming states of  bound to ApoE3WT (Figure 6-
2).  
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Figure 6-2. Global H/DX pulse labeling of ApoE. (A) A comparison between apo-
ApoE2WT (Aβ40 free, blue) and holo-ApoE2WT (Aβ40 bound, red) shows no 
differences in H/DX. (B) A comparison between apo-ApoE3WT (Aβ40 free, blue) and 
holo-ApoE3WT (Aβ40 bound, red) shows significant differences in H/DX after 24 h of 
incubation.  
Carter and coworkers (13) studied the ApoE- interactions among the ApoE 
isoforms by ELISA, and they concluded that the non-lipidated ApoE isoforms interact 
with  without isoform specificity. To test this interpretation, we incorporated 
ApoE2WT into our study. Surprisingly, there are no differences in deuterium uptake of 
ApoE2WT in the presence or absence of  (Figure 6-2A). ApoE3WT, on the other 
hand, showed a significant decrease in deuterium uptake for the  bound state after 
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24 h incubation (Figure 6-2B). Because our longest incubation time was 52 h, which 
might not be long enough for ApoE2 to form stable complex with , we cannot rule 
out the possibility of their interactions. Our results, however, indicate that ApoE3WT 
interacts more strongly with  than ApoE2WT. 
Interestingly, a significant decrease in deuterium uptake also occurred for apo-
ApoE3WT ( free) after 24 h of incubation as compared to 8 h, and the D uptake 
decreased further at longer times (52 h), finally reaching the same level as that for 
ApoE3WT in the presence of  bound. This suggests that ApoE3WT itself forms a 
more complex structure after long incubation, and its self-interaction interfaces may be 
shared in any ApoE3WT- complex. Moreover, ApoE3WT may have a higher 
tendency to form this complex than does ApoE2WT, as the latter does not show this 
phenomenom. Given that there is a significant difference in deuterium uptake between 
apo-ApoE3WT and holo-ApoE3WT at 24 h incubation, we chose this condition to 
conduct H/DX at the peptide-level to provide a more detailed picture of their interactions.     
6.4.2 Peptide-level H/DX kinetics reveals the regions of ApoE3WT involved in 
ApoE3WT-40 interactions   
The higher resolution achievable with bottom-up H/DX may allow localization of 
some minor changes in the solvent assessibility/H-bonding due to ligand binding. 
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Peptide-level H/DX kinetics, as shown in our previous study of ApoE (19), can not only 
identify those regions that are involved in protein-protein or protein-ligand interactions 
but also reveal the dynamics of the interactions. Therefore, we applied this strategy to the 
ApoE3WT- complex under the conditions determined by the global measurement in 
which a 0.5 μM (analytical concentration) ApoE3WT solution containing 2.5 μM 
was equilibrated at 25 °C for 24 h followed by diluting the protein solution 1:3 in 
D2O buffer for various times (30 s to 1 h). After quenching the exchange, we submitted 
the protein to on-line pepsin digestion and analyzed the peptides by LC/MS. 
 
Figure 6-3. Peptide-level H/DX kinetics of the N-terminal regions of ApoE3WT (1-176).  
A comparison between apo-ApoE3WT (Aβ40 free, blue) and holo-ApoE3WT (Aβ40 
bound, red) was plotted for different peptic peptides as a function of H/DX times.   
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Figure 6-4. Peptide-level H/DX kinetics of the C-terminal regions of ApoE3WT (177-
299). A comparison between apo-ApoE3WT (Aβ40 free, blue) and holo-ApoE3WT 
(Aβ40 bound, red) was plotted for different peptic peptides as a function of H/DX times.   
A sequence coverage of ~89% of ApoE3WT ensures a nearly complete picture of 
the protein. We normalized the value of deuterium uptake of each peptide to the 
theoretical maximum uptake, as described previously (30), and corrected the fraction of 
deuterium present in the exchanging solution to evaluate the relative deuterium uptake of 
each peptide (Figure 6-3 and 6-4). Figure 6-3 shows peptide-level H/DX kinetics of 
peptides located at the N-terminal domain of ApoE3WT (residue 1-176). The kinetics 
plots of apo-ApoE3WT present two categories of deuterium uptake: (1) regions showing 
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low deuterium uptake at early exchange times and increasing uptake at longer times, (2) 
regions showing extensive deuterium uptake at the early exchange time and the uptake 
stays relatively constant at longer times. There are three regions of ApoE3WT 
represented by peptide 37-45, 65-78, and 116-125 that undergo H/DX characteristic of 
the first category. These regions, when mapped onto the ApoE3 NMR structure (2L7B) 
(31),  are all located, not surprisingly, on rigid helices that should show slow dynamics.  
Other regions, having the characteristic of the second category, are all located at or near 
the flexible loop regions. Our results of the N-terminal regions of ApoE3WT agree well 
with its tertiary structure. 
Interestingly, one peptide (residue 52-60) showed a significant decrease (~10%) 
of deuterium uptake upon the  binding. Peptide regions 37-45, on the other hand, 
showed reverse trends of H/DX, implicating an increase in flexibility upon binding. 
These results implicate, for the first time, the interfaces of the N-terminal domain of 
ApoE3WT in the ApoE-complexes
The H/DX kinetics of peptide regions located at the C-terminal domain of 
ApoE3WT, shown in Figure 6-4 (177-299), show there are almost no H/DX differences 
in this region between apo-ApoE3WT and ApoE3WT in the presence of excess A. 
Peptides located in region 230-272, however, showed a slow increase in H/DX with time, 
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indicating a region that exhibits slow protein dynamics. This was observed in our 
previous study of ApoE oligomerization (19) and suggests there may be a slow 
dissociation of the ApoE oligomers as reported by the slow uptake of D in this region. 
Given that wild-type ApoE exists as a mixture of monomers, dimers, and tetramers at 500 
nM (27), and the association constants of ApoE itself and ApoE- are similar (~107 M-1) 
(14, 27), the reversible association and dissociation processes of monomer-dimer-
tetramer may compete with any ApoE3WT-interactions located at the C-terminal 
regions of ApoE, and hinder investigation of the interfaces of A and apoE by H/DX.  
Strittmatter and coworkers (15) studied the ApoE-interactions by native-gel 
chromatography and concluded that region 244-272 of ApoE is crucial for binding with 
The ratio of to ApoEused in their study, however, is 70 times higher than that 
used in our experiments. We could not use this relatively high amount of because it 
will seriously suppress ApoE peptide ions in the H/DX-MS experiment and prevent doing 
H/DX experiments at this level.  
Among all the peptides representing full-length ApoE3WT, only peptide region 
52-60 shows protection upon the binding of and only two amide hydrogens in this 
region are affected by this binding. The global H/DX measurement, however, shows that 
approximately 10 amide hydrogens of ApoE3WT are affected by binding of .  
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Given that the peptide sequence coverage is not complete (i.e., nearly 90%), the other 
differences may be located in these 10% missing regions or lost by back exchange during 
the LC separation. Nevertheless, our results indicate a weak interaction of  with 
ApoE3WT at region 52-60 in the N-terminal domain. 
6.4.3 H/DX mapped on a ApoE3 monomeric mutant structure  
 
Figure 6-5. H/DX mapping on the ApoE3MM (F257A/W264R/L279Q and V287E) 
NMR structure (PDB: 2L7B). Region 52-60, having significant decrease of D uptake in 
the presence of Aβ0 is shown in red. Residue W34 and Y36, having significant decrease 
of labeling in the presence of Aβ42 by FPOP, are shown in red. Regions 37-45, having 
allosteric behaviors in the presence of Aβ40 is shown in yellow. The C-terminal domain 
is shown in blue. 
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The high propensity of ApoE to oligomerize has hindered determination of the 
full-length structures of the three wild-type isoforms. Wang and coworkers (31), however, 
recently elucidated the solution NMR structure of a monomeric mutant of ApoE3 
(F257A/W264R/L279Q and V287E) (PDB: 2L7B). To provide a clearer picture of the 
interfaces between ApoE3WT and  we mapped our H/DX results onto this 
structure (Figure 6-5).   
Interestingly, peptide region 52-60 together with regions 37-45, are proximate to 
each other in the actual protein structure (Figure 6-5). Given that Brian Gau of the Gross 
lab used fast photochemical oxidation of proteins (FPOP) on ApoE3WT-
complexes (32) and observed a significant decrease in oxidative modification on 
the side chains of W34 and Y36 of ApoE3WT when was present. Peptides 
containing these residues were unfortunately not detected in the H/DX experiments.  
These two residues, when mapped onto the ApoE3MM NMR structure (Figure 6-5) 
(helix I), are located on adjoining peptide region 52-60 (helix II). Although 
andhave different tendencies to self-associate, they may share the same 
interfaces in the ApoE-complexes. Our results show that these two helices of 
ApoE3WT are the potential binding sites to . Moreover, once they bound to , the 
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structures of region 37-45 may be allosterically affected and become more solvent 
accessible (Figure 6-5, yellow).   
6.5 CONCLUSIONS 
 Apolipoprotein E seems to play an important role in the clearance from the brain 
of , which is the major risk factor in Alzheimer’s disease. The interaction between 
ApoE and however is complicated by the self-association properties of both of these 
proteins solution. Lipidation of ApoE alters its oligomerization properties, modulating its 
interaction with (13, 33). Lipid-freeApoE, on the other hand, may form a stable 
ApoE-complex in the presence of excess  (15). Wild-type ApoE presents as a 
mixture of monomer, dimer, and tetramer at low uM concentrations, and the self-
association involves C-terminal regions (19), which may be the same regions that interact 
with  Thus, the populations of different oligomers of ApoE and in solution may 
be crucial in determining their interactions.  
Our H/DX results are not only consistent with the structure of the N-terminal 
domain of ApoE3WT but also reveal the regions that are affected in the presence of 
40. All of them are located at the N-terminal domain of ApoE3WT. Our results also 
show that self-association of ApoE3WT occurs at the C-terminal domain and that self-
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association may compete with the interaction of 40 and hinder detection of these 
interactions at the C-terminal domain.  
Future studies should be aimed at increasing the population of the ApoE monomer 
in solution to enhance the interactions of ApoE with H/DX and other MS-based 
footprinting approaches may provide the needed insights that will be difficult to obtain by 
high-resolution methods of NMR or X-ray crystallography and certainly by the low-
resolution methods including CD, absorbance, and fluorescence.  
6.6 ACKNOWLEDGEMENT 
We thank Berevan Baban for technical assistance. This project was supported by 
a grant from the National Center for Research Resources (5P41RR000954-35), now the 
National Institute of General Medical Sciences (8 P41 GM103422-35) of the National 
Institutes of Health to MLG.            
- 238 - 
 
6.7 REFERENCES  
1. Kim, J., Jiang, H., Park, S., Eltorai, A. E. M., Stewart, F. R., Yoon, H., Basak, J. 
M., Finn, M. B., and Holtzman, D. M. (2011) Haploinsufficiency of Human 
APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid-β 
Amyloidosis, The Journal of Neuroscience 31, 18007-18012. 
2. Morrow, J. A., Segall, M. L., Lund-Katz, S., Phillips, M. C., Knapp, M., Rupp, B., 
and Weisgraber, K. H. (2000) Differences in Stability among the Human 
Apolipoprotein E Isoforms Determined by the Amino-Terminal Domain, 
Biochemistry 39, 11657-11666. 
3. Stine, W. B., Dahlgren, K. N., Krafft, G. A., and LaDu, M. J. (2003) In Vitro 
Characterization of Conditions for Amyloid-β Peptide Oligomerization and 
Fibrillogenesis, Journal of Biological Chemistry 278, 11612-11622. 
4. Vivekanandan, S., Brender, J. R., Lee, S. Y., and Ramamoorthy, A. (2011) A 
partially folded structure of amyloid-beta(1–40) in an aqueous environment, 
Biochemical and Biophysical Research Communications 411, 312-316. 
5. Yokoyama, S., Kawai, Y., Tajima, S., and Yamamoto, A. (1985) Behavior of 
human apolipoprotein E in aqueous solutions and at interfaces, J. Biol. Chem. 260, 
16375-16382. 
- 239 - 
 
6. Hatters, D. M., Peters-Libeu, C. A., and Weisgraber, K. H. (2006) Apolipoprotein 
E structure: insights into function, Trends in Biochemical Sciences 31, 445-454. 
7. Weisgraber, K. H., C.B. Anfinsen, J. T. E. F. M. R., and David, S. E. (1994) 
Apolipoprotein E: Structure-Function Relationships, In Advances in Protein 
Chemistry, pp 249-302, Academic Press. 
8. Herz, J., and Beffert, U. (2000) Apolipoprotein E receptors: linking brain 
development and alzheimer's disease, Nat. Rev. Neurosci. 1, 51-58. 
9. Zhang, Y., Chen, J., and Wang, J. (2008) A complete backbone spectral 
assignment of lipid-free human apolipoprotein E (apoE), Biomolecular NMR 
Assignments 2, 207-210. 
10. Raussens, V., Drury, J., Forte, T. M., Choy, N., Goormaghtigh, E., Ruysschaert, 
J.-M., and Narayanaswami, V. (2005) Orientation and mode of lipid-binding 
interaction of human apolipoprotein E C-terminal domain, Biochem. J. 387, 747-
754. 
11. Wetterau, J. R., Aggerbeck, L. P., Rall, S. C., and Weisgraber, K. H. (1988) 
Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural 
domains, J. Biol. Chem. 263, 6240-6248. 
- 240 - 
 
12. Vasudevan, S., Sojitrawala, R., Zhao, W., Cui, C., Xu, C., Fan, D., Newhouse, Y., 
Balestra, R., Jerome, W. G., Weisgraber, K., Li, Q., and Wang, J. (2007) A 
Monomeric, Biologically Active, Full-Length Human Apolipoprotein E, 
Biochemistry 46, 10722-10732. 
13. Stratman, N. C., Castle, C. K., Taylor, B. M., Epps, D. E., Melchior, G. W., and 
Carter, D. B. (2005) Isoform-specific interactions of human apolipoprotein E to 
an intermediate conformation of human Alzheimer amyloid-beta peptide, 
Chemistry and Physics of Lipids 137, 52-61. 
14. Petrlova, J., Hong, H.-S., Bricarello, D. A., Harishchandra, G., Lorigan, G. A., Jin, 
L.-W., and Voss, J. C. (2011) A differential association of Apolipoprotein E 
isoforms with the amyloid-β oligomer in solution, Proteins: Structure, Function, 
and Bioinformatics 79, 402-416. 
15. Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., 
Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., and Roses, A. 
D. (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: 
isoform-specific effects and implications for late-onset Alzheimer disease, 
Proceedings of the National Academy of Sciences 90, 8098-8102. 
- 241 - 
 
16. LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., and 
Frail, D. E. (1994) Isoform-specific binding of apolipoprotein E to beta-amyloid, 
Journal of Biological Chemistry 269, 23403-23406. 
17. Liu, Q., Wu, W.-h., Fang, C.-l., Li, R.-w., Liu, P., Lei, P., Hu, J., Sun, X., Zheng, 
Y.-z., Zhao, Y.-f., and Li, Y.-m. (2011) Mapping ApoE/A binding regions to 
guide inhibitor discovery, Molecular BioSystems 7. 
18. Luo, J., Maréchal, J.-D., Wärmländer, S., Gräslund, A., and Perálvarez-Marín, A. 
(2010) In Silico Analysis of the Apolipoprotein E and the Amyloid β Peptide 
Interaction: Misfolding Induced by Frustration of the Salt Bridge Network, PLoS 
Comput Biol 6, e1000663. 
19. Huang, R. Y. C., Garai, K., Frieden, C., and Gross, M. L. (2011) 
Hydrogen/Deuterium Exchange and Electron-Transfer Dissociation Mass 
Spectrometry Determine the Interface and Dynamics of Apolipoprotein E 
Oligomerization, Biochemistry 50, 9273-9282. 
20. Gau, B., Garai, K., Frieden, C., and Gross, M. L. (2011) Mass Spectrometry-
based Protein Footprinting Characterizes the Structures of Oligomeric 
Apolipoprotein E2, E3, and E4 Biochemistry 50, 8117-8126. 
- 242 - 
 
21. Pan, J., Han, J., Borchers, C. H., and Konermann, L. (2011) Conformer-Specific 
Hydrogen Exchange Analysis of A(1-42) Oligomers by Top-Down Electron 
Capture Dissociation Mass Spectrometry, Anal. Chem. 83, 5386-5393. 
22. Chalmers, M. J., Busby, S. A., Pascal, B. D., West, G. M., and Griffin, P. R. 
(2011) Differential hydrogen/deuterium exchange mass spectrometry analysis of 
protein-ligand interactions, Expert Rev. Proteomics 8, 43-59. 
23. Engen, J. R. (2009) Analysis of Protein Conformation and Dynamics by 
Hydrogen/Deuterium Exchange MS, Anal. Chem. 81, 7870-7875. 
24. Wang, L., Pan, H., and Smith, D. L. (2002) Hydrogen Exchange-Mass 
Spectrometry, Mol. Cell. Proteomics 1, 132-138. 
25. Garai, K., Mustafi, S. M., Baban, B., and Frieden, C. (2010) Structural differences 
between apolipoprotein E3 and E4 as measured by 19F NMR, Protein Science 19, 
66-74. 
26. Busby, S. A., Chalmers, M. J., and Griffin, P. R. (2007) Improving digestion 
efficiency under H/D exchange conditions with activated pepsinogen coupled 
columns, Int. J. Mass Spectrom. 259, 130-139. 
27. Garai, K., and Frieden, C. (2010) The Association Dissociation Behavior of the 
ApoE Proteins: Kinetic and Equilibrium Studies, Biochemistry 49, 9533-9541. 
- 243 - 
 
28. Garai, K., Baban, B., and Frieden, C. (2011) Self-Association and Stability of the 
ApoE Isoforms at Low pH: Implications for ApoE-Lipid Interactions, 
Biochemistry 50, 6356-6364. 
29. Westerlund, J. A., and Weisgraber, K. H. (1993) Discrete carboxyl-terminal 
segments of apolipoprotein E mediate lipoprotein association and protein 
oligomerization, J. Biol. Chem. 268, 15745-15750. 
30. Huang, R. Y. C., Wen, J., Blankenship, R. E., and Gross, M. L. (2011) Hydrogen–
Deuterium Exchange Mass Spectrometry Reveals the Interaction of Fenna–
Matthews–Olson Protein and Chlorosome CsmA Protein, Biochemistry 51, 187-
193. 
31. Chen, J., Li, Q., and Wang, J. (2011) Topology of human apolipoprotein E3 
uniquely regulates its diverse biological functions, Proc. Natl. Acad. Sci. 108, 
14813-14818. 
32. Gau, B. (2011) The Advancement of Mass Spectrometry-based Hydroxyl Radical 
Protein Footprinting: Application of Novel Analysis Methods to Model Proteins 
and Apolipoprotein E, In Chemistry, p 212, Washington University in St. Louis, 
St. Louis. 
- 244 - 
 
33. Garai, K., Baban, B., and Frieden, C. (2011) Dissociation of Apolipoprotein E 
Oligomers to Monomer Is Required for High-Affinity Binding to Phospholipid 
Vesicles, Biochemistry 50, 2550-2558. 
 
  
  
- 245 - 
 
Chapter 7* 
Hydrogen-deuterium exchange mass spectrometry reveals the 
interaction of Fenna-Matthews-Olson protein and chlorosome CsmA 
protein 
 
 
 
 
 
 
 
 
* 
This chapter is based on recent publication: Reproduced with permission from Huang, R. 
Y. C., Wen, J., Blankenship R. E., and Gross, M. L. Hydrogen-deuterium exchange mass 
spectrometry reveals the interaction of Fenna-Matthews-Olson protein and chlorosome 
CsmA protein. Biochemistry, 2012, 51, 187-193. Copyright 2012 American Chemical 
Society (Huang, R. Y. C., and Wen, J. contributed equally to this work.)
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7.1 ABSTRACT 
In green-sulfur bacterial photosynthesis, excitation energy absorbed by a 
peripheral antenna structure known as the chlorosome is sequentially transferred through 
a baseplate protein to the Fenna-Matthews-Olson (FMO) antenna protein and into the 
reaction center, which is embedded in the cytoplasmic membrane. The molecular details 
of the optimized photosystem architecture required for efficient energy transfer are only 
partially understood. We address here the question of how the baseplate interacts with the 
FMO protein by applying hydrogen/deuterium exchange coupled with enzymatic 
digestion and mass spectrometry analysis to reveal the binding interface of the FMO 
antenna protein and the CsmA baseplate protein. Several regions on the FMO protein, 
represented by peptides consisting of 123-129, 140-149, 150-162, 191-208 and 224-232, 
show significant decreases of deuterium uptake after CsmA binding. The results indicate 
that the CsmA protein interacts with the Bchl a #1 side of the FMO protein. A global 
picture including peptide-level details for the architecture of the photosystem from green 
sulfur bacteria can now be drawn. 
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7.2 INTRODUCTION 
Billions of years of evolution allowed photosynthetic species to achieve not only 
an optimized structure for an individual light-harvesting complex but also an appropriate 
architecture for the overall photosystem to facilitate efficient energy transfer and 
regulation (1). Investigations of the structure and function of the antenna components and 
their optimized overall architecture are needed to understand their energy-transfer 
mechanism and to provide a sound basis for the design of artificial and bio-hybrid solar 
devices. Advances in biochemical and biophysical approaches (e.g., X-ray 
crystallography, cryo-EM, and ultrafast spectroscopy) have greatly enhanced our 
understanding of the workings of individual antenna complexes. The exploration of the 
overall architecture of the photosystem, however, lags behind owing to their complex 
architecture and the lack of a more complete suite of approaches than is now available to 
study proteins in complex milieu.  
In photosynthetic green-sulfur bacteria, photons are absorbed by the large 
peripheral chlorosome antenna complex (2), which is located on the cytoplasmic side of 
the membrane. Chlorosomes are attached to the cytoplasmic membrane through a 
pigment-protein complex known as a baseplate (3). The baseplate and the Fenna-
Matthews-Olson (FMO) antenna protein (4) form a bridge to transfer sequentially the 
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energy collected by chlorosomes to the reaction center (RC). The baseplate consists of 
the CsmA protein with Bchl a pigments embedded within. The structure of the refolded 
CsmA protein was determined by NMR, demonstrating that it contains only two small 
alpha helices connected by a small turn (3).  
The chlorosome is one of the largest antenna systems known; it contains hundreds 
of thousands of Bchl c, d or e per chlorosome and is enclosed by a lipid monolayer (5). 
The architecture of chlorosomes has evolved to enable certain organisms to live at 
extraordinary low-light intensities under which no other phototrophic organism can grow 
(6). Unlike other light-harvesting antennas, efficient energy transfer is achieved by self-
assembly of the Bchl c/d/e pigments in the chlorosome to yield stable structures without 
the requirement of a scaffold protein (6). Understanding this arrangement is important 
because it can guide the design of artificial light-harvesting systems. Progress in 
understanding the chlorosome can occur by taking advantage of recent biochemical and 
biophysical approaches (7, 8). 
These recent approaches show that the light energy collected by the Bchl 
aggregates is funneled to the baseplate protein, which is located at the side of chlorosome 
closest to the cytoplasmic membrane (9). The baseplate protein is a 2D paracrystalline 
structure that is believed to consist of CsmA (chlorosome protein A) and Bchl a.  
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Chemical crosslinking revealed that CsmA forms oligomers in chlorosomes (10). The 
NMR structure of apo-CsmA (without bound Bchl a) from Chlorobaculum tepidum (59 
amino acids) shows a large extent of alpha helical content. The N-terminal helix (6-36), 
which has the putative Bchl a binding site, is thought to be immersed in the lipid 
monolayer of the chlorosome, whereas the C-terminal helix (41-49) sticks out of the 
membrane and may interact with the FMO protein at that point. The existence of the 
baseplate is predicted to enhance significantly the energy-transfer rate from the 
chlorosome Bchl aggregates to the RC (2) (Figure 7-1).  
 
Figure 7-1. Structure model of the photosystem (A), the FMO trimer (B) and the CsmA 
from baseplate (C). The synthetic peptide of the C-terminal region of CsmA 
(MRINRNAYGSMGGGSLRGS) used in this study is shown in red.  
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The FMO protein, which is located between the baseplate and the cytoplasmic 
membrane (11), exists as a trimer, with a three-fold symmetry axis perpendicular to the 
membrane. This water-soluble protein has been a model system for studies aimed at 
understanding the structural and functional relationships of pigment-binding 
photosynthetic antenna complexes (12-15). The number of pigments embedded in FMO 
is important for its function, and recently an 8
th
 Bchl a was identified in each monomer 
(16, 17). Several lines of evidence suggest that the side of the protein where this 8
th
 Bchl 
is located faces the baseplate/chlorosome (11, 18, 19).  
The connection between the baseplate, the FMO protein, and the RC is likely to 
be optimized so that excitation energy can be efficiently transferred at high quantum 
yield. Previous results from SPR studies (20) suggest that the C-terminal region of 
CsmA, especially the conserved INRNAY residues, interact with the FMO protein. The 
molecular details of their interactions, however, remain unclear. The interaction region 
between the FMO and the RC is also unknown, although homology modeling with a 
divergent FMO protein has suggested a possible binding site (18). 
In this chapter, we describe the use of hydrogen/deuterium exchange (H/DX) 
coupled with mass spectrometry (MS) (21-24) to study the interaction interface and 
dynamics between FMO and CsmA. With H/DX, we followed the relative rates of 
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exchange of amide hydrogens, which are measured on the basis of m/z, not abundance. 
Experimental outcomes are a measure of changes in the stability of the hydrogen bonding 
and the surrounding relative solvent accessibilities of the amides. To achieve resolution at 
the peptide level of FMO and the complex, we coupled H/DX with enzymatic digestion. 
The FMO/CsmA binding information obtained through H/DX not only provides novel 
insights into the interaction interfaces between the proteins but further confirms the 
orientation of FMO in the photosystem. 
7.3 MATERIALS AND METHODS 
7.3.1 Materials 
The FMO protein from Chlorobaculum tepidum was purified following a 
previously described protocol (17). An ESI spectrum of FMO is shown in Figure 7-2. 
The CsmA C-terminal peptide containing 19 amino acids 
(MRINRNAYGSMGGGSLRGS) was purchased from Biomatik LLC (Wilmington, 
Delaware). 
Potassium chloride, calcium chloride, and HEPES hemisodium salt [N-(2-
hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) hemisodium salt] were purchased 
from Sigma-Aldrich (St.Louis, MO). Deuterium oxide was purchased from Cambridge 
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Isotope Laboratories Inc (Andover, MA). Immobilized pepsin on agarose was purchased 
from Pierce (Rockford, IL). 
 
Figure 7-2. ESI mass spectrum of denatured FMO (A) and the deconvoluted spectrum 
(B). 
7.3.2 H/DX Protocol 
To achieve good signal-to-noise ratios for the protein signal of FMO, the final 
concentration of FMO was optimized to 6 M, and the FMO:CsmA ratio was 1:20 to 
ensure the interaction was saturated.  
For global H/DX measurements, 6 L of protein was mixed with 74 L of D2O 
buffer (92.5% D2O) (10 mM HEPES, pD = 7.0, 150 mM KCl) and held for various times 
at 25 °C before quenching by adding 2 L of 1 M HCl to lower the pH to 2.5. To 
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generate the FMO complex with CsmA a modified condition was employed as that used 
by Miller and coworkers (20); the FMO and the CsmA peptide were incubated 4 h at 
room temperature in the dark (in 20 mM Tris/HCl, pH = 8.0, with 150 mM KCl) and then 
kept at 4 °C overnight before conducting the H/DX. 
For the peptide-level H/DX, the quenched solution was added with 15 L of 
immobilized pepsin on agarose. The digestion was conducted on ice for 3 min. After 
digestion, the beads were quickly centrifuged (2-3 s) to pellet the pepsin beads, and the 
supernatant was analyzed by LC/MS.  
7.3.3 LC-ESI/MS Analysis with a Q-TOF Mass Spectrometer 
The quenched protein solution from global-protein and peptide-level H/DX 
experiments was loaded onto a C18 guard column (1 mm x 15 mm, Optimize 
Technologies, Oregon, City, OR), pre-equilibrated with 100 L of 0.2% formic acid in 
water (0 °C), and washed with 300 L of 0.2% formic acid in water (0 °C) to back-
exchange the labile side-chain functional groups of the protein and the peptides. The 
peptides and any remaining protein were eluted with a fast gradient in 8 min starting from 
0% solvent B to 90% solvent B at 40 uL/min (Waters nanoACQUITY UPLC, 
Manchester, U.K; solvent A, 95% water and 5% acetonitrile containing 0.3% formic acid; 
solvent B, 5% water and 95% acetonitrile containing 0.3% formic acid). To minimize 
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back exchange, all LC connection lines, injection valve, and sample loop were immersed 
in water-ice slush (0 °C). 
All ESI mass spectra were acquired in the positive-ion mode on a Maxis (Bruker, 
Billerica, MS) Q-TOF spectrometer equipped with a standard ESI source. The capillary 
voltage was 3.6 kV, the end-plate offset -500 V, and the dry gas flow rate and 
temperature at 4L/min and 180 °C, respectively. The MS profiles used for transmission 
were as follows: funnel RF, 400 Vpp; multipole RF, 400 Vpp; collision cell voltage, 10 V; 
collision RF, 3000 Vpp; transfer time, 140 us; ion cooler RF, 800 Vpp; pre-pulse storage, 
25 s.  
7.3.4 LC-ESI-MS/MS Analysis of Protein Digest  
Peptides produced by pepsin cleavage of FMO were identified by their accurate 
masses and product-ion sequencing on a LTQ-FTMS instrument (Thermo, San Jose, CA). 
The peptide solution from pepsin digestion of 100 pmol FMO was loaded onto a C18 
column, 75 μm diameter, which was prepared with a laser-based column puller (Sutter 
Instruments, Novato, CA) and packed with 12 cm of Magic C18AQ reverse phase media 
(Michrom Bioresources, Auburn, CA). The peptides were separated over 70 min by using 
an Eksigent (Dublin, CA) NanoLC-1D column with an LC gradient from 3 to 97% 
acetonitrile containing 0.1% formic acid at 260 nL/min. The solution was sprayed into 
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the mass spectrometer by using a PicoView PV-500 nanospray source (New Objective, 
Woburn, MA) attached to the LTQ-FTMS instrument. One full mass spectral acquisition 
in the FT mode, operating at a mass resolving power of 100,000 at m/z 400, triggered six 
scans of MS/MS whereby the most abundant precursor ions were activated for 
sequencing. The MS/MS experiments carried out in the LTQ instrument utilized wide-
band activation and dynamic exclusion. The product-ion spectra (MS/MS) data were 
centroided during the acquisition. 
7.3.5 Mascot Database Search 
Thermo RAW files were processed by using extract_msn (2007 version 4.0, 
Thermo Fisher, San Jose, CA) with a grouping tolerance of 0.8 Da, an intermediate scan 
setting of 1, and a minimum of 1 scan per group. The NCBI non-redundant database 
(version 20090623, restricted to Other Bacteria) was searched by using MASCOT 2.2.06 
(Matrix Science, Oxford, U.K.) with the following settings: enzyme, none; MS tolerance, 
10 ppm; MS/MS tolerance, 0.8 Da; maximum number of missed cleavages, 3; peptide 
charge of 1+, 2+ and 3+; oxidation of methionine was included as a variable modification. 
7.3.6 Data Analysis  
For global-protein H/DX experiments, the mass spectrum at each H/D exchange 
time point was deconvoluted by using MagTran 1.03 (Amgen, Thousand Oaks, CA). The 
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deuterium uptake levels at each time point were taken as the average differences of the 
centroided masses of the undeuterated protein and the deuterated protein. The protein 
deuterium uptake was not corrected for back-exchange because the time from quench to 
observation in the mass spectrometer was less than 6 min, and only relative deuterium 
levels needed to be compared in all experiments. All of the experiments were conducted 
in triplicate. 
For peptide-level H/DX experiments, each mass list from three experimental trials 
was extracted from their individual spectra as an x,y file (x: mass-to-charge ratio; y: 
intensity). The centroid and width of the deuterium-containing isotopic distribution for 
each peptide was analyzed using HX-Express software (25).   
7.3.7 Kinetic Modeling 
The global protein kinetic data were fit with a fixed-rate-constant binning model 
by using MathCAD (Math-Soft. Inc. Cambridge, MA) in which the root mean square 
(RMS) was minimized (26, 27). Four rate constants (k = 10, 1, 0.1, 0.01 min
-1
) were 
selected because the kinetic data span 0.5-60 min, hence the brackets of 10 min
-1
 (fast 
exchangers, half-life ~0.07 min) and 0.01 min
-1
 (slow exchangers, half-life ~69 min). 
Three trials were fit separately, and the results were averaged and reported with standard 
deviations. 
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7.4 RESULTS 
7.4.1 H/DX kinetics of FMO and FMO/CsmA 
 
Figure 7-3. H/DX kinetics for FMO from Chlorobaculum tepidum. Apo-FMO 
(diamonds, dark red) shows more extensive D uptake than does holo FMO (CsmA:FMO, 
20:1) (squares, black). The fitted curves are shown as solid lines. 
Previous SPR studies (20) suggest that the interaction between the FMO protein 
and the chlorosome CsmA protein is primarily on the C-terminal helix of CsmA, 
especially with the conserved INRNAY residues (28). The interaction regions on FMO, 
however, remain unclear. Given that the protein conformation and the relative solvent 
accessibilities of FMO will change upon the binding of CsmA, we chose measurements 
of the H/DX kinetics of FMO alone and as the FMO/CsmA complex to examine globally 
their interaction and dynamics (Figure 7-3). Given the highly hydrophobic nature of 
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CsmA, we utilized for interaction a peptide representing the C-terminal region of CsmA, 
which contains 19 amino acids (MRINRNAYGSMGGGSLRGS) and the highly 
conserved INRNAY motif.  
Each FMO monomer has 348 exchangeable amide protons (excluding 19 
prolines). Because the percentage of D2O in the experiment was 92.5%, the maximum 
number of observable exchange events was 322. After 10 min of H/DX, the mass of 
FMO shifted by 89 ± 1 Da, indicating that ~27% of the amides exchanged at this time 
point. Even after 60 min of H/DX, the extent of exchange had only increased to ~30% 
(96 ± 1 amides) at a time when the exchange had leveled off and became relatively 
constant. The small difference is consistent with a compact and stable FMO trimer in 
solution. Approximately 2/3 of the amides of each monomer are protected because they 
form hydrogen bonds, or exist inside each monomer, or they are involved in forming a 
compact trimer. The remaining 1/3 of the amides are solvent-exposed and highly 
dynamic.  
In the presence of CsmA peptide, the number of amides undergoing H/DX 
decreased to 80 ± 2 after 10 min of exchange, indicating that ~9 amides now exchange 
more slowly as a consequence of CsmA binding. The number of amides affected by the 
CsmA binding is relatively small, consistent with the small size of the CsmA peptide and 
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its limited effect on (i) overall FMO stability, (ii) the extent of hydrogen bonding, and (iii) 
the solvent accessibility of FMO.  
Kinetic 
Fit 
Number of H’s per fixed-rate-constant bin 
k ( min
-1
 ) 10 1 0.1 0.01 
apo 25 ± 3 29 ± 4 39 ± 3 4 ± 1 
holo 29 ± 2 20 ± 2 29 ± 1 15 ± 1 
Table 7-1. Numbers of amide hydrogen undergoing deuterium exchange for apo and holo 
FMO. The kinetic modeling used four fi ed e change rate constants and “binned” the 
number of amides with respect to the rate constants. 
To understand better how CsmA
 
binding affects the exchange rate in a 
quantitative way, we fit the kinetic curve with four exchange rate-constant bins (k = 10, 1, 
0.1, 0.01 min
-1
) (Table 7-1). The results show that apo FMO (native FMO trimer without 
the binding of CsmA) has 25 ± 3 sites that exchange with a rate constant of 10 min
-1
, 
whereas after binding with the CsmA peptide (holo FMO), FMO has 29 ± 2 amides that 
exchange with the same rate constant. Although the number of amides exchanging at this 
rate constant are similar for the apo and holo states, there are significant differences for 
those amides that exchange with smaller exchange rate constants. For those exchanging 
with rate constants of 1 min
-1 
and 0.1 min
-1
, the numbers of exchangeable amides for holo 
FMO are lower than for apo by ~10. Some of these sites exchanged with the smallest rate 
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constant of 0.01 min
-1
 as can be seen for the holo state, for which 15 ± 1 sites exchanged. 
For the apo state, only 4 ± 1 amides exchanged with this smallest rate constant. These 
results indicate that CsmA binding slows down the exchange at some sites of the FMO 
protein with medium exchange rate constants and causes FMO either to form a more rigid 
secondary structure or to lose solvent accessibility at certain amide sites.   
7.4.2 The FMO/CsmA binding interface 
Global H/DX of the FMO/CsmA complex shows clear uptake differences 
compared to apo FMO. To locate the interaction regions, we conducted H/DX at the 
peptide level by using pepsin digestion and LC/MS analysis. We expected that changes of 
the peptide-level deuterium uptake of FMO in the presence of CsmA could locate regions 
implicated in CsmA binding.   
We used the same experimental conditions for H/DX as for the global protein 
measurements. After 10 min of exchange, the H/DX at the protein level had become 
relatively constant; further, there is a significant difference in D uptake between apo and 
holo FMO at this time. We were able to identify FMO peptic peptides, as confirmed by 
accurate mass measurement and tandem-MS sequencing that show sequence coverage of 
80% (Figure 7-4). This high coverage ensures that we can localize regional (peptide-
level) changes associated with CsmA binding. 
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Figure 7-4. Sequence coverage (~80%) of peptic peptides from FMO achieved in a 
peptide-level H/DX study. 
There are approximately 10 amides on the FMO protein that are affected by 
CsmA binding. We found five peptic FMO peptides (123-129, 140-149, 150-162, 191-
208, and 224-232) that show decreased deuterium uptake upon the CsmA binding. The 
level of deuterium uptake difference for each of these five peptides is generally small (~ 
2D), which is consistent with the total difference in H/DX measured on the global level. 
To examine these differences in a comparable way, we converted them to the relative 
deuterium uptake based on equation 1 and plotted them as a function of peptic peptides 
(Figure 7-5). 
(1) 
 
deuterium uptake
(#aa’s - Nterm - #Pro)
%D =
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In the equation, %D  is the relative deuterium uptake for each peptide; #aa’s is the 
total exchangable hydrogens on each peptide; Nterm is the number of hydrogens on the N-
terminus of the peptide.  
 
Figure 7-5. Relative deuterium uptakes for peptic peptides from N- to C-terminus of 
FMO after 10 min of H/DX. Peptide regions showing significant differences in D uptake 
(>5  difference; a value of p < 0.05 was considered significant by Student’s t-test) in the 
presence of CsmA are labeled in red font and marked with red stars. 
The plot (Figure 7-5) shows that three regions of the FMO represented by 
peptides 140-149, 150-162, and 224-232 undergo decreased H/DX in the presence of 
CsmA by at least 10% with respect to the apo state. Two other regions (represented by 
peptides 123-129 and 191-208) show smaller changes, ~5% differences. All the other 
detected peptic peptides show virtually no difference with and without CsmA binding. 
Although we didn’t e amine the e tent of e change on the CsmA, given that the CsmA 
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peptide utilized in this study is short and specific, our results conclude that the C-terminal 
region of CsmA, indeed interacts with FMO. 
7.4.3 FMO structural mapping 
 
Figure 7-6. FMO monomer structure mapping (PDB: 3ENI) with the deuterium uptake 
patterns. Peptide regions of FMO undergoing significant D uptake differences between 
apo and holo states are in red. Peptide 233-239 located in the center of the trimer 
underwent low D uptake (blue), whereas peptide 2-17 located on the outer shell of the 
protein underwent relatively extensive D uptake (black). 
To locate the regions on FMO that are implicated in binding with CsmA, we 
mapped the five peptic peptides onto the X-ray crystal structure of FMO from 
Chlorobaculum tepidum (PDB: 3ENI) (16) (Figure 7-6). Interestingly, all sites that 
exchange differently are located on one side of the FMO protein, which is referred to as 
the Bchl a #1 side of the protein (shown in red) (11). This finding agrees well with results 
from a previous study on the membrane orientation of FMO in green-sulfur bacteria (11); 
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those results also show the Bchl a #1 side of the FMO interacts with the chlorosome. This 
study of the peptide-level H/DX further confirms and refines the spatial resolution to a 
region extending over five peptides of FMO. 
  On the basis of the relative peptide-level deuterium uptakes, we can identify 
three categories of deuterium uptake for FMO: (1) regions showing large extents of 
deuterium uptake (>30%) and significant differences when CsmA binds; (2) regions 
showing small extents of deuterium uptake (<10%) and no significant differences in the 
presence and absence of CsmA; and (3) regions showing large extents of deuterium 
uptake (>30%) but no significant differences in the absence or presence of CsmA. These 
results, when mapped onto the structure of FMO (Figure 7-7), show that category #3 
regions include, for example, peptide 2-17 (shown in black in Figure 7-6 and Figure 7-7), 
which is located at or near flexible helices or loops mainly on the outer surface of FMO. 
Those category #2 regions (e.g., peptide 233-239) are located at or near the interface of 
the FMO trimer (shown in blue in Figure 7-6 and Figure 7-7). 
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Figure 7-7. Map of H/DX on the FMO trimer structure (PDB: 3ENI). Peptide regions 
showing relatively extensive H/DX (>30%) and significant differences on D uptake when 
CsmA was bound are in red. Peptide regions showing relatively low D uptake (<10%) are 
in blue. Peptide regions undergoing relatively extensive H/DX (>30%) are in black. 
 
Figure 7-8. Orientation of the FMO trimer structure (PDB: 3ENI). Peptide regions 
undergoing significantly different D uptake in the presence of CsmA are in red. (A) Top 
view of the FMO trimer. (B) Side view of FMO trimer. (C) Bottom view of FMO trimer.  
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7.5  DISCUSSION 
One important link in the green-sulfur bacterial photosystem is a light-harvesting 
chlorosome that absorbs light and transports the energy through a baseplate protein and 
the FMO protein to the reaction center where energy conversion takes place. A gap 
existed in our understanding of the interaction between the baseplate and FMO and 
motivated this study. 
 CsmA, a major component in the baseplate, contains the putative Bchl a binding 
site in its N-terminal region and may be immersed in the lipid monolayer of the 
chlorosome, whereas a region near its C-terminal helix protrudes from the membrane and 
may interact with the FMO protein. A previous SPR study (20) shows that the conserved 
residues (INRNAY) of the C-terminal region of CsmA interact with the FMO protein.  
To investigate this interaction, we chose H/DX because it is a general approach, 
“marking” all the amino acids e cept proline and covering nearly the entire protein 
backbone. H/DX is sensitive to the solution environment surrounding the protein, 
enabling one to capture even minor changes in protein conformation and solvent 
accessibility caused by the changes in hydrogen bonding occurring when peptides bind to 
proteins. In this study, we used a model synthetic peptide of 19 amino acids 
(MRINRNAYGSMGGGSLRGS) from the C-terminal region of CsmA to probe the 
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FMO/CsmA interaction. The peptide, which contains the conserved INRNAY region, 
forms a small alpha helix, as does CsmA itself, and interacts with the FMO protein (3). 
Global-level H/DX shows that only ~10 amides of FMO are affected by the CsmA 
binding. Although the stoichiometry and the binding affinity between FMO and CsmA 
are unknown, this small extent of exchange in a large protein makes a determination of 
the binding affinity by PLIMSTEX (Protein Ligand Interaction by Mass Spectrometry, 
Titration and H/D Exchange) difficult at the protein level (26, 27). Nevertheless, their 
interaction should be strong in vivo possibly because CsmA forms oligomers in the 
baseplate (10), and the oligomeric CsmA interacts more strongly with FMO than does the 
monomer. In addition, the tail of the 8
th
 Bchl a in the FMO protein may play a role in 
vivo by interacting with the carotenoid/Bchl a in the CsmA or with hydrophobic regions 
of CsmA (17). The involvement of oligomeric states further complicates determining a 
relevant affinity by PLIMSTEX or other methods. 
Peptide-level H/DX affords further refinement of the binding interfaces between 
FMO and CsmA. Five regions of FMO, represented by peptides 123-129, 140-149, 150-
162, 191-208, and 224-232, show clear decreases of relative deuterium uptake in the 
presence of CsmA. Interestingly, these regions are all located on the Bchl a #1 side of the 
FMO, and the outcome agrees well with the previous finding that the baseplate interacts 
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with the Bchl a #1 side of the FMO (11, 18). Moreover, our results also localize the C-
terminal region of CsmA that plays an important role in FMO/CsmA interaction. 
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